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ABSTRACT 
Rising rates of pediatric emergency department (ED) visits for psychiatric reasons 
pose a significant burden for healthcare systems in the United States. Utilization of 
outpatient mental health treatment by youth and their families may prevent some 
behavioral health crises requiring emergency services, as well as non-urgent ED visits 
where emergency care is not necessary. This study utilized de-identified electronic health 
records to examine seasonal and secular patterns in both psychiatric ED presentation and 
outpatient mental health care utilization among youth, as well as the association of 
outpatient mental health care with psychiatric ED visits. Racial/ethnic differences in 
service utilization were also examined. The study sample consisted of 25,545 school-
aged youth who were diagnosed with an emotional or behavioral disorder and received 
services at Boston Medical Center (BMC) between 2009 and 2018. Results indicate 
significant seasonal patterns in both psychiatric ED visits and outpatient mental 
healthcare that parallel the school calendar, with more youth receiving services during the 
school year than in the summer. Mental healthcare among youth of color was more 
  vii 
closely aligned with the school calendar than among White youth, suggesting that schools 
may be more instrumental for the referral of youth of color into mental healthcare than 
for White youth. In addition, youth who accessed outpatient care were at decreased risk 
for psychiatric ED presentation as compared to youth who had not accessed outpatient 
services. Longer duration of outpatient treatment and a greater number of visits were 
associated with increased risk for ED presentation, whereas greater frequency of visits 
was associated with decreased risk for ED presentation. Findings suggest that preventive 
outreach for youth and families may be particularly helpful in late summer and early 
winter, prior to significant increases in both psychiatric ED visits and outpatient service 
use. 
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CHAPTER 1: INTRODUCTION 
 
 Recent research suggests that almost half of all school-aged youth experience 
some type of psychiatric disorder by the time they reach adulthood (Merikangas, et al., 
2010) and that these youth are at increased risk for a wide range of negative short- and 
long-term outcomes, including suicide, physical health problems, academic difficulties, 
impairments in social functioning with family and peers, and involvement with the justice 
system (Aarons et al., 2008; Fleischmann et al., 2005; Rapee et al., 2012; Skowyra & 
Cocozza, 2007). Research has identified effective treatments for psychiatric disorders in 
children and adolescents, that can support healthy development and improve outcomes 
(Fabiano et al., 2009; Weisz et al., 2004, 2005, 2006).   
Unfortunately, only about two-thirds of youth with psychiatric disorders ever 
receive mental health services (Costello et al., 2014; Merikangas et al., 2011). Among 
youth who access services, inconsistent or incomplete treatment is a significant barrier to 
symptom improvement and recovery (Gearing et al., 2014; Schwalbe & Gearing, 2012). 
Continuity of outpatient mental health care, which refers to regular appointments with 
consistent providers across time, is associated with treatment adherence, decreased use of 
emergency services and hospitalization, lower costs, and improved health outcomes 
(Adair et al., 2005; Brekke et al., 1999; Tait et al., 2004). In the absence of adequate 
outpatient treatment, youth may experience symptom recurrence and be more likely to 
experience behavioral health crises (Ali et al., 2012; Frosch, 2011).  
 One potential consequence of interrupted or incomplete treatment is that youth 
with psychiatric disorders may be more likely to utilize emergency department (ED) 
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services (Pittsenbarger & Mannix, 2014; Soto et al., 2009). The ED often becomes the 
“default” service provider when patients are not receiving needed outpatient psychiatric 
services and therefore lack regular behavioral healthcare providers when they enter a 
crisis (Larkin et al., 2005; Weber et al., 2005). Recent studies indicate that psychiatric ED 
visits by children and adolescents in the United States are on the rise, and that these 
increases pose a significant resource burden for hospitals (Mahajan et al., 2009; 
Pittsenbarger & Mannix, 2014). Given its potential for crowds, noise, disturbing sights, 
and lack of privacy, the ED tends to be an inadequate setting for non-suicidal or non-
psychotic mental health assessment and treatment (Cooper & Masi, 2007; Dolan & Fein, 
2011). Further, psychiatric ED services are more costly and less intensive than outpatient 
mental healthcare (Cloutier et al., 2010; Cooper & Masi, 2007; Dolan & Fein, 2011). 
Understanding patterns in both psychiatric ED and outpatient service use, as well as the 
association between these two types of mental healthcare, may provide insight into 
improving mental health service provision for some of the most vulnerable patients and 
reducing psychiatric ED presentation.   
One pattern in psychiatric ED use that may suggest important predictors of mental 
health need and service utilization is seasonal. A number of studies have examined 
seasonal patterns in psychiatric emergency service use among school-aged youth (Ali et 
al., 2012; Goldstein et al., 2005; Holder, Rogers, Peterson, & Ochonma, 2017; Peterson 
et al., 1996). These studies indicate that youth ED visits for psychiatric reasons are more 
frequent in the fall than the summer, leading researchers and clinicians to hypothesize 
that youth experience greater mental health challenges when school is in session, and in 
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particular upon initiation of the school year in September (Ali et al., 2012; Goldstein et 
al., 2005; Holder, Rogers, Peterson, & Ochonma, 2017; Peterson et al., 1996). Yet, 
another hypothesis is that potential disruptions in continuity of outpatient mental health 
care during the summer months may be associated with increases in the use of emergency 
services in the fall. However, few studies have examined continuity in outpatient mental 
health treatment or addressed the possibility of seasonal patterns in treatment continuity. 
Understanding seasonal variations in continuity of outpatient mental health care may 
suggest mechanisms underlying interruptions in treatment, inform efforts to reduce 
barriers to care, and increase the likelihood that youth will regularly receive needed care, 
thereby reducing the need for utilization of psychiatric emergency care.   
One important demographic variable that has been shown to be associated with 
youth access to and use of mental health services is race/ethnicity. A rich body of 
research demonstrates that racial and ethnic minority youth with psychiatric diagnoses 
are less likely to access outpatient mental health services (Costello et al., 2014; 
Merikangas et al., 2011), receive fewer treatment sessions when they do access care 
(Alexandre et al., 2010; Cummings & Druss, 2011), and are more likely to use the ED for 
mental health services than their White peers  even after controlling for socioeconomic 
status (e.g., income, poverty index; Bruckner et al., 2014; Snowden et al., 2008, 2009). 
Scholars have suggested some possible reasons for these disparities, including language 
barriers, mental illness stigma, and distrust of mental healthcare (Alegría & Green, 2015). 
Nevertheless, existing studies on seasonal patterns in psychiatric ED use have not 
examined differences in seasonal patterns based on race/ethnicity, either because they 
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were conducted in U.S. or Canadian samples that were primarily White, did not include 
racial/ethnic data (Ali et al., 2012; Goldstein et al., 2005; Holder, Rogers, Peterson, 
Shoenleben, et al., 2017), or because they did not apply statistical methods that accounted 
for racial/ethnic differences (Peterson et al., 1996). An examination of racial/ethnic 
variations in seasonal patterns in psychiatric ED visits and outpatient mental health care 
may help provide a more nuanced understanding of disparities in treatment access and 
utilization.   
In this dissertation, I investigated trends and patterns in continuity of outpatient 
treatment and ED use, in addition to examining whether continuity of outpatient mental 
health care is associated with the use of psychiatric ED services. First, I replicated 
previous research on seasonal patterns and long-term, or secular, trends in youth 
psychiatric ED use and extended this research by examining differences based on 
race/ethnicity. Then, I examined seasonal patterns and secular trends in outpatient 
specialty mental health service use. Finally, I determined whether consistency of 
outpatient mental health service treatment is associated with psychiatric ED visits. As 
outlined in this paragraph, this dissertation addressed three specific research questions:  
1. How do patterns in youth psychiatric ED visits vary throughout the calendar 
year and over time?  
2. How does continuity of youth outpatient mental health care vary throughout 
the calendar year and over time? 
3. Is continuity of youth outpatient mental health care significantly associated 
with psychiatric ED presentation? 
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For each research question, I examined differences by race/ethnicity.  
This study will utilize electronic health records (EHRs) from 2009-2018 at an 
urban healthcare system. This healthcare system includes the largest safety-net hospital in 
the region, and serves a multicultural population of over 140,000 youth and adults. The 
sample for the current study will include patients ages 5-18 who received any behavioral 
health services between September 1, 2009 and May 3, 2018. I hypothesize that 
psychiatric ED visits and continuity of outpatient mental healthcare will decrease during 
the summer months, and that there will be significant differences in these patterns related 
to race/ethnicity (Research Questions 1 and 2). In particular, I expect that racial/ethnic 
minority youth will experience greater use of psychiatric ED services and more 
discontinuity in outpatient specialty mental healthcare, and that these patterns will be 
robust over time. In addition, I hypothesize that more continuous outpatient specialty 
mental health care will be associated with decreased risk for psychiatric ED presentation 
(Research Question 3). 
Results from this study will provide information that can guide practice and 
policy, with the goal of maximizing continuity of outpatient specialty mental healthcare 
for youth with psychiatric disorders and their families and reducing psychiatric ED use. 
For example, findings may indicate times during the year when outpatient service use is 
particularly low, suggesting times when outreach may be helpful to promote continuity of 
care. As another example, understanding disparities in outpatient continuity of care could 
identify sub-populations that may face substantial barriers to accessing consistent care. 
This information has the potential to inform outreach and resource allocation for schools, 
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communities, and behavioral health providers who need to use limited resources as 
efficiently as possible. Ultimately, the results of this study may support both individual 
clinicians and healthcare systems in maximizing continuity of youth mental healthcare 
and add to knowledge that can lead to the minimization of long-term difficulties for 
children and adolescents who receive those services.  
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CHAPTER 2: LITERATURE REVIEW 
 
Almost half of school-aged youth in the United States experience an emotional or 
behavioral disorder by the time they reach adulthood (Merikangas et al., 2010). Many of 
these youth do not receive needed mental health services (Costello et al., 2014; 
Merikangas et al., 2011). Among youth who do receive outpatient mental health 
treatment, there are high rates of incomplete treatment and dropout, which are significant 
barriers to symptom improvement and recovery (Gearing et al., 2014; Schwalbe & 
Gearing, 2012). In addition, increasing numbers of youth are presenting in the emergency 
department (ED) for psychiatric issues, which provides more costly and less adequate 
mental health services (Dolan & Fein, 2011; Kalb et al., 2019). These issues indicate a 
critical need for further research examining patterns in the provision and utilization of 
youth mental health services. In this dissertation, I replicated and extended previous 
research on psychiatric ED use, conducted parallel analyses on outpatient specialty 
mental health service utilization, and examined the association between these two types 
of mental healthcare. To do this, I drew from two theoretical frameworks: (1) Tansella 
and Thornicroft’s (1998) Matrix Model, and (2) Phase II of Pescosolido’s Network 
Episode Model (NEM-Phase II; 2006).  
Theoretical Framework 
 The Matrix Model (Figure 1) was developed with the purpose of describing and 
interpreting organizational data on mental health service provision (Tansella & 
Thornicroft, 1998).  
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Figure 1  
The Matrix Model1 
 
The matrix model consists of two dimensions, geographical and temporal. The 
geographical dimension includes aspects of healthcare that are measured at the 
country/regional level, which distinguishes an area of shared laws and government, the 
local level, defined as the catchment area for a specific healthcare system, and the patient 
level, or the domain in which individual or small-group treatment is provided by 
clinicians. The temporal dimension describes three distinct phases of mental healthcare 
(input, process, and outcome). Inputs describe resources that are invested in the mental 
healthcare system, and can be visible and invisible. Visible inputs include staff, facilities, 
and supplies, while invisible inputs include staff training and the working relationships 
                                                                        
1 From “A conceptual framework for mental health services: the matrix Model,” by M. Tansella and 
G. Thornicroft, 1998, Psychological Medicine, 28(3), p.503-508 (DOI: 10.1017/s0033291796005880). 
Copyright 1998 by Cambridge University Press. Reprinted with permission. 
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between different mental health providers (psychiatrists, social workers, primary care 
physicians, etc.). The process phase consists of the activities involved in the delivery of 
mental health services, such as the content and timing of treatment and the operational 
and administrative policies that determine how treatment is provided. Outcomes are 
defined as changes attributable at least in part to the mental healthcare system, although 
they are subject to many influences (financial, cultural, political, etc.). 
Tansella and Thornicroft (1998) highlight a trend in mental health research that 
places the most value on data from randomized controlled trials (RCTs), which are 
designed to establish the clinical efficacy of specific interventions at the patient level. 
They argue that this narrow focus on RCTs often results in a scarcity of high-quality 
research at the local and regional levels, and that such research is critical to assessing the 
clinical effectiveness of treatment in a less rigorous environment (i.e. routine clinical 
care). However, it becomes more difficult to measure the processes of mental healthcare 
at the local and regional levels, as the content of mental health treatment provided in 
routine clinical care contexts is essentially a “black box” (Garland et al., 2010; Tansella 
& Thornicroft, 1998). The Matrix Model suggests that placing research questions and 
research findings at their correct geographical and temporal levels can improve 
understanding of the complex factors that influence mental health service provision 
(Tansella & Thornicroft, 1998). I employed the Matrix Model as a lens to inform my 
understanding of existing literature on mental health service provision, develop research 
questions that would complement this existing scholarship, and interpret findings 
accordingly.  
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 To better understand the patterns found by analyzing EHR data, I will also draw 
from the Network Episode Model, Phase II (NEM-II; Figure 2), which offers a time- and 
network- centered approach to understanding illness and treatment (Pescosolido, 1991, 
2006; Pescosolido & Boyer, 1999). Although it can be used to describe other types of 
illness, the framework was developed to illustrate the range of factors that impact how 
individuals recognize and respond to mental illness across time. 
This model provided an alternative to frameworks which focused primarily on the 
initial decision to seek and enter care (Pescosolido, 2006; Pescosolido & Boyer, 1999). 
Instead, the NEM-II highlighted the illness career, defined as the “timing and sequencing 
of key role exits and entrances across an entire episode” (Pescosolido, 2006, p.196). For 
example, key events in an illness career include the point at which a patient 
conceptualizes him or herself as mentally ill, as well as the point at which they believe 
they are no longer mentally ill (“the Sick Role”). Other key events include entry and exit 
points from treatment (“the Patient Role”) and significant changes in how an individual 
views their illness (e.g., “the Disabled Role”). An important aspect of the illness career is 
the timing and sequencing of key events, including delays in accessing/receiving mental 
healthcare, the time between treatment sessions, and the duration of treatment 
compliance/adherence. The NEM-II illustrates how the timing and sequencing of key 
events is influenced by an individual’s social context, their social support system, and 
their interaction with the treatment system, if they have any.  
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Figure 2 
Network-Episode Model, Phase II2 
 
 
 As shown in the model, social context describes the demographic characteristics 
of an individual (e.g., gender, race/ethnicity, income) as well as their health background 
(e.g., history of mental illness, insurance status), current clinical characteristics (e.g., 
severity of current episode, impairment in daily functioning), and organizational barriers 
to mental healthcare (e.g., accessibility of services). An individual’s social context not 
                                                                        
2 From “How do people come to use mental health services? Current knowledge and changing 
perspectives,” by B. Pescosolido and C. Boyer, 1999. In A.V. Horwitz & T. L. Scheid (Eds.), A 
handbook for the study of mental health: Social contexts, theories, and systems (p. 392–411). 
Copyright 1999 by Cambridge University Press. Reprinted with permission. 
 12 
only influences the illness career, but may also impact their social support system and 
their interaction with the treatment system (or lack thereof). Social support systems are 
characterized by the structure of an individual’s social network (e.g., the physical and 
emotional closeness of supporters, the number of supporters, reciprocity between an 
individual and his or her supporters), the culture of the network (e.g., stigma related to 
mental illness and/or mental healthcare), and functions of the support network (e.g.,., 
advice, material support, emotional support). The social support system and the illness 
career impact and interact with one another across time. Sometimes the support system 
may influence the illness career (e.g., a family member may help convince an individual 
to seek treatment); at other times, the illness career may impact the social support system 
(e.g., a friend may pull away from an individual because of their refusal to engage in 
care).    
 The treatment system is similar to the social support system in its organization. 
Key aspects include the network structure (e.g., number of providers, communication 
between providers), the content of the network (e.g., attitudes towards patients, treatment 
options, material resources), and the network functions (e.g., information, therapeutic 
tools/strategies, medication). Although it is not included in this model, for youth, the 
treatment system also encompass services provided at school, making communication 
between providers more difficult. Like the social support system, the treatment system 
and the illness career impact and interact with one another across time. Sometimes the 
treatment system may influence the illness career (e.g., effective treatment may decrease 
the duration of the illness); at other times, the illness career may impact the treatment 
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system (e.g., a behavioral health crisis may necessitate new providers being added to the 
treatment team).  
In the illustration, the social support system and the treatment system do not 
directly impact one another; however, for children and adolescents, these two systems 
may actually be in close contact. The parents and/or caregivers, who represent important 
members of youth support systems, may be a primary point of contact for treatment 
systems, particularly for younger children. Parents/caregivers are often the decision-
makers in regards to treatment and exercise a significant degree of control over when and 
how their children access treatment. As children progress through adolescence, the 
distance between the social support system and the treatment system may increase. From 
a developmental perspective, youth treatment patterns may also be influenced by social 
support systems in ways not accounted for by this model. Taking these developmental 
considerations into account, I employed the NEM-II as a framework to inform my 
understanding of the complex factors that influence mental health service utilization at 
the individual level and interpret findings of analyses conducted at the local and 
individual levels accordingly. 
 The NEM-II provides insight into the wide range of treatment patterns that exist 
for individuals with mental illness, while the Matrix Model (Tansella & Thornicroft, 
1998) provides a framework for interpreting treatment patterns on individual, local, and 
regional levels. In particular, the NEM-II suggests important variables that may predict 
differences in treatment patterns, such as race/ethnicity. The Matrix Model suggests the 
importance of examining these socio-demographic differences in treatment patterns not 
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only at the individual level, but also at the local and regional levels. Throughout this 
section, and again in the discussion section, I will highlight how these two frameworks 
informed my understanding of patterns in psychiatric ED use and outpatient mental 
health treatment among school-aged youth, and how these two types of services are 
associated with one another.   
Youth Psychiatric Emergency Services Utilization 
Recent studies demonstrate that pediatric visits to the ED have been increasing 
significantly over the past two decades (Kalb et al., 2019; Mahajan et al., 2009; 
Pittsenbarger & Mannix, 2014). Scholars suggest that this may be a result of a number of 
complex factors, including an increase in prevalence of youth mental illness, increased 
severity of mental illness, increased diagnosis of mental illness, decreased availability of 
inpatient care, and patient difficulty in accessing outpatient care (Holder, Rogers, 
Peterson, & Ochonma, 2017; Holder, Rogers, Peterson, Shoenleben, et al., 2017; 
Pittsenbarger & Mannix, 2014). This is concerning because psychiatric ED visits require 
a disproportionate share of hospital resources, including equipment, staff, and space, as 
compared with non-psychiatric visits; the increasing use of EDs for non-urgent 
psychiatric issues thereby poses a significant burden for hospitals in the United States 
(Edelsohn, 2004; Mahajan et al., 2009; Pittsenbarger & Mannix, 2014).  
Scholars have suggested that increasing youth access to outpatient specialty 
mental healthcare has the potential to reduce rates of psychiatric ED visits (Holder, 
Rogers, Peterson, & Ochonma, 2017; Pittsenbarger & Mannix, 2014; Soto et al., 2009). 
Youth receiving needed outpatient care may be less likely to experience behavioral health 
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crises and more likely to utilize outpatient care for non-urgent psychiatric issues (Ali et 
al., 2012; Frosch, 2011; Soto et al., 2009). This is important given that a significant 
contributor to rising rates of psychiatric ED use among youth is an increase in visits for 
non-urgent psychiatric issues, some of which could have been managed with outpatient 
services, even if they were delayed (Edelsohn et al., 2003; Frosch, 2011; Soto et al., 
2009). Specifically, these studies have found that between 33% and 40% of youth 
psychiatric ED visits are inappropriate, in that they did not involve suicidality or 
psychosis, and involved a low risk for harm or a low severity of complaint (Edelsohn et 
al., 2003; Soto et al., 2009). This has led researchers to hypothesize that the ED acts as a 
“default” service provider when patients who are not receiving needed outpatient services 
do not have access to regular behavioral health care providers if they experience a crisis 
(Larkin et al., 2005; Weber et al., 2005). Furthermore, hospital EDs are one of the only 
locations in which youth with psychiatric symptoms will not be turned away because they 
have limited or no insurance (Dolan & Fein, 2011). 
The primary goal of treatment provided in the ED is stabilization; as a result, 
services are more costly, less intensive, and less focused on rehabilitation than outpatient 
care (Cloutier et al., 2010; Cooper & Masi, 2007; Dolan & Fein, 2011). Medical 
professionals agree that the ED is generally an inadequate setting for non-suicidal, non-
psychotic mental health assessment and treatment (Cooper & Masi, 2007; Dolan & Fein, 
2011). Dolan and Fein (2011) note that the ED is often crowded, noisy, and may involve 
exposure to potentially disturbing sights and sounds; in addition, there may be no quiet or 
private area in which assessment and consultations can take place. One study indicated 
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that pediatric patients in the ED presenting with mental health complaints waited up to 10 
hours for care, almost twice as long as other patients (Christodulu et al., 2002) .  
Less than one-quarter of hospital EDs have mental health specialists available to 
consult with patients (Middleton & Burt, 2006) and over three-quarters of residency 
programs in emergency medicine do not provide formal training in responding to mental 
health emergencies (Santucci et al., 2003). This may contribute to findings that 
approximately 25% of youth presenting in the ED with emotional problems and 30% of 
youth who had attempted suicide were discharged without receiving a mental health 
evaluation by a mental health professional (Baraff et al., 2006; Melese-d’Hospital et al., 
2002; Substance Abuse and Mental Health Services Administration, 2002). Furthermore, 
there is evidence to suggest that when emergency room staff do provide care, they may 
be unprepared or unlikely to implement evidence-based treatment (Grossman et al., 
2003). Although treatment providers in the ED may suggest follow-up and provide 
referrals to outpatient specialty mental health, research examining repeat visits to the ED 
for psychiatric reasons among youth indicates that patients often do not engage in 
adequate follow-up care (Mahajan et al., 2007).  
Overall, research suggests that non-suicidal, non-psychotic youth with mental 
health needs who present in the ED are likely to spend long periods of time waiting for 
suboptimal and inadequate mental health services (cites). Improving utilization of 
outpatient specialty mental healthcare therefore has the potential to improve treatment for 
youth with psychiatric disorders, while at the same time alleviating the significant 
financial burden that psychiatric ED visits place on the healthcare system. This is an 
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example of how different interactions with the treatment system (e.g., engagement in 
outpatient care) can influence illness trajectories, as described in the NEM-II 
(Pescosolido, 2006).  In developing strategies to reduce youth psychiatric ED visits and 
increase outpatient service utilization, examining seasonal patterns in mental healthcare 
may suggest times of year during which prevention and intervention can have the biggest 
impact.  
Seasonal Patterns in Youth Psychiatric ED Presentation 
Previous research has demonstrated that there are seasonal patterns in youth 
psychiatric ED visits. Studies indicate that pediatric mental health visits to the ED are 
less frequent during the summer months and subsequently increase in the fall (Ali et al., 
2012; Goldstein et al., 2005; Holder, Rogers, Peterson, & Ochonma, 2017; Peterson et 
al., 1996). One study showed that, although ED visits for anxiety disorders, mood 
disorders and adjustment disorders are lowest in June, they rise steadily throughout the 
summer and peak in September (Holder, Rogers, Peterson, & Ochonma, 2017). This 
aligns with the NEM-II (Pescosolido, 2006), in that school and seasonal factors are part 
of both the social context and social support system of youth, and will therefore impact 
interactions with the treatment system and illness careers. To explain these patterns, 
researchers have hypothesized that youth experience greater mental health challenges 
when school is in session (Ali et al., 2012; Goldstein et al., 2005; Holder, Rogers, 
Peterson, & Ochonma, 2017). I additionally hypothesize that disruptions in outpatient 
care during the summer may contribute to rising levels of distress over the course of the 
summer and the resulting increase in psychiatric emergency services utilization. Based on 
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well-established racial/ethnic disparities in mental health service provision and access 
(detailed in the next paragraph), I also hypothesize that seasonal patterns in ED visits 
may vary for youth from different racial/ethnic backgrounds.  
Racial and Ethnic Disparities in Mental Health Service Access 
Research has consistently indicated differences in youth mental health service 
provision and utilization based on race/ethnicity. Regardless of season, studies have 
shown that youth of color are significantly more likely to utilize psychiatric emergency 
services (Bruckner et al., 2014; Snowden et al., 2008) and significantly less likely to 
receive any outpatient mental health services than their non-Latino White peers, even 
after accounting for socioeconomic status (Cook et al., 2013; Cummings & Druss, 2011; 
Guo et al., 2014). Comparatively greater use of psychiatric ED services among racial and 
ethnic minority youth may be the result of unmet need for outpatient treatment. Indeed, 
even when racial and ethnic minority youth do access outpatient services, they receive 
significantly fewer sessions than their non-Latino White counterparts (Alexandre et al., 
2010; Cummings & Druss, 2011). Studies also suggest that youth of color are more likely 
to receive inconsistent care or drop out of treatment than White youth (Kazdin & 
Mazurick, 1994; Pellerin et al., 2010). Snowden and colleagues suggest that improving 
regular outpatient care among minority youth would address mental health needs over the 
long-term and potentially reduce disparities in the use of emergency services (Snowden et 
al., 2008). This is consistent with the hypothesis that increasing youth access to outpatient 
specialty mental healthcare has the potential to reduce rates of psychiatric ED visits in 
general (Holder, Rogers, Peterson, & Ochonma, 2017; Pittsenbarger & Mannix, 2014; 
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Soto et al., 2009).  
Youth Outpatient Specialty Mental Healthcare 
 Recent studies demonstrate that the utilization of outpatient mental healthcare 
among youth has been increasing over the past two decades (Gandhi et al., 2016; Olfson 
et al., 2014, 2015). There are increases in the number of youth in the United States 
participating in both psychotherapy and also the number receiving medication 
management (Olfson et al., 2014, 2015). While it is clear that more youth than ever 
before are accessing outpatient services, youth psychiatric ED presentation is increasing 
at much higher rates than outpatient service use (Gandhi et al., 2016). Research also 
suggests that approximately half of youth who receive outpatient mental health services 
attend only a few sessions and drop out of treatment prior to completing the 
recommended number of sessions (Andrade et al., 2000; Baruch et al., 2009; Harpaz-
Rotem et al., 2004), and that this poses a significant barrier to symptom reduction and 
recovery (Gearing et al., 2014; Schwalbe & Gearing, 2012). The extent to which youth 
receive ongoing treatment is one aspect of continuity of care, a construct that offers 
insight into how outpatient mental healthcare may impact individual illness trajectories.  
Continuity of Mental Healthcare  
Leona Bachrach (1981) was one of the first researchers to describe continuity of 
care in relation to mental health, writing that it is “a process involving the orderly, 
uninterrupted movement of patients among the diverse elements of the service delivery 
system” (Bachrach, 1981, p. 1449). Bachrach highlighted continuity of care as a distinct 
aspect of service delivery, separate from the content of treatment (e.g., cognitive 
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behavioral therapy, psychoanalysis). In the almost 40 years since Bachrach first described 
continuity of mental healthcare, researchers have further developed the concept, 
emphasizing qualities such as consistency in providers and maintenance of contact 
(Johnson et al., 1997), appropriate access to needed services and case management (Reid 
et al., 2016), and quality of the patient-provider relationship (Nutting et al., 2003). 
However, some researchers believe that scholarly definitions of continuity of mental 
health care are vague and inadequate, leaving questions about how to best measure and 
promote it in clinical settings (Burns et al., 2009; Joyce et al., 2004; Naert et al., 2017). 
Although there is not yet consensus on one unifying definition of continuity of care, 
scholars agree that it is a multi-dimensional construct that incorporates regular service 
delivery, provider-patient relationships, and coordination of treatment by an organized 
team (Burns et al., 2009; Puntis et al., 2015; Weaver et al., 2017).  
In some literature, regular service delivery is described as treatment adherence 
(Gearing et al., 2014; Nock & Ferriter, 2005). The construct of treatment adherence 
overlaps with some aspects of continuity of care, such as maintenance of contact and 
timeliness of service utilization; however, much of the literature addressing treatment 
adherence does not reference continuity of care, and vice versa. These two domains 
reflect fundamentally different understandings of gaps in care and who is responsible for 
maintaining ongoing treatment. When discussing continuity of care, responsibility for 
ongoing treatment is generally attributed to the healthcare system and providers. The 
literature on treatment adherence places responsibility on the patient, although the role of 
systems and providers is recognized, and research has evaluated strategies that behavioral 
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health providers can use to promote treatment adherence for children and adolescents 
(Cavaleri et al., 2010; Schwalbe & Gearing, 2012; Tait et al., 2004). I will be using 
terminology consistent with that used in the literature describing continuity of care, such 
as regular service delivery, although I am including studies from both domains.   
In adults with mental illness, continuity of outpatient mental health care has been 
associated with treatment adherence, decreased use of emergency services and 
hospitalization, lower healthcare costs, and improved health outcomes (Catty et al., 2013; 
Chien et al., 2000; Greenberg et al., 2003; Greenberg & Rosenheck, 2005; Saultz, 2005). 
However, a 2015 systematic literature review identified significant limitations in the 
literature examining the association between continuity of care and patient outcomes 
(Puntis et al., 2015). In particular, researchers found that inconsistency in the 
measurement of continuity of mental healthcare, small sample sizes, short follow-up 
periods, and conflicting findings across studies, made it difficult to generalize results 
(Puntis et al., 2015).  
Although there are studies describing and evaluating continuity of mental 
healthcare in youth (Naert et al., 2017; Tobon et al., 2014, 2015), there is little research 
about how youth continuity of care is associated with relevant patient outcomes. The few 
studies that have been conducted are promising, and suggest that increased continuity of 
mental healthcare is associated with an improvement in symptoms and decreased 
likelihood of psychiatric ED presentation (Pennap et al., 2020; Tait et al., 2004). In one 
such study, Tait and colleagues (2004) recruited 127 adolescents who presented in the ED 
for an issue related to substance use; higher continuity of care (measured by attendance at 
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treatment sessions) was associated with safer substance use behaviors (non-hazardous 
alcohol consumption and/or non-injecting drug use) and a decline in substance use 
overall (Tait et al., 2004).   
A more recent study analyzed Medicaid claims data for almost 40,000 youth 
living in the Mid-Atlantic US who received at least two outpatient mental visits prior to 
appearing in the ED for psychiatric reasons (Pennap et al., 2020). Continuity of care was 
measured using the Alpha Index, a weighted average incorporating an indicator of the 
concentration of providers and a measure of the sequential continuity of outpatient visits 
(Lou, 2000). Results indicated that increased continuity of care was associated with lower 
odds of psychiatric ED presentation or inpatient hospitalization (Pennap et al., 2020).  
Despite few studies on the subject, the existing body of literature generally 
assumes that consistent and sustained treatment for youth with mental illness is 
associated with better psychosocial outcomes (Brookman-Frazee et al., 2008). This 
assumption is likely based on clinical trials that are designed to determine the impact of 
specific interventions (Boggs et al., 2005; Danko et al., 2016; Kazdin et al., 1994; Kazdin 
& Wassell, 1998). For example, a 1998 study examined treatment attendance for 304 
youth ages 3-13 with externalizing disorders in the context of a clinical trial evaluating 
the efficacy of cognitive problem-solving skills training (Kazdin & Wassell, 1998). 
Results indicated that, within the context of this clinical trial, children and families with 
more cancellations or missed appointments had poorer clinical outcomes than those with 
fewer cancellations or missed appointments (Kazdin & Wassell, 1998). Surprisingly, 
there is very little empirical research that addresses psychosocial outcomes associated 
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with consistency of typical outpatient mental health care, as distinct from treatment 
attrition and completion in clinical trials.  
This is concerning because clinical trials may not be ecologically representative 
of general outpatient mental healthcare for a number of reasons. First, patients who agree 
to participate in intervention research are generally not representative of the population as 
a whole (Kennedy-Martin et al., 2015; Susukida et al., 2016). In addition, the measures 
put into place to control variability and ensure internal validity further narrow the 
characteristics of participants (Sherman et al., 2016). For example, clinical trials 
rigorously screen patients and incorporate specific eligibility criteria for participants prior 
to their participation, whereas community mental health providers cannot preselect the 
characteristics of their patients (Sherman et al., 2016). In clinical trials, specialized 
personnel conduct manualized protocols; in contrast, typical outpatient mental health 
providers tailor treatment timelines and content to the characteristics and circumstances 
of each individual patient (Shean, 2014). Although clinical trials are essential to the 
development of effective interventions, there is also a critical need for research 
examining continuity of outpatient mental healthcare in naturalistic settings. In fact, 
medical scholars are increasingly recommending analysis of “real-world evidence,” such 
as Electronic Health Records (EHRs), to complement and inform the work of clinical 
trials (Booth & Tannock, 2014; Sherman et al., 2016). This aligns with the Matrix Model 
(Tansella & Thornicroft, 1998), which highlights the role that observational research at 
the local and regional levels can play in interpreting findings from clinical trials and 
translating research into practice. In order to conduct quality research on patterns of 
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outpatient service use, it is first important to discuss and select appropriate methods for 
measuring continuity of care.   
Measuring Continuity of Care. Continuity of care is considered an important 
indicator when evaluating the quality of mental health service provision, and researchers 
have therefore developed a number of methods for assessing it (Burns et al., 2009). The 
earliest measures were developed to assess continuity of care for adults with mental 
illness. For example, Ware and colleagues (2003) developed a patient interview to 
measure continuity of care, which was validated in a sample of 400 adults with 
psychiatric disorders (Ware et al., 2003). Interview questions address patient experiences 
related to the provider-patient relationship, provider availability, coordination across 
services, and transitions between different types of services (emergency, inpatient, and 
outpatient; Ware et al., 2003). Whereas the measure developed by Ware and colleagues 
(2003) was intended for use by mental health service researchers, the Alberta Continuity 
of Services Scale for Mental Health (Durbin et al., 2004) was designed, and later refined, 
for providers and healthcare organizations to monitor continuity of care as an indicator of 
service quality (Adair et al., 2005).  The Alberta Continuity of Services Scale for Mental 
Health combines a patient self-report survey with a staff assessment package. The patient 
survey addresses perceptions of the availability of needed services, mechanisms to 
improve access (e.g., appointment reminders), relationships with providers, and 
coordination across services (Durbin et al., 2004). For each patient, staff complete 
measures of patient functioning and a service utilization report of estimated need and 
actual receipt of clinical and case management services (Durbin et al., 2004).  
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In 2014, Tobon and colleagues published the first tool to assess continuity of 
mental healthcare for children. The Continuity of Care in Children’s Mental Health 
Measure is a parent survey with an additional youth self-report component for 
adolescents (Tobon et al., 2014). Both parents and youth are asked to respond to items 
about case management, individualized services, relationships with providers, 
consistency of services over time, and transitions between services and providers (Tobon 
et al., 2014). The Continuity of Care in Children’s Mental Health Measure was intended 
to provide healthcare organizations and providers a tool to monitor and improve 
continuity of mental health care for youth with psychiatric disorders.  
An alternative approach to assessing continuity of mental health care involves the 
use of medical records. In 2003, Fortney and colleagues observed that many aspects of 
continuity of outpatient mental healthcare could be readily assessed using administrative 
data, and noted that surprisingly little research had addressed this possibility. 
Administrative data is routinely collected in healthcare systems, often in the form of 
EHRs, and includes demographic information, medical records, and insurance claims 
(Evans et al., 2010; Spiranovic et al., 2016). Fortney and colleagues (2003) described 
how administrative data could be analyzed to address five distinct aspects of continuity of 
outpatient mental healthcare: (1) the frequency of mental health visits by a patient could 
be used as an indicator of the timeliness of service provision, (2) quantity of visits over a 
given period of time could provide a proxy for the intensity of services received, (3) the 
number of different services received by a patient could be used as an indicator of the 
comprehensiveness of services provided, (4) the consistency of providers across time 
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could be used to indicate the stability of the patient-provider relationship, and (5) the 
receipt of case management services could provide as a proxy for the coordination of 
service provision. 
Electronic health records (EHRs) represent a readily available source of 
administrative data, which have the potential to inform the field’s understanding of 
continuity of mental health care. Utilization of existing data is both cost-effective and 
non-invasive, as it presents minimal risk to patients (Evans et al., 2010; Spiranovic et al., 
2016). In addition, EHRs are longitudinal by nature, and can therefore be employed to 
examine patient interactions with the treatment system and aspects of illness trajectories 
across time, as described in the NEM-II (Evans et al., 2010; Pescosolido, 2006). 
Furthermore, EHRs offer opportunities to analyze data at the local and regional levels, 
areas for which the Matrix Model highlights the need for quality research (Tansella & 
Thornicroft, 1998). Despite their availability, there is a scarcity of research utilizing 
EHRs to assess the continuity of outpatient behavioral health services, in particular for 
children and adolescents. 
In examining mental health service provision, administrative data offer the 
opportunity to examine substantially different aspects of continuity of care than patient 
and clinician interviews and surveys. Research highlighting patient and provider 
perceptions of continuity of care is valuable, but requires substantial time and funding to 
obtain; alternatively, administrative data can accurately provide a timeline of mental 
health care and important events, across different providers and departments. However, 
there are some limitations when utilizing EHRs for retrospective analysis, as 
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administrative data are not collected with research in mind. Disadvantages include the 
potential for inconsistencies in reporting across providers, difficulty linking data from 
multiple sources, and the availability of relevant variables (Spiranovic et al., 2016; 
Weiskopf & Weng, 2013). For example, a provider in the ED may not diagnose a 
psychiatric disorder the same way as an outpatient provider, but both diagnoses will 
appear in the medical record. In addition, different medical software programs may be 
used in the ED and in outpatient clinics; merging the data from different software 
programs can be a complicated and time-consuming process.  Scholars have responded to 
these concerns by outlining a number of steps researchers can take to minimize problems, 
(Castillo et al., 2015; Spiranovic et al., 2016), which are further discussed in Chapter 3.  
Correlates of Continuity of Outpatient Mental Health Care. A few recent 
studies have identified factors that may be associated with continuity of outpatient mental 
health treatment in youth. A 2015 study examined factors that were associated with 
continuity of outpatient mental health care among 952 Ohio youth diagnosed with 
schizophrenia and bipolar disorder in the foster care system (Fontanella et al., 2015). 
Administrative data were extracted from Medicaid eligibility and claims files, the Area 
Resource File (Health Resources and Services Administration, 2007-2010), and Ohio 
State Psychology and Social Work Licensure Boards. Results indicated that access to 
previous outpatient care, chronic medical illness, comorbid anxiety, and the use of 
multiple psychotropic medications were associated with greater likelihood of regular 
outpatient treatment (defined in this study as the receipt of at least one outpatient mental 
health visit per month; Fontanella et al., 2015). Youth living in urban areas and regions 
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with fewer psychiatrists per capita were less likely to receive regular outpatient mental 
health care (Fontanella et al., 2015). Generalizability of findings were limited by the 
narrow and specific population of interest, changes in service utilization after health care 
reform in 2010, and the information available from the data sources (e.g., there were no 
data related to patient-provider relationships or clinical outcomes). Overall, the findings 
suggest that youth in the foster care system with mental illness received inadequate 
continuity of outpatient mental health care.    
In 2010, Pellerin and colleagues examined demographic and clinical factors 
associated with youth psychosocial treatment completion among 250 families at an urban 
community mental health clinic in southeast Louisiana (Pellerin et al., 2010). Data were 
obtained from the clinic’s database of patient records. It is unclear how treatment 
completion was assessed by the authors; the authors indicate that individual treatment 
plans were developed for each patient, but do not state who determined whether treatment 
had been completed or guidelines for how that determination was made. Results indicated 
that lower levels of parent educational attainment and higher levels of parental stress 
were associated with treatment drop-out (Pellerin et al., 2010). In addition, youth with 
more severe symptoms and functional impairment were less likely to complete the 
recommended number of treatment sessions (Pellerin et al., 2010). These findings seem 
to contrast to those of Fontanella and colleagues (2015), who found that indicators of 
severity (comorbidity, use of medication) were positively associated with higher 
continuity of care; differences in the population studied (foster children from across Ohio 
vs. families at one urban clinic in Louisiana likely contribute to contrasting results. 
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Pellerin and colleagues’ (2010) findings were consistent with results from a 2008 study 
that analyzed data from 169 adolescents aged 11-18 receiving treatment at two 
community mental health clinics in San Diego County (Brookman-Frazee et al., 2008). 
Results indicated that youth who reported greater severity of symptoms engaged in 
significantly more treatment sessions than those who reported less severe symptoms 
(Brookman-Frazee et al., 2008). 
Racial/Ethnic Disparities in Continuity of Care. There are also a few studies 
that specifically examine differences in continuity of youth outpatient mental healthcare 
based on race/ethnicity. In 2010, Alexandre and colleagues analyzed data from the 
nationally representative 2005 National Survey on Drug Use and Health. They identified 
a sample of 1,688 youth between the ages of 12 and 17 who reported a major depressive 
episode in the previous year. Findings indicated that the odds of receiving adequate care 
for a major depressive episode (defined as either an appropriate prescription plus at least 
four visits with a provider or at least eight visits with a mental health provider) were 1.5 
times greater for White youth than for youth of color (Alexandre et al., 2010). A similar 
study from 2011 analyzed data from the same nationally representative survey for the 
years 2004 to 2007, and identified a sample of 7,704 youth between the ages of 12 and 17 
who reported a major depressive episode in the previous year (Cummings & Druss, 
2011). In this study, findings indicated that Hispanic youth received significantly fewer 
outpatient mental health visits (approximately 3 fewer visits per year) than White youth; 
there were no differences in the number of visits between Black youth or Asian youth and 
their White peers (Cummings & Druss, 2011). However, given that existing studies 
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employ either dichotomous measures of continuity of outpatient care or a simple count of 
the number of outpatient visits, research would benefit from using additional measures of 
continuity, such as the frequency of visits over time (Fortney et al., 2003). Given the 
importance of seasonal patterns in psychiatric ED presentation, it may also be important 
to examine seasonal patterns in outpatient treatment, which may offer additional clues 
about reasons for interruptions in mental health service provision and utilization. 
Seasonal Patterns in Outpatient Mental Health Care  
Despite evidence related to seasonal patterns in youth psychiatric ED visits (Ali et 
al., 2012; Goldstein et al., 2005; Holder, Rogers, Peterson, & Ochonma, 2017), limited 
research has addressed the impact of seasonality on outpatient mental healthcare. There is 
a narrowly focused body of research looking at ‘drug holidays’ for youth with ADHD. 
Studies have found that between 25% and 60% of youth taking medication for ADHD 
intentionally skipped medication administration at least once during the course of 
treatment, and that this was usually done during weekends and summer vacation 
(Barnard-Brak et al., 2013; Dosreis et al., 2003; Faraone et al., 2007; Hugtenburg et al., 
2005; Snyman & Truter, 2012; Wilens et al., 2005). A 2008 study of prescription records 
between 2003 and 2007 indicated that the total monthly volume of ADHD medication 
prescriptions decreases approximately 25% between May and July (Cascade et al., 2008). 
A recent review of the literature on ADHD drug holidays found that studies that analyzed 
prescription records found a lower prevalence of drug holidays among youth with ADHD 
than studies that used parent report data (Ibrahim & Donyai, 2015). In addition, the most 
recent practice guidelines published by the American Academy of Child and Adolescent 
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Psychiatry recommend intentional breaks from medication administration to assess 
ongoing need for treatment (American Academy of Child and Adolescent Psychiatry, 
2007).  It is unclear whether breaks from medication administration, whether supervised 
by a doctor or not, would be associated with fewer outpatient visits or appear on the 
medical record in a meaningful way.   
Beyond the administration of ADHD medication, seasonal factors such as 
weather, holidays, and scheduling represent potential barriers to continuity of outpatient 
care for youth with a range psychiatric disorders (Laughlin, 2010; Tovar et al., 2010). 
Identifying when youth are most likely to experience disruptions in mental health care 
may suggest times of year when outreach may be particularly important or effective, or 
when extra staffing may be necessary. Below I describe two examples of how seasonal 
factors may impact patterns in outpatient mental health service utilization.  
First, the closure of most schools in the summer likely affects childcare, 
scheduling, and finances for families with children (Laughlin, 2010). Given that all three 
of these represent recognized barriers to mental health service use and treatment 
adherence (DeRigne, 2010; Mendez et al., 2009; Schwalbe & Gearing, 2012), families 
may find it difficult to continue regular mental health care for children during the summer 
months. Providers may limit their schedules during the summer or take time off for 
vacation, limiting the availability of appointments. Second, schools often facilitate the 
referral process for mental health services, such as regular counseling from a behavioral 
health care provider (Green et al., 2013; Wood et al., 2005). A lack of contact with 
trained teachers and school staff, who interact with students over time, may mean that 
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students in need are not identified or supported in accessing care during the summer 
months. Another opportunity for interruptions in mental health service use may be the 
period between Thanksgiving and Christmas, which can be a stressful time for families. 
In addition, families and providers may be especially busy and/or traveling throughout 
this approximately six-week period, and as a result regular schedules may be disrupted 
and appointments may be missed.  
Outpatient Mental Healthcare and Psychiatric ED Visits 
 Scholars who study psychiatric ED presentation among youth consistently 
hypothesize that difficulties accessing outpatient mental healthcare are contributing to 
increases in ED visits and that increasing youth access to and utilization of outpatient 
care will help reduce psychiatric ED visits (Ali et al., 2012; Holder, Rogers, Peterson, & 
Ochonma, 2017; Pittsenbarger & Mannix, 2014; Soto et al., 2009). However, few studies 
have actually examined the association between youth outpatient mental health service 
use and psychiatric ED presentation. A 2009 study analyzed a year of ED records from a 
hospital in Queens, New York for children and adolescents under the age of 18 who 
presented for psychiatric reasons (approximately 1,000 ED visits; Soto et al., 2009). They 
found that over two-thirds of patients were currently receiving some form of outpatient 
mental healthcare. A lack of current outpatient treatment was significantly associated 
with inappropriate ED presentation (that could have been handled in an outpatient setting, 
even if delayed); however, this relationship was non-significant in models that controlled 
for symptom severity and other clinical characteristics (Soto et al., 2009).  
 Frosch and colleagues (2011) examined the association between outpatient mental 
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healthcare and repeat psychiatric ED presentation among 338 youths who presented in 
the Johns Hopkins Hospital Pediatric Emergency Department on two occasions within 6 
months of each other between 2008 and 2009.  Consistent with results from Callahan 
Soto (2009), nearly two-thirds of youth in the sample were already connected with an 
outpatient mental health provider at both ED visits in the study period (Frosch, 2011). In 
addition, most of these repeat ED users presented with non-suicidal, non-psychotic 
complaints at both visits (exact percentage not provided in article; Frosch, 2011). 
Because existing studies only include youth who utilize emergency services for 
psychiatric reasons, it is impossible to draw conclusions about whether youth receiving 
outpatient mental health treatment are less likely to present in the ED for psychiatric 
reasons. In addition, existing studies used dichotomous variables to indicate outpatient 
treatment (yes/no); incorporating measures of continuity of care into future studies would 
provide more insight into what aspects of outpatient care might help prevent psychiatric 
ED presentation. Given that scholars have repeatedly hypothesized that improving youth 
access to and utilization of outpatient mental healthcare has the potential to prevent 
behavioral health crises, reduce psychiatric ED presentation, and address racial/ethnic 
disparities treatment provision, the lack of research evaluating this possibility represents a 
critical gap in the literature.   
Current Study 
 There is a need for more research examining seasonal and secular patterns in 
youth behavioral health care, including both ED visits and outpatient services. This 
project will replicate previous research by examining seasonal patterns and secular trends 
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in psychiatric ED presentation, and then extend the literature by examining seasonal 
patterns and secular trends in specialty outpatient mental health service utilization. In 
addition, I will also consider whether continuity of outpatient mental health care is 
associated with psychiatric ED presentation. Within each analysis, I will investigate 
potential differences in treatment utilization based on race and ethnicity. Understanding 
seasonal patterns in behavioral health care may suggest times during the year when there 
may be a high need for child and adolescent mental health supports, providing 
opportunities for early identification and prevention. Identifying potential connections 
between continuity of care and ED presentation may suggest methods for reducing 
psychiatric ED visits, which could in turn help reduce the significant burden these visits 
place on the healthcare system. Understanding disparities in service use may help identify 
specific populations that would benefit from outreach and engagement efforts. Overall, 
this study has the potential to inform outreach and resource allocation for schools, 
communities, and mental health providers who support youth with emotional and 
behavioral disorders throughout the year.   
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CHAPTER 3: METHODOLOGY 
 
This study used de-identified electronic health records (EHRs), which included 
emergency department and outpatient medical records at an urban healthcare system from 
September 1, 2009- May 3, 2018. Boston Medical Center (BMC) is an academic 
community health care system and the largest safety net hospital in New England, serving 
a multicultural population of over 140,000 patients, regardless of whether they have 
insurance or are able to pay for services. Close to three-quarters of BMC patients yield 
from underserved populations, including low-income and immigrant families. Seventy 
percent of patients are from racial and ethnic minority backgrounds, almost half of whom 
do not speak English as a primary language. A range of mental health services are 
available for youth within the BMC system, including assessment, outpatient and 
inpatient treatment, and emergency services, as well as consultations for schools, courts, 
and child serving agencies. These services are facilitated primarily by the Department of 
Child and Adolescent Psychiatry.  
Data Source 
All data were obtained from the Clinical Data Warehouse (CDW) at BMC, which 
compiles and consolidates EHRs from the BMC Electronic Medical Record Systems. 
Researchers do not have direct access to the CDW; instead, they consult with clinical 
research data managers employed by the CDW. Through these consultations, an ID-
coded dataset with demographic and clinical information was developed. The CDW 
serves to minimize some of the limitations related to the use of EHRs; for example, the 
role of the data managers is to compile and merge data from the software programs used 
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across the BMC system, and they have experience managing inconsistencies between 
these programs. Once this dataset was extracted, it was stored on Boston University’s 
secure password-protected servers and were accessible only to the research team. IRB 
approval for this study was obtained from both the Boston University School of Medicine 
and the Charles River Campus. Records from September 1, 2009 to May 3, 2018 were 
compiled, to allow for the analysis of seasonal and secular trends since the enactment of 
Massachusetts and federal healthcare reform (2006 and 2008, respectively). 
In accordance with literature related to limitations of EHRs, I took a number of 
steps during the data extraction process to minimize possible issues (Castillo et al., 2015). 
First, I discussed the goals of my project with a clinical research data manager with the 
purpose of identifying the variables of interest (Castillo et al., 2015). This allowed us to 
consider what data fields, both structured and unstructured, might contain the information 
needed. This discussion was important because, while I had a clear sense of the 
information I wanted, the data manager understood the software systems from which the 
data were being extracted and the issues related to these systems. Second, we used an 
iterative process to extract data (Castillo et al., 2015). For example, after receiving an 
initial dataset, I was concerned about missing data in the race and ethnicity data fields; 
after discussing this with the data manager, we decided to include the patient’s zip code 
in the final data set, since this information could potentially be used to impute 
race/ethnicity data. Third, I consulted with providers in the Department of Psychiatry and 
the Department of Pediatrics to develop clear procedures for data cleaning, which are 
described in the following sections.   
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Sample 
The sample was comprised of 25,545 school-age children and adolescents (ages 
5-18) who were treated at BMC between September 1, 2009 and May 3, 2018, and who 
were identified as having an emotional and/or behavioral diagnosis. Patients were 
included in the study if they had been diagnosed with any of the following 
disorders/symptoms as indicated by the International Classification of Disease (ICD) 
codes listed in Table 1. 
Table 1 
Emotional and behavioral diagnoses included in the study 
 
ICD-10  ICD-9  Category 
F10-F19 303-305 Substance use disorders 
F20-F29 295, 297, 298, 301 Schizophrenia, schizotypal, delusional, and other 
non-mood psychotic disorders 
F30-F39 296, 298, 300, 311 Mood (affective) disorders 
F40-F49 298, 300, 307-309, 
V40, V62 
Anxiety, dissociative, stress-related, somatoform 
and other nonpsychotic mental disorders 
F50-F59 302, 307, 316 Behavioral syndromes associated with physiological 
disturbances and physical factors 
F60-63,  
F65-69 
302, 312 Disorders of personality and behavior (excluding 
gender identity disorders) 
F80-F89 299, 315 Pervasive and specific developmental disorders 
F90-F98 307, 309, 312-314, 
V62 
Behavioral and emotional disorders with onset 
usually occurring in childhood and adolescence 
F99 V40 Mental disorder, not otherwise specified 
R45 V62 Symptoms and signs involving emotional state 
R46 V40 Symptoms and signs involving appearance and 
behavior 
T14  Suicide attempt 
T50  Poisoning, intentional self-harm 
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Measures  
 Study variables were created using the dataset developed with the CDW. The 
procedures for creating each of these variables is described below.  
Diagnostic Category   
To categorize the range of diagnoses that patients had been assigned, I first 
developed a master list of emotional/behavioral diagnoses in the sample using the ICD 
codes indicated in the problem list and visit diagnosis sections of the medical records. 
ICD-10 codes were used whenever available. If only an ICD-9 code was available, a 
crosswalk prepared by psychiatrists at Boston Medical Center was used to find the 
equivalent ICD-10 code (See Appendix A). This was then checked using an online 
coding and crosswalk tool (American Academy of Professional Coders, 2020). Diagnoses 
were then organized into 13 categories based on the Diagnostic and Statistical Manual of 
Mental Disorders (DSM–5; American Psychiatric Association, 2013). Two additional 
indicator variables were created to identify mental health issues that may be treated, but 
do not themselves constitute a specific disorder: (1) symptoms and signs involving 
emotional state, appearance, and behavior, and (2) suicide attempt. Diagnostic categories 
and the ICD-10 codes associated with them are described in Table 2. 
Comorbidity 
The number of diagnostic categories a patient was assigned was summed to create 
a continuous variable representing the total number of diagnoses from distinct disorder 
categories a patient was associated with during the study period (score of 0-13).  
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Table 2 
Diagnostic categories 
 
Diagnostic category ICD-10 
Code 
Additional description  
Substance use disorders F10-F19; 
F55 
 
Schizophrenia, 
schizotypal and 
delusional disorders 
F20-F29; 
F53 
 
Mood (affective) 
disorders 
F30-F39; 
F53 
Examples include MDD and bipolar disorders 
Anxiety and 
somatoform disorders 
F40-F42; 
F44-F49; 
F93 
Examples include GAD and specific phobias 
Traumatic and 
attachment disorders 
F43 Examples include PTSD and reactive 
attachment disorder 
Eating and related 
disorders 
F50; F98 Examples include anorexia, bulimia, pica, and 
enuresis 
Sleep disorders F51 Examples include insomnia and parasomnia 
Otherwise specified 
childhood onset 
emotional and 
behavioral disorders 
F54; F93; 
F98 
Diagnoses with these codes are generally listed 
as ‘unspecified behavioral and emotional 
disorders with onset occurring in childhood and 
adolescence’, ‘childhood emotional disorder, 
unspecified’, or something equally vague  
Personality and 
behavior disorders 
F60-F63; 
F68-F69 
Examples include APD and IED 
Pervasive and specific 
developmental disorders 
F80-F89; 
F94-F95 
Includes Developmental Delays, ASD, and 
Tourette’s Disorder 
ADHD F90; F98  
Conduct disorders F91 Examples include conduct disorders and ODD 
Other mental disorder F99 Diagnoses with these codes are generally listed 
as ‘mental disorder, NOS’, ‘psychiatric illness’, 
or something equally vague 
Symptoms and signs 
involving emotional 
state, appearance, and 
behavior 
R45, R46 Includes, but is not limited to, suicidal ideation, 
homicidal ideation, agitation, hostility, poor 
hygiene, strange behavior, slowness or over-
activity, and violent behavior 
Suicide attempt  T14, T50 Includes intentional overdose 
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In addition, a binary variable was created to identify whether patients had only one 
disorder (or multiple disorders from only one category; scored 0) or they had 2 or more 
disorders from multiple categories (scored 1). For example, a patient who was diagnosed 
with generalized anxiety disorder and a panic disorder (which are both from the same 
diagnostic category), would have a score of 1 for the continuous indicator of comorbidity 
and a score of 0 for the dichotomous indicator of comorbidity. Throughout this 
dissertation, these two variables will be referred to as the continuous indicator of 
comorbidity and the dichotomous indicator of comorbidity.  
Psychiatric ED Utilization 
Psychiatric ED use was determined by the date (MM/DD/YYYY) of each 
psychiatric ED presentation. ED visits were included in the study if the visit diagnosis 
(ICD codes) recorded in the EHR was related to mental health, using the same coding 
criteria described to identify patients for inclusion in the study.  
Outpatient Specialty Mental Health Services Utilization  
Outpatient visits were included primarily based on Current Procedural 
Terminology (CPT) codes used for medical billing. Using billing guides developed for 
psychiatrists, psychologists, and social workers (American Academy of Child and 
Adolescent Psychiatry, 2018; American Psychiatric Association, 2013; American 
Psychological Association, 2019; National Association of Social Workers, 2017), I 
developed a list of potential CPT codes for inclusion. A number of codes were included 
in the study that had been retired in 2013 and are no longer in use. The initial list of codes 
was then circulated to an interdisciplinary team of BMC psychiatrists (3), clinical 
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psychologists (2), and social workers (2) who work with children and adolescents, for 
their review and feedback. Codes identified by this team that were not already on the list 
were added (e.g., codes used by psychiatrists for medication management); the team did 
not identify any codes to be removed.  
The CPT codes selected for inclusion in the study included two types of 
outpatient visits. The first was CPT codes associated with only mental health issues. 
These included visits coded for psychotherapy (90804, 90806, 90807, 90809, 90832-
90834, 90836-90838 90847, 90849, 90853), psychiatric therapeutic procedures (90805), 
and psychopharmacologic management (90862). Visits associated with these CPT codes 
were always included in the study. However, a second group of CPT codes used by 
mental health professionals was not used exclusively for mental health purposes. CPT 
codes 97110, 97112, 97116, 97150, and 97535 are used primarily for physical and 
occupational therapy, but may also be used for some behavioral health services (e.g., 
music therapy). There are also a number of CPT codes used regularly by psychiatrists for 
office visits and services such as medication management. These codes indicate office or 
other outpatient services- new patient (99201-99205), office or other outpatient services- 
established patient (99211-99215), office or other outpatient consultations (99241-
99245), and prolonged outpatient services with direct patient contact (99354, 99355). 
These codes are also used by physicians across many fields of medicine, so additional 
steps were taken to determine whether a visit with these codes would be included in the 
study.  
For visits coded 97110, 97112, 97116, 97150, 97535, 99201-99205, 99211-
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99215, 99241-99245, 99345, and 99355, I identified both the department in which the 
appointment took place and the primary department with which the provider was 
affiliated. An outpatient visit with these CPT codes was included in the study if either the 
visit took place in or the provider’s primary department was one of the following 
departments associated primarily with mental health services: adolescent social services, 
adult psychiatry, behavioral health, child and adolescent psychiatry, 
developmental/behavioral pediatrics, pediatric behavioral health, and social work. 
Continuity of Outpatient Care. Continuity of outpatient specialty mental health 
care was measured within treatment periods. Because I was analyzing treatment for a 
wide range of psychiatric disorders, and practice guidelines for adequate care differ for 
each specific disorder, (American Academy of Child and Adolescent Psychiatry, 2020), it 
was necessary to determine criteria for identifying distinct treatment periods that would 
be appropriate for many disorders. Based on prior studies that examined psychiatric 
treatment episodes among youth and adults (Cook et al., 2017; Cook et al., 2014; 
Tansella et al., 1995), a treatment period was defined as beginning the day of the initial 
visit (or initial visit after a break in treatment 90 days or longer) and ending when care 
stopped for 90 days or longer.   
Once outpatient visits had been organized into distinct treatment periods, 
continuity of care was measured in three distinct ways. As suggested by Fortney et al. 
(2003), I examined the duration of a treatment period days between the first visit and the 
last visit and the quantity of outpatient visits during a treatment period. In addition, I 
examined the frequency of outpatient visits, defined as the average number of days since 
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the previous outpatient appointment across the treatment period (Fortney et al., 2003). To 
calculate frequency of visits, I calculated the number of days since the previous 
outpatient appointment for each day of the treatment period; I then calculated the average 
of these values.  
When calculating the duration of a treatment period and the quantity of visits, it 
was necessary to account for both left- and right- censoring in the data. To correct for 
left-censoring in the data, adjustments were made to exclude treatment periods that may 
have begun prior to the first day for which data were available. Treatment periods that 
started during the first 90 days for which outpatient data were available may have in fact 
begun earlier, and were therefore excluded from analysis related to duration and quantity 
of treatment. This resulted in the exclusion of 240 treatment periods (4.0%). Right 
censoring was managed through the selection of appropriate statistical methods, as 
described in the analysis section of this chapter.   
Race/ethnicity  
Within the medical records, each patient could be identified as only one race from 
the following categories: Black, White, Hispanic or Latino, Asian, American 
Indian/Native American, Native Hawaiian/Pacific Islander, Middle Eastern, Vietnamese, 
multi-racial, other, and unknown/declined. In accordance with the way data is collected 
for federal records, the medical records also contained a separate indicator of ethnicity, 
which could be either Hispanic or non-Hispanic. The indicators of race and ethnicity 
from the medical records were used to create a composite variable, in which youth were 
categorized as: (1) Black, (2) Hispanic or Latino, (3) White, or (4) multi-racial/other as 
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indicated in the medical record. Patients who were identified as Hispanic (ethnicity) and a 
different race were categorized as Hispanic.  
Sex  
The medical records system includes a binary indicator used to describe sex at 
birth. Consultation with primary care physicians in the pediatrics department suggested 
that there is no systematic way of identifying transgender and gender non-conforming 
youth (TGNC) within the medical record. For example, some doctors may do this by 
putting an alternative name in parentheses under the patient’s given name, and others 
may use ICD codes developed for gender dysphoria and gender identity disorder. Due to 
the fact that there is no way to indicate gender identity in the medical record, the existing 
binary sex indicator was used to as a variable of whether a patient was born male or 
female.  
Age 
Age was calculated in relation to the ED visit or outpatient visit being analyzed. 
When examining continuity of outpatient care, which is measured across time, age was 
designated as the age at the start of each treatment period. 
Insurance Class  
Insurance class was used as a proxy for socioeconomic status (Carson et al., 
2011). Because insurance status may change over time, it is recorded in the medical 
record in relation to specific ED visits or outpatient visits. When examining continuity of 
outpatient care, which is measured across time, insurance status will be designated as the 
type of insurance used for the first visit of each treatment period. A binary indicator 
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variable will indicate each class of insurance (commercial, Medicaid, or free health 
care/health safety net) associated with an ED visit or outpatient treatment period. 
Commercial health insurance refers to any private health insurance plan that is not 
administered by the government. Medicaid refers to insurance provided through the 
government specifically through the Medicaid program. Because BMC is a safety net 
hospital, services may be provided for free or be covered by the Massachusetts Health 
Safety net, which pays for some services for qualified low-income patients. In addition, 
three lifetime insurance variables were created to indicate whether a patient had ever used 
each type of insurance.  
Analysis 
 Descriptive analyses were conducted to describe the sample and calculate 
frequencies for all main study variables. Throughout the paper, significant results are 
indicated in tables with asterisks (*p<.05, **p<.01, ***p<.001). 
Missing Data  
The only variable for which there was substantial missing data was race/ethnicity 
(16.8% missing). Sex was missing for 5 patients (< .0002% of the sample), and all other 
data were complete. I conducted a number of analyses to examine differences in 
outcomes and predictor variables for individuals with and without race/ethnicity data, to 
establish whether these data were missing at random. Patients who were missing 
race/ethnicity data were significantly younger (Mage = 15.61, SD = 4.87) than patients 
with race/ethnicity data (Mage = 17.65, SD = 5.36), t(6,951.67) = 24.95, p < .001). 
Patients who were missing race/ethnicity data were more likely to be male (63.0%) than 
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patients with race/ethnicity data (56.7%), χ2(1) = 61.10, p < .001. There were no 
significant differences between patients with and without race/ethnicity data and the 
number of comorbid disorder categories (continuous indicator of comorbidity), 
t(7,013.81) = 1.43, p = .15.  There were also significant differences between patients with 
and without race/ethnicity data on reports of insurance. Patients missing race/ethnicity 
data were significantly less likely to use Medicaid (66.9%) than patients with 
race/ethnicity data (72.8%), χ2(1) = 61.91, p < .001. Those missing race/ethnicity data 
were also significantly less likely to use Health Safety-net services (8.5%) than those 
with race/ethnicity data (12.5%), χ2(1) = 55.22, p < .001. Finally, youth missing 
race/ethnicity data were significantly more likely to use private health insurance (41.8%) 
than youth with race/ethnicity data (37.9%), χ2(1) = 24.43, p < .001. Taken together, 
these results indicate that the data were not missing completely at random, and that the 
use of multiple imputation was appropriate (Jakobsen et al., 2017).  
To account for missing data, I used the method of multiple imputation with 
chained equations (MICE) and implemented this procedure is IBM SPSS Statistics 25. 
The MICE procedure imputes missing values for each variable using a chained equations 
approach whereby multiple complete datasets are created (10 datasets in this case), the 
regression model is estimated for each dataset, and standard rules are used to combine the 
estimates and adjust the standard errors for uncertainty due to imputation. The following 
study variables were used as predictors in the imputation process: current age (calculated 
using date of birth), sex, the continuous indicator of comorbidity, lifetime use of 
Medicaid (yes/no), lifetime use of private insurance (yes/no), lifetime use of health 
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safety-net services (yes/no). Patient zip code, which was also available in the medical 
record, potentially offered additional information that would be useful in the imputation 
model. To accomplish this, racial and ethnic demographic information from the 2010 
census for all Massachusetts zip codes were obtained from the United States Census 
Bureau (2020). These demographic data were matched with patient zip code, and also 
included in the imputation model. All main analyses were conducted both with the raw 
data and with imputed data, as sensitivity analyses. The results obtained using the raw 
data are reported in the main body of this paper, with notes about whether these results 
differed from those obtained using the imputed data. Results obtained using the imputed 
data are fully reported in specific appendices, as noted in the main body of the paper.  
Research Question 1  
The first research question addresses seasonal and secular patterns in youth 
psychiatric ED visits. Direct comparison of monthly psychiatric ED visits in youth, 
including graphing trends, were used to replicate analyses of seasonal patterns from 
previous studies (Ali et al., 2012; Christiansen et al., 2012; Goldstein et al., 2005; Holder, 
Rogers, Peterson, & Ochonma, 2017). Monthly rates of ED were adjusted for a common 
month length to account for differences (e.g., February is shorter than January; Barnett. et 
al., 2012; Barnett & Dobson, 2010; Christiansen et al., 2012). Monthly counts were 
standardized to 30.44 days (the average day of a month across one calendar year; Barnett 
& Dobson, 2010) with the following formula:  
Monthly rate = 
𝑣𝑖𝑠𝑖𝑡 𝑐𝑜𝑢𝑛𝑡 ×30.44
𝑑𝑎𝑦𝑠 𝑝𝑒𝑟 𝑚𝑜𝑛𝑡ℎ
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 A generalized linear model (GLM) with the adjusted monthly rates of ED was fit 
using a log-linear Poisson function, which allowed for the identification of multiple 
annual peaks and estimation of peak-to-low ratios (Barnett & Dobson, 2010; Brookhart & 
Rothman, 2008; Christensen et al., 2011; Christiansen et al., 2012). Mean rate ratios and 
95% confidence intervals were compared to determine statistical significance in rates of 
ED use between months. A second model was estimated to evaluate and correct for 
secular trends.  
Log (𝐸𝐷 𝑣𝑖𝑠𝑖𝑡𝑠) =𝑠𝑒𝑎𝑠𝑜𝑛𝑎𝑙 𝑣𝑎𝑟𝑖𝑎𝑡𝑖𝑜𝑛+𝑠𝑒𝑐𝑢𝑙𝑎𝑟 𝑡𝑟𝑒𝑛𝑑 
To examine differences in seasonal patterns by race/ethnicity, the same sequence of two 
GLMs were estimated in sub-samples stratified by racial/ethnic category. As in the 
models described above, Model 1 served as a baseline model and Model 2 corrected for 
secular trends.  
To address secular trends in the data, I graphed the rates of ED use by year and 
observed the shape of the graph (e.g., linear, curvilinear). Based on these observations, I 
conducted multiple time-trend analyses to evaluate changes in psychiatric ED visits over 
the study period, both for the entire sample and within each racial/ethnic group. First, 
Spearman correlation coefficients were calculated, as this method requires no 
assumptions related to the nature of potential associations or outcome distribution (Ely et 
al., 1997). Simple time-series regression models were also estimated to test for linear 
trends (Ely et al., 1997). Based on the observed patterns in the data and the quality of fit 
for linear models, curvilinear regression models were also estimated (Ely et al., 1997).  
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Research Question 2  
The second research question addresses seasonal and secular patterns in youth 
outpatient specialty mental health care. The date of the initial visit of a treatment period 
was used as the temporal reference for each data point. The series of analyses used to 
address Research Question 1 was then replicated to examine seasonal and secular trends 
in visit counts of outpatient specialty mental health care. Monthly averages were 
calculated across the sub-sample of participants who accessed outpatient mental health 
services and adjusted for a common month length (Barnett & Dobson, 2010; Christiansen 
et al., 2012). GLMs using a log-linear Poisson function were estimated to determine 
annual patterns and compute peak-to-low ratios (Barnett & Dobson, 2010; Brookhart & 
Rothman, 2008; Christensen et al., 2011; Christiansen et al., 2012). Mean rate ratios and 
95% confidence intervals were compared to determine statistical significance in counts of 
outpatient visits between months. A second model corrected for secular trends 
(Christiansen et al., 2012). To examine differences in patterns of outpatient specialty 
mental healthcare utilization based on race/ethnicity, the same series of analyses (visual 
inspection, GLM baseline model, GLM model with control for secular trends) was 
performed within each racial/ethnic sub-sample.  
To address secular trends in the data, data were again visually examined and 
appropriate time-trend analyses were applied to evaluate potential changes in outpatient 
specialty mental healthcare across the study period. Trends in both in the entire sample 
and within each racial/ethnic sub-sample were examined. Spearman correlation 
coefficients, simple time-series regression models, and curvilinear analyses were 
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estimated as appropriate (Ely et al., 1997).  
Continuity of Outpatient Care. Continuity of outpatient care was examined for 
the sample of youth who attended more than one outpatient specialty mental health visit 
during the study period. For each patient, outpatient visits were organized into treatment 
periods. A treatment period was defined as the period beginning the day of a patient’s 
initial visit, or their initial visit after a break in treatment of 90 days or longer, and ending 
when care stops for 90 days or longer (a duration used in prior research; Cook et al., 
2017; Cook et al., 2014; Tansella et al., 1995).  It was measured in three distinct ways, as 
recommended by Fortney et al. (2003): duration of treatment period, quantity of visits 
during a treatment period, and frequency of visits during a treatment period.  
Duration of Treatment Period. The duration of a treatment period was defined as 
the number of days from the first visit in a treatment period to the last day in a treatment 
period. To correct for left-censoring in the data, adjustments were made to exclude 
treatment periods that may have begun prior to the first day for which data were 
available; treatment periods for which the first visit was within 90 days of the first day for 
which data were available were thus excluded from analysis. To account for right-
censoring in the data, Kaplan-Meier survival estimation was used to examine treatment 
duration. Survival analysis allows for the possibility that some treatment periods may not 
have been completed after the study period ended. Any treatment periods that ended 
within 90 days of the last day for which data were available were assigned as censored, 
meaning they may have ended after the study period. Kaplan-Meier survival analyses 
allow for the estimation of both the average and median duration of treatment period (i.e. 
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the survival time). The median treatment duration was reported instead of the average 
treatment duration, because average values are heavily influenced by the right-censored 
nature of the data (Zwiener et al., 2011).  
A series of Kaplan-Meier survival curves were estimated to examine bivariate 
sociodemographic differences in treatment duration. Because these analyses cannot 
handle continuous independent variables, age was recoded as a categorical variable with 
three categories: (1) 5-9 years old, (2) 10-13 years old, and (3) 14-18 years old. The 
dichotomous indicator of comorbidity was used to examine differences in treatment 
duration based on the number of diagnoses within difference disorder categories.  In 
order to examine seasonal variation in treatment duration, Kaplan-Meier survival curves 
were estimated for treatment initiated in each month of the calendar year. This analysis 
was repeated within each racial/ethnic sub-sample to examine seasonal patterns based on 
race/ethnicity.  
To examine secular patterns in treatment duration, Kaplan-Meier survival 
analyses were used to examine treatment duration for each year during the study period. 
Median estimates were then graphed, and appropriate time-trend analyses were applied to 
evaluate significant changes in duration of outpatient specialty mental health care across 
the study period. Spearman correlation coefficients, simple time-series regression models, 
and curvilinear analyses were estimated as appropriate (Ely et al., 1997). This series of 
analyses (Kaplan-Meier survival analysis, graphing of median estimates, Spearman 
correlation coefficients, and appropriate regression models) were performed within each 
racial/ethnic sub-sample, to examine seasonal patterns based on race/ethnicity.   
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Treatment Quantity. The quantity of visits during a treatment period was defined 
as the number of outpatient specialty mental health visits that occurred between the first 
visit in a treatment period and the last visit in a treatment period. The method used to 
examine treatment quantity was identical to that used to analyze treatment duration. To 
correct for left-censoring, treatment periods that may have begun prior to the first day for 
which data were available were excluded from analysis. To account for right-censoring in 
the data, Kaplan-Meier survival estimation was used to examine treatment quantity.  
A series of Kaplan-Meier survival curves were estimated to examine bivariate 
sociodemographic differences in treatment quantity. As noted in the previous section, 
categorical variables were used for age and comorbidity due to the requirements for 
Kaplan-Meier survival analysis. To examine seasonal variation in treatment quantity, 
Kaplan-Meier survival curves were estimated for treatment initiated in each month of the 
calendar year. This analysis was repeated within each racial/ethnic sub-sample to 
examine seasonal patterns based on race/ethnicity.  
To examine secular patterns in treatment quantity, Kaplan-Meier survival 
analyses were used for treatment quantity for each year during the study period. Median 
estimates were then graphed, and appropriate time-trend analyses were applied to 
evaluate significant changes in quantity of outpatient specialty mental health care across 
the study period. Spearman correlation coefficients, simple time-series regression models, 
and curvilinear analyses were estimated as appropriate (Ely et al., 1997). This series of 
analyses (Kaplan-Meier survival analysis, graphing of median estimates, Spearman 
correlation coefficients, and appropriate regression models) were performed within each 
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racial/ethnic sub-sample, to examine seasonal patterns based on race/ethnicity.   
Treatment Frequency. Frequency of outpatient treatment was defined as the 
average number of days between visits during the treatment period. I first calculated the 
number of days since the previous visit for every day within the study period, and then 
calculated the average of these values. Treatment frequency is not subject to right-
censoring in the same way as treatment duration and quantity. Although treatment 
frequency might change for an incomplete treatment period (one that started before the 
study period began or after the study period ended), there is no reason to believe that it 
would only change in one direction. For example, we know that treatment duration and 
quantity for an unfinished treatment period would only stay the same or increase past the 
end of the study period; in comparison, treatment frequency could change in either 
direction; I therefore used the frequency value for the available data for each treatment 
period, concluding that it was as a reasonable estimate of treatment frequency for 
unfinished treatment periods. For this reason, a different series of analyses was used to 
examine treatment frequency than that used to examine treatment duration and quantity. 
To examine seasonal patterns in treatment frequency, monthly averages were 
calculated for treatment frequency of outpatient specialty mental healthcare across the 
sub-sample of participants who accessed outpatient mental health services. Then, a series 
of three GLMs were estimated to determine seasonal patterns and compute peak-to-low 
ratios (Barnett & Dobson, 2010; Brookhart & Rothman, 2008; Christensen et al., 2011; 
Christiansen et al., 2012). First, a baseline model will examine monthly patterns. A 
second model corrected for secular trends, and a third model added sociodemographic 
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covariates (Christiansen et al., 2012). Mean rate ratios and 95% confidence intervals were 
compared to determine statistical significance in frequency of outpatient specialty mental 
healthcare between months. The same sequence of analyses (calculation and graphing of 
monthly averages, series of three GLMs) was performed within each racial/ethnic sub-
sample, to examine difference in seasonal patterns in treatment frequency by 
race/ethnicity.   
To address secular trends in the data, yearly and month-yearly averages of 
treatment frequency were calculated and graphed for visual inspection. Based on these 
results, Spearman correlation coefficients, simple time-series regression models, and 
curvilinear analyses were estimated as appropriate (Ely et al., 1997).  The same series of 
analyses were conducted within each racial/ethnic sub-sample to examine difference in 
secular trends based on race/ethnicity.  
Research Question 3 
The third research question is designed to determine whether youth outpatient 
mental health care is significantly associated with psychiatric ED presentation. First, a 
series of logistic regression models determined whether the use of any outpatient 
specialty mental health services is associated with psychiatric ED presentation, when 
controlling for sex, race/ethnicity, lifetime insurance use, and the continuous indicator of 
comorbidity. Age could not be included in this analysis because it could only be 
calculated in relation to a specific ED or outpatient visit. Because the analysis did not 
reference a specific ED or outpatient visit, the lifetime insurance use variable was 
included in the analysis. A similar series of linear regressions was then used to determine 
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the association between any outpatient specialty mental health services and the number of 
psychiatric visits to the ED.  
To examine whether the use of outpatient services was associated with subsequent 
psychiatric ED presentation, Cox proportional hazard regression was used among the 
sample patients who received any outpatient specialty mental health care. These survival 
analyses estimated whether each aspect of continuity of outpatient care (duration, 
quantity, and frequency of treatment) was associated with an increased risk for 
subsequent psychiatric ED presentation. Model 1 included duration of treatment 
measured in days, and Model 2 included quantity of treatment measured by the number 
of outpatient specialty mental health visits. To estimate the association between 
frequency of treatment and risk for subsequent psychiatric ED presentation (Model 3), 
only the sample of patients with two or more outpatient visits was used (the only patients 
for whom frequency of treatment could be calculated). A fourth and final model was 
estimated among the same sample of patients with two or more outpatient visits, 
including both quantity and frequency of treatment. Quantity was included to account for 
the total treatment “dose” and frequency was included to account for the total period of 
time over which treatment occurred. The purpose of this model was to determine whether 
treatment quantity and treatment frequency were associated with subsequent psychiatric 
ED presentation when accounting for the other.
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CHAPTER 4: RESULTS 
 
Descriptive Statistics 
The analytic sample consisted of 25,549 school-age children and adolescents 
(ages 5-18) with an identified emotional or behavioral disorder, who were treated at BMC 
between September 1, 2009 and May 3, 2018. Over half of patients (57.8%) were male. 
Patients most commonly identified as Black or African-American (40.5%); 28.3% were 
Hispanic, 26.1% were White, and 5.1% were multi-racial or another race/ethnicity. The 
most common emotional or behavioral disorders were pervasive and developmental 
disorders (40.9%), ADHD (34.8%), and conduct disorders (24.3%). Table 3 shows the 
frequencies for each of the 13 diagnoses, as well as those related to the presentation of a 
suicide attempt or signs and symptoms involving emotional state. Comorbidity was 
common in the sample. On average, youth had diagnoses in 1.98 (SD = 1.36) categories. 
As shown in Table 4, over 50% of youth had diagnoses in 2 or more categories.  
Patients used many different kinds of insurance for medical care, including mental 
health care. Close to three-quarters of the sample (71.8%) had at least some medical care 
covered by Medicaid at some point during the study period. A much smaller subset 
(11.8%) were covered under free care, or health safety-net services, at some point during 
the study period. Over one-third of patients (38.6%) utilized private health insurance to 
cover medical services at some point during the study period. Many patients had changes 
in their insurance during the study period; 19.8% of youth were covered by different 
classes of insurance at different times during the study period.   
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Table 3 
Frequencies of disorder categories in the study sample 
 
Disorder category Frequency Percent 
Pervasive and developmental disorders 10,453 40.9 
ADHD 8,900 34.8 
Conduct disorders 6,199 24.3 
Anxiety and somatoform disorders 5,882 23.0 
Traumatic and attachment disorders 5,408 21.2 
Mood (affective) disorders 5,362 21.0 
Substance use disorders 2,588 10.1 
Personality and behavior disorders 1,838 7.2 
Mental disorder, not otherwise specified 1,431 5.6 
Eating disorders 896 3.5 
Sleep disorders 666 2.6 
Other unspecified emotional or behavioral disorders 643 2.5 
Schizophrenia, schizotypal and delusional disorders 442 1.7 
   
Symptoms and signs involving emotional state, 
appearance, and behavior 
3,046 11.9 
Suicide attempt  58 0.2 
 
 
 
Table 4 
Comorbidity frequencies 
 
Number of diagnostic categories Frequency Percent 
One 12,338 48.3 
Two 6,175 24.2 
Three 3,335 13.1 
Four or more 3,338 13.1 
 
 
  There were significant differences in the number of disorder categories a patient 
was assigned based on race/ethnicity. Black youth carried diagnoses in significantly more 
disorder categories (M = 2.14, SD = 1.52) than Hispanic youth (M = 2.01, SD = 1.38), 
White youth (M = 1.82, M = 1.16), and youth identified as multi-racial or another 
 58 
race/ethnicity (M = 1.59, M = 1.07). Hispanic youth carried diagnoses in significantly 
more disorder categories than White youth and youth identified as multi-racial or another 
race/ethnicity. White youth carried diagnoses in significantly more disorder categories 
than youth identified as multi-racial or another race/ethnicity. Analysis of multiply 
imputed data yielded similar results (detailed results in Appendix B).  
 There were also significant differences by race/ethnicity in lifetime use of 
Medicaid [χ2(3) = 3,725.61, p < .001], health safety-net services [χ2(3) = 289.00, p < 
.001], and private insurance [χ2(3) = 1,620.88, p < .001]. Pairwise comparisons indicated 
that all differences between racial/ethnic groups were significant (except between 
Hispanic youth and youth identified as multi-racial or from another racial/ethnic 
background in relation to the use of health safety-net services). As compared with 
Hispanic youth, black youth were significantly less likely to utilize Medicaid and 
significant more likely to use health safety-net services or private insurance. In addition, 
Black youth were significantly more likely to use Medicaid and health safety-net services 
than White youth and youth who were multi-racial or another race/ethnicity. Hispanic 
youth were significantly more likely to utilize Medicaid than their peers who were White 
or multi-racial or another race/ethnicity; Hispanic youth were also more likely to utilize 
health safety-net services than White youth. Youth of color were significantly less likely 
to utilize private health insurance than White youth. Similarly, White youth were 
significantly less likely to use Medicaid or health safety-net services than youth identified 
as multi-racial or from another racial/ethnic background. Analysis of multiply imputed 
data yielded similar results (detailed results in Appendix C-E). 
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Research Question 1: Psychiatric ED visits 
 
 To examine seasonal and secular patterns in youth psychiatric ED visits, I 
analyzed 9,771 psychiatric ED visits by 6,091 youth in the sample (23.8%). An ED visit 
was considered a psychiatric visit if it was associated with a diagnosis related to mental 
health (using the same ICD codes described in the methods section). Youth presenting in 
the ED for psychiatric reasons were, on average, 13.75 years old (SD = 3.76) and 54.1% 
male. Over half of youth presenting in the ED for psychiatric reasons were Black 
(53.9%); the remainder were Hispanic (26.2%), White (16.0%), or identified as multi-
racial or from another racial/ethnic background (3.9%).  Almost three-quarters (73.3%) of 
these patients were insured through Medicaid and an additional 6.0% received free health 
care or safety-net services; the remaining 20.6% had private insurance.   
 As shown in Table 5, psychiatric ED visits were most often associated with issues 
relating to conduct disorders (32.1% of visits) and mood disorders (23.1% of visits). 
Visits could be associated with multiple diagnoses or issues; indeed, 41.3% of visits were 
associated with two or more comorbid disorders or issues. Over one-quarter of youth who 
presented in the ED for psychiatric reasons visited the ED multiple times during the study 
period, as shown Table 6.  Youth presenting in the ED for psychiatric services averaged 
1.6 visits (SD = 1.58). On average, youth aged 10-13 (M = 1.83, SD = 1.85) presented in 
the ED for psychiatric reasons significantly more times than youth aged 5-9 (M = 1.46, 
SD = 1.06) and youth aged 14-18 (M = 1.57, SD = 1.59), F(6090) = 16.92, p < .001. Male 
youth (M = 1.67, SD = 1.67) presented in the ED for psychiatric reasons significantly 
more times than females (M = 1.53, SD = 1.47), t(6,073.89) = 3.40, p < .01. 
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Table 5 
Diagnostic categories associated with ED visits 
 
Disorder Frequency Percent 
Conduct disorders 3,134 32.1 
Mood (affective) disorders 2,258 23.1 
Traumatic and attachment disorders 1,862 19.1 
Substance use disorders 1,855 19.0 
ADHD 1,665 17.0 
Anxiety and somatoform disorders 1,200 12.3 
Pervasive and developmental disorders 865 8.9 
Schizophrenia, schizotypal and delusional disorders 351 3.6 
Mental disorder, not otherwise specified 171 1.8 
Personality and behavior disorders 74 0.8 
Other unspecified emotional and behavioral 
disorders 
56 0.6 
Eating disorders 35 0.4 
Sleep disorders 22 0.2 
   
Symptoms and signs involving emotional state, 
appearance, and behavior 
1,912 19.6 
Suicide attempt  11 0.1 
 
 
 
Table 6 
Frequencies for total number of ED visits per patient 
 
Number of ED visits Frequency Percent 
One 4,363 74.0 
Two 801 13.6 
Three or more 731 12.4 
 
 
Youth insured through Medicaid (M = 1.77, SD = 1.76) presented in the ED for 
psychiatric reasons significantly more than youth with private insurance (M = 1.33, SD = 
1.19) or youth using health safety-net services (M = 1.11, SD = .49), F(6090) = 71.53, p < 
.001. Youth with private insurance also presented significantly more times than youth 
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using health safety-net services. Youth visiting the ED for multiple psychiatric diagnoses 
or issues (M = 1.88, SD = 1.82) presented significantly more often than those diagnosed 
with only one disorder (M = 1.45, SD = 1.41), t(3,591.25) = -9.41, p < .001. 
There were also significant racial and ethnic differences in the number of times 
youth visited the ED, F(5,794) = 49.40, p < .001. In particular, Black youth (M = 1.85, 
SD = 1.95) presented in the ED for psychiatric reasons significantly more times than 
Hispanic youth (M = 1.57, SD = 1.34), White youth (M = 1.27, SD = 1.05), and multi-
racial youth or those from another racial and ethnic background (M = 1.13, SD = .52). 
Additionally, Hispanic youth used psychiatric ED services significantly more times than 
White youth and those from another racial and ethnic background. Additional analysis 
using multiple imputation was used to account for missing race/ethnicity data in the 
sample. The results for all 10 imputations showed the same significant differences 
(detailed results in Appendix F).  
Seasonal Patterns  
Monthly psychiatric ED visits were calculated using an adjustment for common 
month length, as depicted in Figure 3 (Barnett et al., 2012; Barnett & Dobson, 2010; 
Christiansen et al., 2012). ED visits for psychiatric reasons were lowest in July (average 
of 58.8 visits per month), and increased through August, September, and into October, 
when they were highest (average of 112.4 visits per month). Visits then decreased 
through November and into December (average of 87.2 visits per month). There was then 
an increase in visits through January, February, and March (average of 110.3 per month). 
Visits remained steady into May, and then decreased sharply into June and July.  
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Figure 3 
Seasonal patterns in psychiatric ED visits  
 
 A series of GLMs with the adjusted monthly rates of ED use were fit using a log-
linear Poisson function. First, a baseline model was fit. A second model was then fit to 
control for secular trends. January was used as a reference month, because the average 
number of visits in January (92.5) was closest to the average number of visits per month 
(adjusted for common month length: 93.5). Mean rate ratios and 95% confidence 
intervals from this second model are shown in Table 7. As shown in the table, the rate of 
visits in March, April, May, October, and November were significantly higher than the 
rate of visits in January. In addition, the rate of visits in July and August were 
significantly lower than the rates of visits in January. This indicates the presence of two 
peaks (March-May, October/November) and two low points (July/August, 
December/January) during the calendar year.  
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Table 7 
Seasonal patterns in psychiatric ED visits: GLM 
 
Month Rate ratio 95% CI Z-value p-value 
January ref - - - 
February 1.04 .95, 1.15 .88 .38 
March 1.19 1.09, 1.31 3.78 <.001*** 
April 1.11 1.01, 1.22 2.12 .03* 
May 1.21 1.11, 1.33 4.04 <.001*** 
June .94 .85, 1.04 -1.29 .20 
July .65 .58, .73 -7.58 <.001*** 
August .72 .65, .81 -5.87 <.001*** 
September 1.08 .98, 1.19 1.60 .11 
October 1.26 1.15, 1.38 4.99 <.001*** 
November 1.17 1.06, 1.28 3.28 .001** 
December 0.98 0.89, 1.08 -.44 .07 
 
 
The same series of analyses (direct comparison, sequence of two GLMs) was 
applied to sub-samples stratified by race/ethnicity. Figure 4 depicts monthly rates of 
psychiatric ED visits for Black youth, Hispanic youth, White youth, and youth identified 
as multi-racial or from another racial/ethnic background. These rates represent the 
number of ED visits per 10,000 youth, and were calculated using the number of youth 
from each racial/ethnic category in the full study sample (youth in the BMC system 
during the study period who were identified as having an emotional or behavioral 
disorder).   
A series of GLMs with the adjusted monthly rates of ED use were fit for each 
sub-sample using a log-linear Poisson function. First, a baseline model was fit. A second 
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model was then fit to control for secular trends. Mean rate ratios for the second model are 
shown in Table 8. In addition, a larger table with 95% confidence intervals is available in 
Appendix G.  
Figure 4 
Racial/ethnic variations in seasonal psychiatric ED patterns 
 
 
 
As shown in both Figure 4 and Table 8, seasonal patterns in psychiatric ED visits 
are different as a function of race/ethnicity. Although visit rates are significantly lower in 
the summer across all ethnic groups, patterns during the rest of the year vary. Among 
Black youth, visit rates increase significantly in March and May. Among Hispanic youth, 
visit rates are not significantly different across the winter and early spring, but they are 
significantly higher in October and November than they are in January. Similar to 
Hispanic youth, rates of psychiatric ED visits among White youth are not significantly 
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different across the winter and early spring. Visit rates among White youth are also 
significantly higher in the fall, although the increase occurs earlier in the fall (September 
Table 8 
Racial/ethnic variations in seasonal psychiatric ED patterns: GLMs 
 
 Black Hispanic White Multi-
racial/other 
 (n=5054) (n=2459) (n=1498) (n=365) 
Month Mean rate ratios 
January ref ref ref ref 
February .95 1.15 1.09 1.79* 
March 1.24*** 1.18 1.08 1.04 
April 1.10 1.17 .92 1.33 
May 1.36*** 1.23* .71* 1.13 
June 1.01 .87 .80 .83 
July .68*** .62*** .60*** .52 
August .77*** .65*** .69** .62 
September .92 1.01 1.44** 2.19** 
October 1.10 1.24* 1.57*** 2.16** 
November 1.12 1.25* 1.07 1.80* 
December 1.01 .97 .77* 1.61 
 
and October) than for Hispanic youth (October and November). In addition, visit rates 
among White youth drop significantly in May. Among youth identified as multi-racial or 
from another racial/ethnic background, visit rates in February are significantly higher 
than in January; rates are also significantly higher from September through November 
than they are in January.   
Secular Trends  
To address secular trends in the use of services for mental health issues, I first 
plotted psychiatric ED visits among children and adolescents across time to consider the 
shape of this graph. Figure 5 shows psychiatric ED visits graphed by month-year, and 
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Figure 6 shows visits graphed only by year. In Figure 5, increasing rates of psychiatric 
ED visits can be observed even when accounting for the consistent seasonal patterns. 
Figure 6 allows for the observation of secular trends without the noise of the seasonal 
patterns. Both graphs indicate that psychiatric visits to the ED among children and 
adolescents increased across the study period (net increase from 2010 to 2017 was 146 
visits per year, a 13.9% increase).   
Figure 5 
Secular trends in youth psychiatric ED visits by month-year 
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Figure 6  
Secular trends in youth psychiatric ED visits by year 
 
 
 
To further examine potential secular trends in the data, Spearman correlation 
coefficients were calculated, as this method requires no assumptions related to the nature 
of potential associations or outcome distribution (Ely et al., 1997). Spearman correlations 
were calculated for the association between both year (2010, 2011, etc.) and year-month 
(e.g., January 2010, February 2010, etc.) to better account for the seasonal patterns 
established in previous sections. The Spearman correlations indicated a significant 
positive association between month-year and count of psychiatric ED visits (ρ = .38, p <. 
001) as well as year and count of psychiatric ED visits (ρ = .79, p <. 05), suggesting that 
youth psychiatric ED visits were significantly increasing during the study period.   
I then estimated simple time-series regression models to test for linear trends (Ely 
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et al., 1997). Because the counts for each year and year-month are large (>10), the 
Poisson distribution can be approximated adequately with the normal distribution, and 
simple linear regression may be used. Regressions using both month-year (β = .37, p < 
.001) and year (β = .75, p < .05) as independent variables indicated a significant upward 
trend in psychiatric ED visits. The similarity between the Spearman correlation 
coefficients and the linear regression coefficients suggests that the upward trend is, in 
fact, linear (as opposed to another shape). These two regression models are displayed in 
Figure 7 and Figure 8.  
An identical series of analyses (graphing, Spearman correlations, and linear 
regression) were performed on sub-samples of the data by race/ethnicity, to examine 
secular trends across racial and ethnic groups. Figure 9 shows the rate of psychiatric ED 
visits (per 10,000 youth) by year, within each racial/ethnic subsample. Figure 9 seems to 
indicate that rates of psychiatric ED visits are steadily increasing among Hispanic youth 
and youth identified as multi-racial or from another racial/ethnic background, slightly 
increasing among Black youth, and decreasing among White youth.  
To further explore secular trends within racial and ethnic sub-samples, Spearman 
correlation coefficients and simple linear regression models were estimated. Results are 
depicted in Table 9. These results confirm that rates of psychiatric ED use among 
Hispanic youth significantly increased across the study period. They further suggest that 
rates among Black youth have increased slightly and rates among White youth may have 
decreased slightly.  
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Figure 7 
Secular trends in psychiatric ED visits by month-year: linear regression 
 
 
 
Research Question 2: Outpatient visits 
 
 To answer research question 2, I analyzed 32,487 outpatient visits by 3,894 youth 
in our sample (15.2%). Visits took place between August 1, 2010 and May 3, 2018. 
Youth utilizing psychiatric outpatient treatment were an average of 10.97 years old (SD = 
4.04) at their first psychiatric outpatient visit. Over half of the sample was male (59.4%). 
Approximately half of youth receiving psychiatric outpatient treatment were Black 
(48.1%); the remainder were Hispanic (31.2%), White (17.2%), or identified as multi-
racial or from another racial/ethnic background (3.5%). Almost three-quarters (73.4%) of 
these patients were insured through Medicaid and an additional 1.8% received free health 
care or safety-net services; the remaining 24.9% had private commercial insurance.  As 
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shown in Table 10, youth receiving psychiatric outpatient treatment were most often 
diagnosed with pervasive and developmental disorders (54.8%), ADHD (53.4%), and 
conduct disorders (51.9%). In addition, 85.2% of youth were diagnosed with more than 
one disorder. Over half of youth (62.2%) had diagnoses of three or more comorbid 
disorders.     
Figure 8 
Secular trends in psychiatric ED visits by year: linear regression 
 
 
  
Over one-quarter (29.6%) of patients utilized psychiatric outpatient services only 
one time during the study period. Patients received an average of 8.34 visits (SD = 14.87) 
during the study period. There were no significant differences in the number of outpatient 
visits received by sex or insurance status. Patients who were older at treatment initiation 
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initiation (B = .77, SE = .06, p < .001). Youth with two or more comorbid psychiatric 
disorders (M = 9.14, SD = 15.77) received significantly more outpatient visits than those 
diagnosed with only one disorder (M = 3.74, SD = 6.10), t(2,174.01) = -14.46, p < .001. 
Figure 9 
Racial/ethnic variations in secular psychiatric ED trends 
 
 
There were also significant differences in the number of outpatient visits received based 
on race/ethnicity F(3,267) = 10.09, p < .001. In particular, Black patients (M = 10.42, SD 
= 17.13) received significantly more visits than Hispanic patients (M = 7.71, SD = 12.24), 
White patients, (M = 7.61, SD = 16.23) and multi-racial patients or those from another 
racial/ethnic background (M = 5.73, SD = 8.19). Analyses were repeated in with the 
imputed data.  The results for all 10 imputations showed the same significant racial/ethnic 
differences as found in the raw data (detailed results in Appendix H) 
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Table 9 
Secular trends in psychiatric ED visits: Time-trend analyses 
 
 Year Month-year 
 Spearman 
Correlation 
Coefficient 
(ρ) 
Linear 
Regression 
Coefficient (β) 
Spearman 
Correlation 
Coefficient 
(ρ) 
Linear 
Regression 
Coefficient (β) 
Black .62 .67 .33** .31** 
Hispanic .83* .84** .46*** .46*** 
White -.48 -.55 -.19* .16 
Multi-racial/ other .54 .49 -.03 -.02 
 
 
Table 10 
Diagnostic categories of youth receiving outpatient specialty mental health services 
Disorder Frequency Percent 
Pervasive and developmental disorders 2,134 54.8 
ADHD 2,078 53.4 
Conduct disorders 2,022 51.9 
Traumatic and attachment disorders 1,638 42.1 
Anxiety and somatoform disorders 1,596 41.0 
Mood (affective) disorders 1,463 37.6 
Personality and behavior disorders 595 15.3 
Mental disorder, not otherwise specified 369 9.5 
Substance use disorders 248 6.4 
Eating disorders 231 5.9 
Other unspecified emotional and behavioral 
disorders 
209 5.4 
Schizophrenia, schizotypal and delusional disorders 148 3.8 
Sleep disorders 93 2.4 
   
Symptoms and signs involving emotional state, 
appearance, and behavior 
700 18.0 
Suicide attempt 11 0.3 
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Seasonal Patterns.  
Average monthly outpatient visits were calculated using an adjustment for 
common month length, as depicted Figure 10 (Barnett, Baker, & Dobson, 2010; 
Christiansen et al., 2012). Outpatient specialty mental health visits were lowest in July 
and September (average of 296.2 and 297.4 visits), and increased steadily through 
November (average of 372.7 visits). Visits decreased in December, but then rose from 
January through March, when visits were highest (average of 404.6 visits). Visits then 
decreased through April, May, and June. For comparative purposes, the average monthly 
ED visits for the same time period are included in Figure 10.   
Figure 10 
Seasonal trends in outpatient specialty mental health treatment 
 
 
 A series of GLMs with the adjusted monthly rates of outpatient psychiatric visits 
were fit using a log-linear Poisson function. December was used as the reference month, 
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because the average number of visits in December (348.8) was closest to the average 
number of visits per month (adjusted for common month length; 348.7). First, a baseline 
model was fit. A second model was then fit to control for secular trends. Mean rate ratios 
and 95% confidence intervals from this second model are shown in Table 11.  
Table 11 
Seasonal patterns in outpatient specialty mental health treatment: GLM 
 
Month Rate ratio 95% CI Z-value p-value 
January 1.06 1.01, 1.12 2.24 .03* 
February 1.11 1.06, 1.17 3.96 <.001*** 
March 1.20 1.14, 1.26 6.95 <.001*** 
April 1.11 1.05, 1.17 3.86 <.001*** 
May 1.06 1.01, 1.12 2.28 .02* 
June .99 .93, 1.04 -.47 .64 
July .86 .82, .91 -5.13 <.001*** 
August .88 .83, .93 -4.66 <.001*** 
September .85 .82, .90  -5.13 <.001*** 
October .98 .93, 1.03 -.89 .37 
November 1.07 1.01, 1.13 2.52 .01* 
December ref - - - 
 
 
As shown in the table, there were significantly more outpatient visits in November and 
January through May than there were in December. In addition, there were significantly 
fewer visits in July through September than in December. This indicates the presence of 
one peak (March) and one low point (July-September) during the calendar year.  
The same series of analyses (direct comparison, sequence of two GLMs) was applied to 
sub-samples stratified by race/ethnicity. Figure 11 depicts monthly rates of psychiatric 
outpatient visits for Black youth, Hispanic youth, White youth, and youth identified as 
multi-racial or from another racial/ethnic background. These rates represent the number 
of outpatient visits per 10,000 youth, and were calculated using the number of youth from 
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each racial/ethnic category in the full study sample (youth in the BMC system during the 
study period who were identified as having an emotional or behavioral disorder).  A 
series of GLMs with the adjusted monthly averages for outpatient visits were fit for each 
sub-sample using a log-linear Poisson function. First, a baseline model was fit. A second 
model was then fit to control for secular trends. Mean rate ratios for each month are 
shown in Table 12. A table with 95% confidence intervals is available in Appendix I. 
Figure 11 
Racial/ethnic variations in seasonal outpatient treatment patterns 
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Table 12 
Racial/ethnic variations in seasonal outpatient treatment patterns: GLMs 
 
 Black Hispanic White Multi-racial/ 
other 
 n = 1572 n = 1021 n = 562 n = 113 
Month Mean rate ratios 
January 1.03 1.10 1.12 .96 
February 1.08* 1.21*** 1.17* .95 
March 1.23*** 1.26*** 1.23** .96 
April 1.11** 1.23*** 1.02 1.01 
May 1.08* 1.18** .96 1.25 
June .98 1.07 .95 .85 
July .87*** .97 .77** 1.12 
August .87*** .91 .87 1.09 
September .83*** .92 .91 .96 
October .95 1.07 .97 1.19 
November 1.01 1.15** 1.15 1.24 
December ref ref ref ref 
 
As illustrated in both the figure and the table, seasonal patterns in psychiatric 
outpatient treatment varies as a function of race/ethnicity. Among Black youth and 
Hispanic youth, there are significantly more visits in February through May than in 
December. Among White youth, there are significantly more visits in February and 
March than on average. There is also a decrease in visits among Black youth in July 
through September. Although outpatient visits among Hispanic youth did not decrease 
significantly in the summer, there were significantly fewer visits among White youth in 
July than on average. There were no significant differences in outpatient visits across the 
calendar year among multi-racial youth or those from another racial/ethnic background, 
although this could be due to the small sub-sample size for these youth.   
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Secular trends  
To address secular trends in the data, I first plotted monthly and yearly counts of 
outpatient specialty mental health visits among children and adolescents, in order to 
consider the shape of the graph. Figure 12 shows outpatient visits graphed by month and 
year, and Figure 13 shows visits graphed only by year. For comparative purposes, 
monthly and yearly counts for psychiatric ED visits during the same period are also 
included on the graphs. Both graphs indicate that outpatient specialty mental health visits 
among children and adolescents decreased between 2011 and 2014, and then increased 
from 2014 through 2017.   
Figure 12 
Secular trends in outpatient specialty mental health services by month-year 
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Figure 13 
Secular trends in outpatient specialty mental health services by year 
 
 
To further examine secular trends in outpatient specialty mental health visits, 
Spearman correlation coefficients were calculated, as this method requires no 
assumptions related to the nature of potential associations or outcome distribution (Ely et 
al., 1997). Spearman correlations were calculated for the association between both year-
month and year to better account for the seasonal patterns established in previous 
sections. The Spearman correlations indicated that there were not significant monotonic 
associations between month-year and count of outpatient visits (ρ = -.10, p = .32) or 
between year and count of outpatient visits (ρ = -.21, p = .65), suggesting that the number 
of outpatient visits did not change monotonically as a function of time.   
Based on the shape of the data as graphed in Figures 12 and 13, I estimated a 
quadratic regression model to test for a parabolic trend. Results, as shown Table 13, 
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indicated a significant parabolic trend in outpatient visits. Additionally, both regression 
models are displayed in Figures 14 and 15, along with the observed data.  
Table 13 
Secular trends in outpatient specialty mental health services: Quadratic regressions 
 
 Year Month-year 
 Standardized β Standardized β 
Time -4.49** -2.51*** 
Time2 4.20** 2.39*** 
   
Model R2 .94** .39*** 
 
 
           An identical series of analyses (graphing, Spearman correlations, and quadratic 
regression) were performed on sub-samples of the data stratified by race/ethnicity, to 
examine secular trends across racial and ethnic groups. Figure 16 shows the rate of 
outpatient specialty mental health visits (per 10,000 youth) by year, within each 
racial/ethnic subsample. Figure 16 suggests that rates of outpatient specialty mental 
health visits decreased from 2011 to 2014 and increased from 2014 to 2017 across all 
racial/ethnic groups. To further explore these secular trends within racial and ethnic sub-
samples, spearman correlation coefficients and quadratic regression models were 
estimated. Results are shown in the Table 14. 
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Figure 14 
Secular trends in psychiatric ED visits by month-year: Quadratic regression 
 
 
These findings confirm that rates of outpatient specialty mental health service use among 
youth in the study sample followed similar quadratic patterns from late 2010 through 
early 2018 across racial and ethnic groups. In addition, the spearman correlation 
coefficients suggest that overall, outpatient visits by Black patients increased and by 
White patients decreased.  
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Figure 15 
Secular trends in psychiatric ED visits by month-year: Quadratic regression 
 
 
 
Continuity of Care 
 Continuity of care was examined for the sample of 2,741 youth who received 2 or 
more outpatient treatment sessions (70.4% of youth receiving any outpatient care, 11.2% 
of study sample). For each patient, outpatient visits were organized into treatment 
periods. A treatment period is defined as the period beginning the day of a patient’s initial 
visit, or their initial visit after a break in treatment of 90 days or longer, and ending when 
care stops for 90 days or longer (a duration used in prior research; Cook et al., 2017; 
Cook et al., 2014; Tansella et al., 1995). Using these procedures, 29,026 outpatient 
specialty mental health visits were organized into 6,034 treatment periods.  
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Figure 16 
Racial/ethnic variations in secular outpatient treatment trends 
 
 
  
Table 14 
Secular trends in outpatient specialty mental health services: Time-trend analyses 
 
 Year Month-year 
 Spearman 
Correlation 
Coefficient (ρ) 
Quadratic  
coefficient 
(time2) 
Spearman 
Correlation 
Coefficient (ρ) 
Quadratic  
coefficient 
(time2) 
Black -.64 2.87** -.51*** 1.44*** 
Hispanic .00 4.44** .20 2.44*** 
White .21 4.40** .27** 2.83*** 
Multi-racial/other -.04 4.34** .07 1.05* 
 
 
Youth who received multiple outpatient specialty mental health visits averaged 
2.16 treatment periods (SD = 1.86) during the study period. Male youth experienced 
significantly more treatment periods (M = 2.39, SD = 2.10) than female youth (M = 1.84, 
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SD = 1.39), t(2,500.76) = 7.84, p < .001. There were also significant differences in in the 
number of treatment periods youth engaged on based upon insurance class F(2,505) = 
8.13, p < .001. Patients using Medicaid (M = 2.25, SD = 1.96) engaged in significantly 
more treatment periods than those using private insurance (M = 1.91, SD = 1.49). Youth 
with two or more comorbid psychiatric disorders (M = 2.23, SD = 1.91) experienced 
significantly more treatment periods than those diagnosed with only one disorder (M = 
1.57, SD = 1.24), t(434.22) = -7.68, p < .001.  
There were also significant racial and ethnic differences in the number of 
treatment periods that patients engaged in, F(2,127) = 10.81, p < .001. In particular, 
Black youth (M = 2.48, SD = 2.22) experienced significantly more outpatient treatment 
periods than Hispanic youth (M = 2.23, SD = 1.95), White youth (M = 1.83, SD = 1.34), 
and multi-racial youth or those from another racial and ethnic background (M = 1.65, SD 
= .71). Additionally, Hispanic youth experienced significantly more treatment periods 
than White youth. Analysis of multiple imputed data yielded similar results (detailed 
results in Appendix J). Five of ten imputations indicated no significant differences 
between Black and Hispanic youth and five of ten imputations indicated that Hispanic 
youth engaged in significantly more treatment periods than youth identified as multi-
racial or from another racial/ethnic group. Despite these inconsistencies, analyses clearly 
showed that Black and Hispanic youth engaged in significantly more treatment periods 
than White youth. Practically speaking, youth who engage in more treatment periods 
experience more interruptions in treatment over the long term, than youth who engage in 
fewer treatment periods.   
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Continuity of care was further measured in three distinct ways: duration of 
treatment period, quantity of visits during a treatment period, and frequency of visits 
during a treatment period (calculated as the average number of days since the previous 
visit across a treatment period). To correct for left-censoring in the data, adjustments 
were made to exclude treatment periods that may have begun prior to the first day for 
which data were available. Treatment periods that started between August 1, 2010 and 
October 30, 2010 (the first 90 days for which data were available) may have in fact begun 
prior to August 1, 2010, and were therefore excluded from analysis. This resulted in the 
exclusion of 240 treatment periods (4.0%). There were no significant differences in 
patient sex, race/ethnicity, or insurance class between treatment periods that were 
excluded and those that were not. However, excluded treatment periods were involved 
patients who were significantly older, t(6032) = -6.57, p < .001, and had diagnoses from 
significantly more categories, t(6032) = -6.63, p < .001, than treatment periods that were 
not excluded.  
Treatment duration. To account for right-censoring in the data, Kaplan-Meier 
survival estimation was used to examine treatment duration. These analyses allow for the 
estimation of both the average and median duration of treatment period (i.e. the survival 
time). The median treatment duration was reported instead of the average treatment 
duration, because the average values are heavily influenced by the right-censored nature 
of the data (Zwiener et al., 2011). Analysis indicated a median treatment duration of 
48.00 days (SE = 1.85). The Kaplan-Meier survival curve is shown in Figure 17.  
A series of Kaplan-Meier survival curves were estimated to examine 
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sociodemographic differences in treatment duration. Because Kaplan-Meier analysis does 
not handle continuous independent variables, age and comorbidity were recoded as 
categorical variables.  Median estimates for treatment duration and 95% confidence 
intervals are show in Table 15. Analyses indicated that female patients engaged in 
significantly longer treatment periods than male patients (difference in median estimates 
= 14 days). There were no significant differences in treatment duration based on age at 
treatment initiation or race/ethnicity. Treatment duration for patients using Medicaid was  
Figure 17 
Kaplan-Meier survival curve for treatment duration 
 
 
significantly longer than for patients using private health insurance (difference in median 
estimates = 17 days). Patients with diagnoses from 2 or more disorder categories engaged 
in significantly longer treatment periods than patients with diagnoses from one category.   
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Seasonal Patterns. In order to examine seasonal variation in treatment duration, 
Kaplan-Meier survival curves were estimated for treatment initiated in each month of the 
calendar year. Figure 18 shows the median treatment duration for each month, with 95% 
confidence intervals. Treatment initiated in May had a significantly shorter duration than 
treatment initiated in February, March, September, and October.  
Table 15 
Median estimates for treatment duration: Kaplan-Meier survival analysis 
 
 Median estimate 95% confidence interval 
Sex   
     Male 42.00 37.62, 46.38 
     Female 56.00 50.27, 61.73 
Age   
     5-9 years 48.00 42.08, 53.92 
     10-13 years 42.00 35.02, 48.98 
     14-18 years 52.00 45.66, 58.34 
Race/ethnicity   
     Black 48.00 42.57, 53.43 
     Hispanic 54.00 48.11, 59.89 
     White 51.00 40.43, 61.57 
     Multi-racial/other 25.00 .30, 49.70 
Insurance class   
     Medicaid 51.00 46.76, 55.25 
     Health safety-net 36.00 10.15, 61.85 
     Private 34.00 26.86, 41.14 
Comorbidity   
     1 disorder category 26.00 19.02, 32.98 
     2+ disorder categories 49.00 45.32, 52.68 
 
To examine racial/ethnic differences in seasonal variation in treatment duration, 
Kaplan-Meier survival curves were estimated for treatment duration within three sub-
samples stratified for race/ethnicity (Black, Hispanic, and White). Youth identified as 
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multi-racial or another race/ethnicity were excluded from this analysis because of the 
small sample size (N=119), which did not allow for the calculation of standard errors and 
confidence intervals for many of the median estimates. Figure 19 and Table 16 show the 
median treatment duration estimates for each month, within each racial/ethnic subsample. 
In addition, Table 16 includes 95% confidence intervals. 
Figure 18 
Seasonal patterns in treatment duration: Kaplan-Meier median estimates 
 
 
As shown in Figure 19, treatment duration among Black youth is longest for 
treatment initiated in March, and then seems to decrease for treatment initiated through 
June. Duration then increases drastically for treatment periods initiated in July, and 
remains relatively steady for treatment initiated for the rest of the year. Treatment 
initiated in June was significantly shorter in duration than treatment initiated in January, 
March, August, and October. Treatment initiated in April and May was significantly 
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shorter in duration than treatment initiated in March.  
Figure 19 
Racial/ethnic variations in seasonal patterns for treatment duration 
 
 
 
Among Hispanic youth treatment duration is highest for treatment initiated in January 
and June. Treatment duration seems to decrease for treatment initiated in February 
through May. After the spike in duration for treatment initiated in June, duration drops 
drastically for treatment initiated in July. Duration time then rises for treatment initiated 
in August and remains relatively steady for the rest of the year. Also, among Hispanic 
youth, treatment initiated in July was significantly shorter in duration than treatment 
initiated in all other months (except May). Treatment initiated in May was significantly 
shorter in duration than treatment initiated in January, February, June, and December.    
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Table 16 
Seasonal patterns in treatment duration: Kaplan-Meier median estimates 
 
 Black (n = 2,740) Hispanic (n = 1,534) White (n = 680) 
 Median 95% CI Median 95% CI Median 95% CI 
January 56.00 36.94, 75.06 70.00 49.48, 90.52 14.00 .00, 38.10 
February 45.00 22.61, 67.39 62.00 51.87, 72.13 64.00 35.85, 92.15 
March 62.00 49.27, 74.73 48.00 37.85, 58.15 48.00 34.10, 61.90 
April 37.00 26.83, 47.17 51.00 36.19, 65.81 62.00 .00, 126.38 
May 30.00 17.46, 42.54 33.00 19.92, 46.08 81.00 55.09, 106.91 
June 17.00 .71, 33.29 69.00 46.92, 91.08 11.00 n/a 
July 50.00 24.28, 75.72 14.00 .00, 29.69 46.00 20.32, 85.83 
August 54.00 36.74, 71.26 56.00 36.87, 75.13 1.00 n/a 
September 50.00 31.67, 68.33 51.00 38.43, 63.57 64.00 40.24, 87.76 
October 51.00 35.49, 66.51 55.00 38.50, 71.50 93.00 65.03, 120.97 
November 48.00 31.23, 64.77 58.00 27.93, 88.07 42.00 .00, 120.44 
December 55.00 28.05, 81.95 54.00 48.11, 59.89 51.00 40.43, 61.57 
 
 
Among White youth, treatment duration was highest for treatment initiated in 
October, and then seems to generally decrease for treatment initiated through January. 
Duration then generally increases for treatment initiated through May. Among White 
youth, treatment initiated in January was significantly shorter in duration than treatment 
initiated in May, September, October, or December.  Treatment initiated in March or 
December was significantly shorter in duration than treatment initiated in October.  Due 
to the small sample size for this population (N = 680) in relation to the number of months 
per year (12), SPSS was unable to calculate standard errors for treatment initiated in June 
and August. It is therefore difficult to draw conclusions about patterns for treatment 
initiated in June through August.  
Secular trends. In order to examine secular trends in treatment duration, Kaplan-
Meier survival curves were estimated for treatment initiated in the years 2011-2017 (for 
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which data were available for the full calendar year). The graph below shows the median 
treatment duration for each year, with 95% confidence intervals. As shown in Figure 20, 
treatment duration seems to be significantly increasing across the study period. As a 
sensitivity analysis, the same procedure was performed on a dataset including the 240 
cases excluded due to left censoring; results indicated the identical median estimates for 
each year (details in Appendix K).  
Figure 20 
Secular trends in treatment duration: Kaplan-Meier median estimates 
 
 
To further examine secular trends in treatment duration, Spearman correlation 
coefficients were calculated for the median yearly estimates. The Spearman correlation 
coefficient indicated that there were not significant associations between year and count 
of outpatient visits (ρ = .71, p = .07). Failure to reach significance may be related to the 
small sample size (n = 7 years).  I also estimated a simple time-series regression model to 
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test for linear trends (Ely et al., 1997). Results indicated a significant linear increase in 
the median treatment duration across the study period (β = .80, p < .05). The similarity 
between the Spearman correlation coefficient and the linear regression coefficient 
suggests that the upward trend was linear (as opposed to another shape).  
 To examine racial/ethnic differences in secular trends in treatment duration, 
Kaplan-Meier survival curves were estimated for treatment duration within three sub-
samples stratified for race/ethnicity (Black, Hispanic, and White). Youth identified as 
multi-racial or another race/ethnicity were excluded from this analysis because of the 
small sample size (N=119), which did not allow for the calculation of standard errors and 
confidence intervals for many of the median estimates.  Figure 21 shows the median 
treatment duration within each subsample. As shown, median treatment duration 
increased across all racial/ethnic groups during the study period.  Spearman correlations 
and linear regression models were estimated for median duration estimates from the 
Kaplan-Meier analyses. Table 17 shows the Spearman correlation coefficients and 
regression coefficients within each sub-sample. Results indicated that treatment duration 
significantly increased across the study period only among Hispanic youth. 
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  Figure 21 
Racial/ethnic variations in secular trends for treatment duration 
 
 
 
Table 17 
Racial/ethnic variations in secular trends for treatment duration: Time-trend analyses 
 
 Spearman 
Correlation 
Coefficient (ρ) 
Linear 
Regression 
Coefficient (β) 
Black .51 .51 
Hispanic .82* .84* 
White .63 .68 
 
 
Treatment Quantity. To account for right-censoring in the data, Kaplan-Meier 
survival estimation was used to examine treatment quantity. Analysis indicated a median 
quantity of 2.00 visits (SE = .042) for each treatment period. The median treatment 
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quantity was reported instead of the average treatment quantity, because the average 
values are heavily influenced by the right-censored nature of the data (Zwiener et al., 
2011). The Kaplan-Meier survival curve is shown in Figure 22.  
Figure 22 
Kaplan-Meier survival curve for treatment quantity 
 
 
 
A series of Kaplan-Meier survival curves were then estimated to examine 
sociodemographic differences in treatment quantity. Because Kaplan-Meier analysis does 
not handle continuous independent variables, age and comorbidity were recoded as 
categorical variables.  Median estimates for treatment quantity and 95% confidence 
intervals are show Table 18. Analyses indicated that female patients received 
significantly more treatment visits within a given treatment period than male patients 
(difference in median estimates = 1 visit). In addition, patients aged 14-18 at treatment 
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initiation received significantly more treatment visits within a given treatment period than 
patients aged 5-9 and patients aged 10-13 at treatment initiation (difference in median 
estimates = 1 visit). White patients received significantly more treatment visits within a 
given treatment period than Black patients, Hispanic patients, and those identified as 
multi-racial or another race/ethnicity (difference in median estimates = 1 visit). There 
were no significant differences in treatment quantity based on insurance class at treatment 
initiation or diagnoses from 2 or more disorder categories.    
Table 18 
Median estimates for treatment quantity: Kaplan-Meier survival analysis 
 
 Median estimate 95% confidence interval 
Sex   
     Male 2.00 1.92, 2.08 
     Female 3.00 2.86, 3.14 
Age   
     5-9 years 2.00 1.91, 2.09 
     10-13 years 2.00 1.84, 2.16 
     14-18 years 3.00 2.83, 3.17 
Race/ethnicity   
     Black 2.00 1.88, 2.12 
     Hispanic 2.00 1.85, 2.15 
     White 3.00 2.75, 3.25 
     Multi-racial/other 2.00 1.39, 2.61 
Insurance class   
     Medicaid 2.00 1.91, 2.09 
     Health safety-net 2.00 1.23, 2.77 
     Private 2.00 1.87, 2.13 
Comorbidity   
     1 disorder category 2.00 1.75, 2.25 
     2+ disorder categories 2.00 1.91, 2.09 
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Seasonal Patterns. In order to examine seasonal variation in treatment quantity, 
Kaplan-Meier survival curves were estimated for treatment initiated in each month of the 
calendar year. Figure 23 shows the median treatment quantity for treatment periods in 
each month of the year, with 95% confidence intervals. Patients who initiated treatment 
in October received significantly more treatment visits within a given treatment period 
than patients who initiated treatment any other time during the year.    
Figure 23 
Seasonal patterns in treatment quantity: Kaplan-Meier median estimates 
 
 
To examine racial/ethnic differences in seasonal variation in treatment quantity, 
Kaplan-Meier survival curves were estimated for treatment quantity within three sub-
samples stratified for race/ethnicity (Black, Hispanic, and White). Youth identified as 
multi-racial or another race/ethnicity were excluded from this analysis because of the 
small sample size (N=119), which did not allow for the calculation of standard errors and 
0
0.5
1
1.5
2
2.5
3
3.5
Tr
ea
tm
en
t 
vi
si
ts
 96 
confidence intervals for many of the median estimates.  Figure 24 shows the median 
treatment quantity within each subsample, and Table 19 also includes 95% confidence 
intervals.  
Figure 24 
Racial/ethnic variations in seasonal patterns for treatment quantity 
 
 
 
Treatment quantity among Black youth was significantly higher for treatment 
initiated in March and October than during the rest of the year. Among Hispanic youth, 
treatment quantity was significantly higher in October than in March, July, and August, 
and significantly higher in January than in March and July. Among White youth, 
treatment quantity was significantly higher in October than in January, August, and 
November and significantly higher in December than in January. Due to the small sample 
size for this population (N = 680) in relation to the number of months per year (12), SPSS 
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was unable to calculate standard errors for treatment initiated in June. It is therefore 
difficult to draw conclusions about patterns for treatment initiated in June.  
Table 19 
Seasonal patterns in treatment quantity: Kaplan-Meier median estimates 
 
 Black Hispanic White 
 Median 95% CI Median 95% CI Median 95% CI 
January 2.00 1.54, 2.46 3.00 2.42, 3.58 2.00 1.36, 2.64 
February 2.00 1.74, 2.26 3.00 2.34, 3.66 3.00 1.52, 4.48 
March 3.00 2.62, 3.38 2.00 1.61, 2.38 3.00 2.20, 3.80 
April 2.00 1.73, 2.27 2.00 1.43, 2.57 3.00 1.91, 4.09 
May 2.00 1.69, 2.31 2.00 1.51, 2.49 3.00 2.22, 3.78 
June 2.00 1.63, 2.38 3.00 2.14, 3.86 2.00 n/a 
July 2.00 1.44, 2.56 2.00 1.59, 2.41 3.00 1.72, 4.28 
August 2.00 1.61, 2.39 2.00 1.55, 2.45 2.00 1.16, 2.84 
September 2.00 1.69, 2.31 2.00 1.56, 2.44 3.00 2.35, 3.65 
October 3.00 2.60, 3.40 3.00 2.46, 3.54 4.00 3.10, 4.90 
November 2.00 1.57, 2.43 2.00 1.52, 2.48 2.00 1.18, 2.83 
December 2.00 1.88, 2.12 3.00 2.27, 3.73 2.00 2.75, 3.25 
 
 
Secular Trends. In order to examine secular trends in treatment quantity, Kaplan-
Meier survival curves were estimated for treatment initiated in the years 2011-2017 (for 
which data were available for the full calendar year). Figure 25 shows the median 
treatment quantity for each year, with 95% confidence intervals. As shown on the graph, 
median treatment quantity increased in 2013 and 2015, but overall remained steady 
across the study period.  To further examine secular trends in treatment duration, 
spearman correlation coefficients were calculated for the median yearly estimates. The 
spearman correlation coefficient indicated that there were not significant associations 
between year and median quantity of visits (ρ = .00, p = 1.00). I also estimated a simple 
time-series regression model to test for linear trends (Ely et al., 1997). Results indicated 
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that year and median treatment quantity were not associated across the study period (β = 
.00, p < 1.00). Taken together, these results indicate that quantity of treatment visits did 
not change significantly during the study period.  
Figure 25 
Secular trends in treatment quantity: Kaplan-Meier median estimates 
 
 
 To examine racial/ethnic differences in secular trends in treatment quantity, 
Kaplan-Meier survival curves were estimated for treatment quantity within three sub-
samples stratified for race/ethnicity (Black, Hispanic, and White). Youth identified as 
multi-racial or another race/ethnicity were excluded from this analysis because of the 
small sample size (N=119), which did not allow for the calculation of standard errors and 
confidence intervals for many of the median estimates.  Figure 26 shows the median 
treatment quantity for each year within each subsample. In addition, Table 20 shows the 
median treatment quantity for each year, with 95% confidence intervals.  
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Figure 26 
Racial/ethnic variations in secular trends for treatment quantity 
 
 
Among Black youth, median treatment quantity in 2012 and 2013 was 
significantly greater than in 2011, 2014, 2015, 2016, and 2017. Overall treatment 
quantity remained roughly the same across the study period. Among Hispanic youth, 
median treatment quantity in 2013 was significantly greater than in 2011 and 2016. 
Median treatment quantity in 2015 was significantly greater than in 2011, 2012, 2014, 
2016, and 2017. Overall treatment quantity remained roughly the same across the study 
period.  Among White youth, although treatment quantity does seem to be increasing 
with the duration of time, there were no significant differences in median treatment 
quantity between any years in the study period. However, for 2011, the survival function 
did not reach .45, and thus confidence intervals could not be calculated. 
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Table 20 
Racial/ethnic variations in secular trends for treatment quantity 
 
 Black Hispanic White 
 Median 95% CI Median 95% CI Estimate 95% CI 
2011 2.00 1.80, 2.20 2.00 1.76, 2.24 2.00 n/a 
2012 3.00 2.61, 3.40 2.00 1.50, 2.50 2.00 .99, 3.01 
2013 3.00 2.59, 3.41 3.00 2.34, 3.66 2.00 1.43, 2.57 
2014 2.00 1.75, 2.26 2.00 1.43, 2.57 3.00 1.77, 4.23 
2015 2.00 1.63, 2.38 3.00 2.61, 3.39 3.00 2.04, 3.96 
2016 2.00 1.77, 2.23 2.00 1.78, 2.22 3.00 2.32, 3.68 
2017 2.00 1.72, 2.28 2.00 1.65, 2.36 3.00 2.19, 3.81 
 
 
Spearman correlations and linear regression models were estimated for median 
treatment quantity estimates from the Kaplan-Meier analyses. The table below shows the 
Spearman correlation coefficients and regression coefficients within each sub-sample. 
Results indicated that treatment quantity significantly increased across the study period 
only among White youth.  The similarity between the spearman-rank correlation 
coefficients and the linear regression coefficients indicates that the trend is in fact linear.  
Table 21 
Racial/ethnic variations in secular trends for treatment quantity: Time-trend analysis 
 
 Spearman 
Correlation 
Coefficient (ρ) 
Linear 
Regression 
Coefficient (β) 
Black -.47 -.47 
Hispanic .00 .00 
White .87* .87* 
 
 Treatment frequency. To calculate treatment frequency, I first calculated the 
number of days since the previous visit for every day within the study period. I then took 
the average of these values. Treatment frequency is not subject to right-censoring in the 
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same way as treatment duration and quantity. Although treatment frequency might 
change for an unfinished treatment period, there is no reason to believe that it would only 
change in one direction. For example, we know that treatment duration and quantity for 
an unfinished treatment period would only stay the same or increase past the end of the 
study period; in comparison, treatment frequency could change in either direction, and 
therefore the value for an unfinished treatment period can be used as a reasonable 
estimate for what treatment frequency might be for the entire study period. For this 
reason, a different series of analyses was used to examine treatment frequency.   
Frequency of outpatient visits during a treatment period could only be calculated 
for treatment periods with at least 2 visits that spanned more than one day (N = 3,871, 
64.2% of treatment periods). The average frequency of visits during a treatment period 
was 21.33 days between visits (SD = 10.17). Male youth received significantly less 
frequent visits (M = 22.39 days between visits, SD = 10.30) than female youth (M = 
19.52, SD = 9.97), t(3,423) = 7.99, p < .001. Patients who were older at treatment 
initiation received significantly less frequent visits than those who were younger at 
treatment initiation (B = -.13, SE = .05, p<.01). There were significant differences in the 
frequency of visits by insurance class F(3,425) = 13.21, p < .001; patients using Medicaid 
(M = 21.76, SD = 10.21) received less frequent treatment than those using private 
insurance (M = 19.67, SD = 10.34). Youth with two or more comorbid psychiatric 
disorders (M = 21.54, SD = 10.18) received significantly less frequent visits than those 
diagnosed with only one disorder (M = 18.14, SD = 10.85), t(3,424) = -5.03, p < .001. 
There were few racial and ethnic differences in the frequency of visits within a 
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treatment period, F(3,415) = 3.77, p < .05. Black youth (M = 21.60, SD = 10.20), 
Hispanic youth (M = 21.49, SD = 10.20), and White youth (M = 21.10, SD = 9.83) 
engaged in treatment significantly less frequently than youth who were multi-racial or 
another race (M = 17.53, SD = 8.12). Analysis of multiply imputed data yielded similar 
results, although with some discrepancies regarding youth identified as multi-racial or 
from another racial/ethnic background (detailed results in Appendix L). In most 
imputations, the differences between youth in the multi-racial/other category and youth in 
the three other categories (Black, Hispanic, White) were non-significant (in six of ten 
imputations for multi-racial/other youth as compared to White youth; in three of ten 
imputations for multi-racial/other youth as compared to Black and Hispanic youth). 
Overall, results indicate no significant racial/ethnic differences in frequency of treatment 
between the three largest groups in the study, Black, Hispanic, and White youth.  
Seasonal Patterns. The average monthly values for treatment frequency are 
shown in Figure 27.  Treatment periods initiated in September tended to have less 
frequent visits and treatment periods initiated in February and April tended to have more 
frequent visits. Generalized linear modeling was used to estimate seasonal variations in 
treatment frequency. The reference month was the month with the average frequency 
closest to the average frequency for the entire sample (December). First, a baseline model 
was fit. A second model was then fit to control for secular trends. A final model was fit to 
control for sociodemographic covariates (age, sex, race/ethnicity, insurance class, and the 
number of comorbid diagnosis categories). Regression coefficients and standard errors 
from each model are shown in Table 22.  
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Figure 27 
Seasonal patterns in treatment frequency 
 
 
 
These results cannot be interpreted in the same way that as the results for 
treatment duration and quantity. In this case, the dependent variable, frequency of 
treatment, is higher for treatment that is less consistent (more days between visits) and 
lower for treatment that is more consistent (fewer days between visits). When interpreting 
regression coefficients, a negative value indicates more frequent visits (an indicator of 
good continuity of services) and a positive value indicates less frequent visits (an 
indicator of poor continuity of services).   
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Table 22 
Seasonal patterns in treatment frequency: GLMs 
 
 Model 1 Model 2 Model 3 
 B (SE) 
Month    
     January .19 (.79) -.90 (.79) -.85 (.76) 
     February -.91 (.82) -1.75 (.82)* -1.84 (.79)* 
     March -1.00 (.76) -1.73 (.76)* -1.77 (.73)* 
     April -1.44 (.82) -1.91 (.81)* -1.95 (.78)* 
     May .21 (.83) -.40 (.82) -.44 (.79) 
     June -.52 (.88) -.81 (.87) -.63 (.85) 
     July -.39 (.88) -.91 (.87) -.91 (.84) 
     August .22 (.76) .23 (.75) .29 (.73) 
     September 1.38 (.77) 1.37 (.76) 1.18 (.74) 
     October -.33 (.77) -.50 (.76) -.43 (.74) 
     November .40 (.80) .19 (.79) .39 (.76) 
     December ref ref ref 
Year  .68 (.07)*** .73 (.07)*** 
Age   -.39 (.04)*** 
Female   -2.32 (.33)*** 
Race/Ethnicity    
     Black   ref 
     Hispanic   -.31 (.37) 
     White   .18 (.50) 
     Multi-racial/other   -3.56 (1.19)** 
Insurance    
     Medicaid   ref 
     HSN   -2.91 (1.25)* 
     Private   -1.55 (.41)*** 
Comorbidity   .44 (.09)*** 
 
Consistent with Figure 27, the GLM estimates in Table 22 indicate that patients 
who initiated treatment in February, March, and April, engaged in treatment significantly 
more frequently than in December. In particular, this was true when the model accounted 
for secular trend, in which treatment frequency significantly decreased across the study 
period. The seasonal patterns also remained when controlling for sociodemographic 
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variables.  
Patients who were older at treatment initiation engaged in treatment significantly 
more frequently than patients who were younger at treatment initiation. Treatment was 
also significantly more frequent among female youth than male youth in the sample. 
Treatment was significantly more frequent among patients who used private health care 
or health safety-net services than among those who used Medicaid. Finally, patients with 
diagnoses from more disorder categories engaged in treatment significantly less 
frequently than patients with diagnoses from fewer categories. Hispanic and White youth 
engaged in treatment about as frequently as Black youth; however, youth identified as 
multi-racial, or from another racial/ethnic background, engaged in treatment significantly 
more frequently than Black youth. Analysis in multiply imputed data sets yielded similar 
findings (pooled results are available in Appendix M).  
The same series of analyses (direct comparison, sequence of three GLMs) was 
applied to sub-samples stratified by race/ethnicity. Figure 28 shows the monthly averages 
for treatment frequency for Black youth, Hispanic youth, and White youth. Youth 
identified as multi-racial or from another racial/ethnic background were excluded from 
this series of analyses, as the sample size was very small (N=69). The trend line for the 
entire sample is included for comparative purposes. 
A series of GLMs were fit to estimate treatment frequency for each racial/ethnic 
sub-sample. First, a baseline model was fit. A second model was then fit to control for 
secular trends. A final model was fit to adjust for sociodemographic covariates (age, sex, 
insurance class, and number of comorbid disorder categories). The reference month for 
 106 
each model was the month for which the average treatment frequency was closest to the 
average treatment frequency for the corresponding racial/ethnic sub-sample. Regression 
coefficients and standard errors for each of the final models are shown in Table 23. 
Figure 28 
Racial/ethnic variations in seasonal patterns for treatment frequency 
 
 
 
The only significant seasonal effects in treatment frequency occurred among 
Black and Hispanic youth. Among Black youth only, treatment initiated in September 
was associated with significantly less frequent treatment sessions than treatment initiated 
during the reference month and treatment initiated in February was associated with 
significantly more frequent treatment sessions that treatment initiated during the 
reference month. Among Hispanic youth, treatment initiated in April was associated with 
significantly more frequent treatment sessions than treatment initiated during the 
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reference month. Results also indicated that treatment became significantly less frequent 
across the study period among all racial/ethnic sub-samples.  
Table 23 
Racial/ethnic variations in seasonal patterns for treatment frequency: GLMs 
 
 Black Hispanic White 
Month B (SE) 
     January -.76 (1.08) -.15 (1.34) -1.42 (2.42) 
     February -2.63 (1.18)* -1.10 (1.37) -1.00 (2.22) 
     March -1.25 (1.03) -2.62 (1.30)* -2.61 (2.27) 
     April -1.26 (1.10) -1.81 (1.45) -2.02 (2.52) 
     May -.28 (1.16) .63 (1.41) .07 (2.36) 
     June -1.49 (1.25) 1.64 (1.44) -1.99 (2.69) 
     July -1.06 (1.20) -.49 (1.61) 1.02 (2.53) 
     August .76 (1.02) .98 (1.31) -.28 (2.40) 
     September 2.96 (1.04)** ref -.60 (2.28) 
     October .03 (1.06) -.23 (1.32) .79 (2.19) 
     November .21 (1.08) 1.41 (1.34) -.55 (2.30) 
     December ref 1.28 (1.42) ref 
Year .78 (.10)*** .97 (.13)*** .50 (.28)** 
Age -.35 (.06)*** -.44 (.08)*** -.25 (.13)* 
Female -2.11 (.48)*** -3.12 (.62)*** -2.38 (.93)* 
Insurance class    
     Private -.81 (.59) -3.49 (.99)*** -2.44 (.96)* 
     HSN -2.62 (2.15) -3.29 (2.47) -.02 (2.80) 
     Medicaid ref ref ref 
Comorbidity .30 (.13)* .47 (.17)** .60 (.25)* 
 
Age at treatment initiation was significantly associated with treatment duration 
among Black, Hispanic, and White youth, such that youth who were older at treatment 
initiation engaged in significantly more frequent treatment than those who were younger 
at treatment initiation. Sex was also associated with treatment frequency among Black, 
Hispanic, and White youth, such that female youth engaged in significantly more 
frequent treatment sessions than male youth. Insurance class was associated with 
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treatment duration only among Hispanic and White youth, such that those using private 
health insurance engaged in significantly more frequent treatment than those using 
Medicaid. Among all youth, those with psychiatric diagnoses from a greater number of 
disorder categories received significantly less frequent treatment than those with 
diagnoses from fewer categories.   
Secular Trends. To further explore secular trends in frequency of outpatient 
specialty mental health treatment, I first plotted averages for frequency of outpatient 
specialty mental health visits among children and adolescents by month-year and year. 
Figure 29 shows secular patterns by month-year and Figure 30 shows secular patterns by 
year. Both graphs indicate a small but steady increase in the average time between 
outpatient specialty mental health visits across the study period. 
To further examine frequency of outpatient specialty mental health visits, 
spearman correlation coefficients were calculated, as this method requires no 
assumptions related to the nature of potential associations or outcome distribution (Ely et 
al., 1997). Spearman correlations were calculated for the association between both 
month-year and year to better account for the seasonal patterns established in previous 
sections. The spearman correlations indicated a significant positive association between 
month-year and number of days between visits (ρ =.60, p < .001) as well as, between 
year and number of days between visits (ρ = .96, p < .001), suggesting that frequency of 
visits decreased across the study period.   
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Figure 29 
Secular patterns in treatment frequency by month-year 
 
 
 
Based on the shape of the data in Figures 29 and 30, I estimated simple linear 
regression models to test for linear trend. Results indicated that both month-year (β = .56, 
p < .001) and year (β= .92, p < .001) were significantly and positively associated with the 
average number of days between outpatient visits. This confirms that visit frequency 
significantly decreased across the study period. The similarity between the spearman 
correlation coefficients and the linear regression coefficients suggests that the upward 
trend is linear. 
An identical series of analyses (graphing, spearman correlations, and linear 
regression) were performed on sub-samples of the data stratified by race/ethnicity, to 
examine secular trends across racial and ethnic groups. Figure 31 shows the average 
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number of days between visits by year within each racial/ethnic subsample. The graph 
indicates that the number of days between outpatient specialty mental health visits 
increased across the study period, meaning that treatment became less frequent over time.  
Figure 30 
Secular patterns in treatment frequency by year 
 
 
   
To further explore these secular trends within racial and ethnic sub-samples, 
spearman correlation coefficients and linear regression models were estimated. Results 
are shown in Table 24. Findings indicate that number of days between outpatient 
specialty mental health visits among Black and Hispanic youth was increasing at a 
similar rate across the study period; among White youth, number of days between 
treatment sessions was increasing, but less than among non-White youth. 
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Figure 31 
Racial/ethnic variations in secular patterns for treatment frequency 
 
 
   
Table 24 
Racial/ethnic variations in secular patterns for treatment frequency: Time-trend analyses 
 
 Year Month-year 
 Spearman 
Correlation 
Coefficient (ρ) 
Linear 
regression 
coefficient (β) 
Spearman 
Correlation 
Coefficient (ρ) 
Linear 
regression 
coefficient (β) 
Black .75 .89** .48*** .43*** 
Hispanic .96*** .98*** .46*** .41*** 
White .75 .63 .31** .26* 
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Research Question 3: Outpatient Care and Psychiatric ED Presentation 
A series of binary logistic regression models were estimated to examine the 
association between any outpatient specialty mental health service use during the study 
period and any psychiatric ED presentation, among the sample of youth with diagnosed 
emotional and behavioral disorders. Model 1 included only sociodemographic covariates 
(sex, race/ethnicity, and the continuous indicator of comorbidity). Model 2 included a 
binary indicator of outpatient specialty mental healthcare at any time during the study 
period. Odds ratios and 95% confidence intervals for these models are shown in Table 25.  
Table 25 
Association between any outpatient treatment and psychiatric ED presentation 
 
 Model 1 Model 2 
 OR 95% CI OR 95% CI 
Female 1.41*** 1.33, 1.49 1.41*** 1.33, 1.50 
Race/ethnicity     
     Hispanic 1.20*** 1.12, 1.29 1.21*** 1.12, 1.30 
     White 1.05 .96, 1.13 1.04 .95, 1.12 
     Multi-racial/other 1.69*** 1.47, 1.94 1.69*** 1.47, 1.95 
Lifetime use of Medicaid 1.03 .95, 1.12 1.05 .97, 1.15 
Lifetime use of safety-net care 1.93*** 1.78, 2.10 1.95*** 1.80, 2.13 
Lifetime use of private insurance .89** .83, .96 .91* .85, .98 
Comorbidity 1.24*** 1.21, 1.26 1.29*** 1.26, 1.32 
Outpatient service use   .71*** .65, .77 
 
Results indicated that female patients were more likely to present in the ED for 
psychiatric reasons than male patients. Hispanic youth and youth identified as multi-
racial or from another racial/ethnic background were at greater risk for psychiatric ED 
presentation than Black youth; there were no significant differences in ED presentation 
between Black and White youth. Patients who had utilized health safety-net care at any 
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point during the study period were more likely to present in the ED for psychiatric 
reasons than their peers who had not utilized health safety net services. Additionally, 
patients who had used private health insurance at any point during the study period were 
less likely to present in the ED for psychiatric reasons than their peers who had not used 
private health insurance. Youth with diagnoses from more disorder categories were at 
greater risk for psychiatric ED presentation than youth with diagnoses from fewer 
disorder categories. Finally, Patients who received any outpatient specialty mental health 
services during the study period were significantly less likely to visit the ED for 
psychiatric reasons than patients who did not receive outpatient care.    
Analyses conducted in multiply imputed data accounting for missing 
race/ethnicity data yielded similar results overall, with notable discrepancies related to 
race/ethnicity and lifetime insurance use. Pooled results for model 2 indicated that 
Hispanic youth (OR = .79, CI = .73, .85, p < .001) and White youth (OR = .56, CI = .52, 
.61, p < .001) were significantly less likely to present in the ED for psychiatric reasons 
than Black youth. These results also indicated that there were no significant differences in 
probability of psychiatric ED presentation between Black youth and youth identified as 
multi-racial or from another racial/ethnic background (OR = 1.02, CI = .88, 1.18, p = 
.80). Pooled results for model 2 indicated that patients who had utilized Medicaid at any 
point during the study period were significantly less likely to present in the ED for 
psychiatric reasons than patients who had not utilized Medicaid (OR = .89, CI = .81, .96, 
p < .01). The finding that patients with any outpatient specialty mental health services use 
were less likely to present in the ED for psychiatric reasons than patients without 
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outpatient service use was comparable using the imputed data. Pooled estimates for both 
models are provided in Appendix N.  
 A similar series of two linear regression models were estimated to determine the 
association between any outpatient specialty mental health service use and the number of 
times a patient presented in the ED for psychiatric reasons, among the sample of youth 
with diagnosed emotional and behavioral disorders. Regression coefficients and standard 
errors are shown in Table 26.   
Table 26 
Association between any outpatient treatment and number of psychiatric ED visits 
 
 Model 1 Model 2 
 B SE B SE 
Female .10*** .01 .10*** .01 
Race/ethnicity     
     Hispanic .01 .02 .01 .02 
     White -.05** .02 -.05** .02 
     Multi-racial/other .05 .03 .05 .03 
Lifetime use of Medicaid .08*** .02 .08*** .02 
Lifetime use of safety-net care .18*** .02 .18*** .02 
Lifetime use of private insurance -.01 .02 -.01 .02 
Comorbidity .22*** .01 .24*** .01 
Outpatient service use   -.14*** .02 
 
Similar to the results of the logistic regression, sex, race, comorbidity, and 
outpatient specialty mental health service use were significantly associated with a greater 
number of psychiatric ED visits. Female youth presented in the ED significantly more 
times than male youth. White youth presented in the ED significantly less times than 
Black youth. Youth who utilized Medicaid or safety-net services at any point during the 
study period presented in the ED for psychiatric reasons significantly more times than 
 115 
youth who had not utilized Medicaid or safety-net services, respectively. Patients with 
diagnoses from a greater number of disorder categories visited the ED for psychiatric 
reasons more times than patients with diagnoses from fewer categories.  Any use of 
outpatient specialty mental health services was associated with fewer visits the ED for 
psychiatric reasons.   
 Analyses conducted in multiply imputed data accounting for missing 
race/ethnicity data yielded similar results overall, with notable discrepancies related to 
race/ethnicity and lifetime insurance use. Pooled results for model 2 indicated that, 
Hispanic youth (B = -.13, SE = .02, p < .001) and youth identified as multi-racial or from 
another racial/ethnic background (B = -.09, SE = .03, p < .01) presented in the ED for 
psychiatric on significantly fewer occasions than Black youth. Results also indicated that 
lifetime use of Medicaid was not significantly associated with psychiatric ED 
presentation (B = -.02, SE = .02, p < .23). The finding that patients with any outpatient 
specialty mental health services use presented in the ED for psychiatric reasons 
significantly fewer times than patients without outpatient service use was comparable 
using the imputed data. Pooled estimates for both models are provided in Appendix O.   
 To better understand the association between outpatient specialty mental health 
service use and psychiatric ED presentation, Cox proportional hazards regression was 
used among the sample of patients who utilized outpatient services. This series of models 
estimated whether psychiatric ED presentation occurred after outpatient service use. For 
patients who presented in the ED for psychiatric reasons, the earliest ED visit that 
occurred after any outpatient treatment was selected, and survival time was calculated as 
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the number of days between the last outpatient appointment prior to that ED visit and that 
ED visit. For patients who did not present in the ED for psychiatric reasons or who only 
presented in the ED for psychiatric reasons prior to outpatient care, survival time was 
calculated as the number of days between the last outpatient appointment and the last day 
of the study period (May 3, 2018).   
 First, a baseline model (model 1) was estimated to examine the association 
between psychiatric ED presentation and sociodemographic covariates (age at outpatient 
treatment initiation, sex, race/ethnicity, insurance type at treatment initiation, and the 
continuous indicator of comorbidity). A second model (model 2) was estimated to control 
for previous psychiatric ED visits during the study period. Hazard ratios and 95% 
confidence intervals for each model are presented in Table 27.  
Table 27 
Psychiatric ED presentation among youth who received outpatient treatment 
 
 Model 1 Model 2 
 λ 95% CI λ 95% CI 
Age 1.00 .98, 1.02 .98 .96, 1.00 
Female 1.24** 1.06, 1.45 1.28** 1.10, 1.50 
Race/ethnicity     
     Black ref - ref - 
     Hispanic .99 .83, 1.18 1.02 .85, 1.21 
     White .67** .51, .89 .68** .51, .90 
     Multi-racial/other .66 .37, 1.17 .70 .39, 1.24 
Insurance     
     Medicaid ref - ref - 
     Health safety-net 1.18 .68, 2.05 1.31 .75, 2.27 
     Private .67*** .54, .82 .71** .57, .88 
Comorbidity 1.50*** 1.45, 1.56 1.47*** 1.41, 1.52 
# previous ED visits   1.42*** 1.33, 1.52 
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Results indicated that female patients who received outpatient care were at greater 
risk for psychiatric ED presentation than male patients who received outpatient care. 
White youth were at decreased risk for psychiatric ED presentation than Black patients. 
Patients using private health insurance at outpatient treatment initiation were at decreased 
risk for psychiatric ED presentation, as compared to patients using Medicaid. Patients 
with a higher number of comorbid diagnoses were at increased risk for psychiatric ED 
presentation, as compared to patients with fewer comorbid disorders. Finally, for each 
previous psychiatric ED visit, a patient had 42% greater risk for subsequent psychiatric 
ED presentation.    
 Analysis in multiply imputed data accounting for missing race/ethnicity data 
differed in regards to the association between age and race/ethnicity with risk of 
psychiatric ED presentation. Pooled results for model 2 indicated that as age increased 
the risk for psychiatric ED presentation decreased slightly (λ = .98, CI = .96, 1.00, p < 
.05). Pooled results for model 2 also indicated that Hispanic youth (λ = .83, CI = .69, 
1.00, p < .05) and youth identified as multi-racial or from another racial/ethnic 
background (λ= .55, CI = .31, 1.00, p < .05) were at decreased risk for psychiatric ED 
presentation as compared to their Black peers. Pooled estimates for both models are 
provided in Appendix P.  
  Next, I examined the association between continuity of care and subsequent 
psychiatric ED presentation. For patients who presented in the ED for psychiatric 
reasons, the earliest ED visit that occurred after any outpatient treatment was again 
selected. The last treatment period before that ED visit was used to calculate each of the 
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three indicators of continuity of care (duration of treatment, quantity of treatment, and 
frequency of treatment). Only the outpatient visits that occurred prior to the ED visit were 
considered for these calculations. Survival time was again calculated as the number of 
days between the last outpatient appointment prior to the ED visit and the ED visit. For 
patients who did not present in the ED for psychiatric reasons, or who presented prior to 
outpatient care, the most recent treatment period was used to calculate each aspect of 
continuity of care. Survival time was calculated as the number of days between the last 
outpatient appointment and the last day of the study period (May 3, 2018).  All analyses 
controlled for the number of previous psychiatric ED visits as well as the number of prior 
outpatient treatment periods. Model 1 included duration of the most recent outpatient 
treatment period and model 2 included the quantity of outpatient visits in the most recent 
treatment period. Results are provided in Table 28.  
Results for sociodemographic covariates were comparable to those in the baseline 
models. Youth who had engaged in a greater number of previous treatment periods were 
at greater risk for subsequent psychiatric ED presentation than youth who had engaged in 
fewer previous treatment periods. In addition, longer treatment duration and a greater 
number of outpatient visits were associated with greater risk for subsequent psychiatric 
ED presentation. Analysis in multiply imputed data accounting for missing race/ethnicity 
data yielded similar results. In fact, the only difference was in regards to insurance status. 
Specifically, results indicated no significant difference in risk for psychiatric ED 
presentation between youth with private health insurance and youth with Medicaid 
(results from model 2: λ = .82, CI = .66, 1.01, p = .06). Pooled results for both models are 
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provided in Appendix Q.  
Table 28 
Continuity of outpatient treatment and subsequent psychiatric ED presentation 
 
 Model 1 Model 2 
 λ 95% CI λ 95% CI 
Age 1.00 .98, 1.02 1.00 .98, 1.02 
Female 1.40*** 1.20, 1.64 1.39*** 1.19, 1.63 
Race/ethnicity     
     Black ref - ref - 
     Hispanic 1.01 .85, 1.21 1.03 .86, 1.22 
     White .73* .55, .98 .70* .53, .94 
     Multi-racial/other .80 .45, 1.43 .80 .45, 1.42 
Insurance     
     Medicaid ref - ref - 
     Health safety-net 1.29 .74, 2.24 1.30 .75, 2.25 
     Private .78* .63, .97 .77* .62, .96 
Comorbidity 1.36*** 1.30, 1.41 1.36*** 1.31, 1.41 
# previous ED visits 1.44*** 1.35, 1.55 1.45*** 1.35, 1.55 
# previous treatment periods 1.25*** 1.21, 1.29 1.25*** 1.22, 1.29 
Treatment duration (days) 1.00*** 1.00, 1.00   
Treatment quantity (visits)   1.02*** 1.02, 1.02 
 
 
Next, I estimated a third model to examine the association between treatment 
frequency (measured in average number of days between visits) and subsequent ED 
presentation. This model was estimated only in the sample of patients who received 2 or 
more outpatient visits (the only patients for which treatment frequency could be 
calculated). A fourth, and final model, estimated among patients who received 2 or more 
outpatient visits, predicted subsequent psychiatric ED presentation from both quantity 
and frequency of outpatient visits.  Results from these models are provided in Table 29.  
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Table 29 
Continuity of outpatient care and subsequent psychiatric ED presentation 
 
 Model 3 Model 4 
 λ 95% CI λ 95% CI 
Age 1.02 .99, 1.05 1.02 .99, 1.04 
Female 1.21 .99, 1.47 1.21 .99, 1.47 
Race/ethnicity     
     Black ref - ref - 
     Hispanic .91 .72, 1.15 .91 .72, 1.15 
     White .87 .62, 1.23 .82 .58, 1.15 
     Multi-racial/other .68 .30, 1.54 .69 .31, 1.56 
Insurance     
     Medicaid ref - - ref 
     Health safety-net 1.04 .51, 2.10 1.11 .55, 2.25 
     Private .78 .59, 1.04 .78 .59, 1.03 
Comorbidity 1.37*** 1.30, 1.45 1.33*** 1.26, 1.41 
# previous ED visits 1.35*** 1.23, 1.48 1.37*** 1.25, 1.50 
# previous treatment periods 1.19*** 1.14, 1.24 1.21*** 1.16, 1.26 
Treatment quantity (visits)   1.02*** 1.01, 1.02 
Treatment frequency (days) 1.01 1.00, 1.02 1.01* 1.00, 1.02 
 
 
Among the sample of patients who engaged in two or more outpatient specialty 
mental health visits, there were no significant differences in likelihood of a subsequent 
psychiatric ED visit based on age, sex, race, or insurance status.  The continuous 
indicator of comorbidity, the number of previous psychiatric ED visits, and the number of 
previous outpatient treatment periods were all significantly associated with increased risk 
for a subsequent psychiatric ED visit.  Treatment frequency was only significant in the 
model that also controlled for quantity of outpatient specialty mental health visits, such 
that the longer the time between visits, the greater the risk for subsequent psychiatric ED 
presentation. Analysis of multiply imputed data accounting for missing race/ethnicity 
data yielded similar overall results. However, pooled estimates indicated that White 
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youth had significantly lower risk of psychiatric ED presentation than Black youth at any 
given time point (model 4 results: λ = .62, CI = .43, .88, p < .01). Pooled results from 
both models are provided in Appendix R.   
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CHAPTER 5: DISCUSSION 
 
 Emotional and behavioral disorders are common among youth, and place them at 
greater risk for health, academic, and social difficulties (Aarons et al., 2008; Breslau et 
al., 2008; Fleischmann et al., 2005; Merikangas et al., 2010; Rapee et al., 2012; Skowyra 
& Cocozza, 2007). Although evidence-based treatments for psychiatric disorders have 
been developed and evaluated, many youth never receive these services (Costello et al., 
2014; Merikangas et al., 2011). Furthermore, youth who do receive mental healthcare 
may not receive effective or appropriate treatment. Studies indicate a considerable gap 
between the availability of evidence-based interventions and their use by clinicians in 
common treatment settings (Aarons & Sawitzky, 2006; Cook et al., 2017; England et al., 
2015).  In addition, research demonstrates that 28-75% of youth terminate mental health 
treatment prematurely, suggesting that youth may not complete interventions being 
provided by clinicians (de Haan et al., 2013; Gearing et al., 2014; Schwalbe & Gearing, 
2012). Finally, increasing numbers of school-aged youth are seeking mental health 
services in the ED, which is often an inadequate and inappropriate setting for mental 
healthcare, and seeks primarily to triage and stabilize crises rather than to treat complex 
emotional and behavioral disorders (Cloutier et al., 2010; Cooper & Masi, 2007; Dolan & 
Fein, 2011).  
 This study sought to examine patterns in how a diverse sample of youth with 
emotional and behavioral disorders utilized hospital-based mental health services over a 
period of almost 8 years. Using the lens of Tansella and Thornicroft’s Matrix Model 
(1998), I sought to better understand the process phase of service provision on a local 
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level. This understanding may inform the development and evaluation of interventions 
reflecting treatment utilization in real-world settings and the identification of areas in 
which outreach may promote youth engagement in mental healthcare (e.g., vulnerable 
populations, important times during the year). This research is meant to complement 
research being conducted on an individual patient level, which is typically designed to 
assess needs, deliver care, and evaluate psychosocial outcomes (e.g., randomized 
controlled trials). By its nature, individual-level research does not account for population 
trends and patterns related to routine clinical care at the community-level. This study is 
also designed to complement statewide, national, and global studies, which provide 
insight into widespread patterns in service expenditure, mental health policy, rates of 
hospital admission, and illness prevalence. However, studies on these state, national, and 
global levels often mask differences by race/ethnicity, socioeconomic status, and other 
factors that may be particularly important in local settings.  
 Pescosolido’s NEM-II (1991, 2006) also provided a framework for understanding 
the process of mental health service delivery and utilization. Central to this framework is 
the concept of an “illness career,” with important contextual and temporal aspects. It 
would be easy to imagine that emotional and behavioral disorders were issues that simply 
appeared, would respond to treatment, and then be cured. In reality, this is not the 
trajectory for many psychiatric disorders. The NEM-II emphasizes how social and 
clinical contexts impact the development of mental illness across time, including 
remission and relapse. Varying illness careers may result in patients entering and leaving 
treatment at various times for clinical, practical, and social reasons. Symptoms may 
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resolve and reappear in response to life events, stress, seasonal factors, and interactions 
with the treatment system (if any exist), all of which influence long-term illness 
trajectories. The current study aims to describe specific aspects of patients’ interactions 
with the treatment system, including psychiatric ED presentation and continuity of 
outpatient care, accounting for a number of clinical and sociodemographic characteristics. 
In doing this, it is important to remember that results reflect a wide range of illness 
careers and that many factors, including factors that the data are unable to account for, 
shaped patients’ and families’ decisions regarding treatment utilization. The purpose of 
this study was therefore to describe treatment patterns and significant associations 
between variables, without judgement as to what amount of treatment would have been 
most appropriate or ideal. An understanding these patterns and associations can then 
support clinicians in selecting interventions that reflect the utilization patterns of their 
patients and suggest outreach and engagement efforts that may help inform patients about 
available services and how to get the most out of them. This study can also inform the 
development and evaluation of mental health interventions that reflect utilization patterns 
in real-world clinical settings, such as brief interventions that require fewer treatment 
sessions.  
Research Question 1: Psychiatric ED Visits 
 The first research question in this dissertation addressed both seasonal and secular 
patterns in psychiatric ED visits among school-aged youth. Consistent with previous 
research, findings indicated that psychiatric ED visits were lowest during the summer 
months and were significantly higher in the fall months, particularly October (Ali et al., 
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2012; Goldstein et al., 2005; Holder, Rogers, Peterson, & Ochonma, 2017). Also similar 
to previous research, although less discussed, I found that psychiatric ED visits dropped 
in December/January (although not as low as they did in the summer) and spiked again in 
the spring to levels similar to that in October (Ali et al., 2012; Goldstein et al., 2005; 
Holder, Rogers, Peterson, & Ochonma, 2017). This pattern mirrors the school calendar in 
the Boston area (a typical pattern for US school districts). Psychiatric ED visits were 
lowest in July and August, when school was out for summer vacation, and was also low, 
although not to the same extent, in December, which corresponds to the longest school 
break (the period from Christmas through New Year’s) besides summer vacation. 
 This study extended previous research by examining these monthly patterns in 
sub-samples stratified by race/ethnicity. Prior studies have not examined racial or ethnic 
differences in these patterns, often because studies were conducted in U.S. samples that 
were primarily White (Holder, Rogers, Peterson, & Ochonma, 2017) or Canadian 
samples that did not include racial/ethnic data (Ali et al., 2012; Goldstein et al., 2005). 
Considering potential differences in seasonal patterns based on race/ethnicity is important 
because racial and ethnic disparities in mental health care, and in particular the use of 
psychiatric ED services, have been well-established in the literature (Bruckner et al., 
2014; Snowden et al., 2008, 2009). Indeed, my analysis revealed significant differences 
in seasonal patterns based on race/ethnicity.   
 For youth of color, but not White youth, rises in psychiatric ED visits 
corresponded to the months when school was in session, and drops in visits corresponded 
to months when school was not in session. Among White youth, psychiatric ED visits 
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peak in September and October and then drop markedly in November and December. 
Visits then remained low through the spring and only drop slightly further into the 
summer. Among youth of color, there was a drastic decline in visits from May to July 
that was not present in White youth. Black and Hispanic youth also show a more gradual 
increase in visits from July through October than their White peers.  Among Black youth 
there were two marked drops in psychiatric ED visits in February and April, which are 
separated by distinct peaks in March and May; these patterns seem to correspond with the 
February and April school vacations (i.e., youth are in school fewer days during these 
two months). One possible explanation for these results is that school staff may be 
driving many of the psychiatric ED referrals among youth of color. A 2014 study at a 
large urban hospital in the northeast US, with a similar population to that of BMC, found 
that 44.1% of psychiatric ED evaluations were initiated by schools, and that youth of 
color were over-represented in these referrals as compared with White youth (Grudnikoff 
et al., 2015). 
Even if racial/ethnic disparities are not driven by referrals from school staff, it 
may be that inequities in the school setting related to discipline, setting, and delivery of 
special education supports create difficulties for students of color with emotional and 
behavioral disabilities that have effects outside of school, prompting parents and 
caregivers to seek emergency care. A large body of research has documented inequities in 
the way youth of color are treated in US schools. Youth of color are less likely to receive 
special education services and significantly more likely to receive exclusionary school 
discipline or be placed in more restrictive learning environments (Blanchett et al., 2009; 
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Morgan et al., 2017; Noltemeyer & Mcloughlin, 2012; Okonofua et al., 2016; Sullivan, 
2017). As a result of these disparities, time in school may be particularly difficult for 
youth of color who are struggling with emotional and behavioral disorders. Among White 
students, who are less likely to experience inequities in school settings, it may be that the 
transition to school after summer vacation presents difficulties, explaining the spike in 
visits early in the fall and the lack of dramatic changes in visit rates the rest of the year.  
 Findings also indicated that psychiatric ED visits in the BMC system increased 
from 2010 to 2017, which is consistent with recent research documenting increases in 
psychiatric ED use among children and adolescents in both regional Canadian and 
nationally representative US samples (Gandhi et al., 2016; Kalb et al., 2019; Mapelli et 
al., 2015; Pittsenbarger & Mannix, 2014). Of note, the net increase in youth psychiatric 
ED visits at BMC from 2010-2017, 13.9%, was markedly lower than the estimated net 
increase in youth psychiatric ED visits from 2011-2015 in a nationally representative 
probability study using the National Hospital Ambulatory Medical Care Survey, 26.1%  
(Kalb et al., 2019). Consistent with the findings from Kalb and colleagues (2019), I found 
that increases in rates of psychiatric ED visits among youth were driven by youth of 
color; with the highest increases among Hispanic youth and smaller, but significant 
increases among Black youth. Like Kalb and colleagues (2019), I found that visit rates 
had not changed significantly across the study period for White youth or those from 
another racial/ethnic background. These findings are consistent with trends documented 
for the prior decade (2000-2010; Pittsenbarger & Mannix, 2014; Simon & Schoendorf, 
2014). It is also possible that these changes are related to demographic shifts in the city of 
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Boston; according to a 2019 report by the Boston Planning and Development Agency, 
between 2010 and 2017 Boston’s minority population increased significantly, particularly 
the Latino population, while the city’s White population decreased. Furthermore, the 
population of Boston has increased by approximately 10% over the same period, which 
may account for some of the increase in youth psychiatric ED visits (Boston Planning and 
Development Agency, 2019).   
In the current study, the most common reasons for psychiatric ED presentation 
were conduct disorders and mood disorders. This finding is consistent with Kalb and 
colleagues’ (2019) finding that mood and anxiety disorders (combined into one category 
in their study) represented the most common reason for psychiatric ED presentation 
among 6-24 year olds; if mood and anxiety disorders were combined in the current study, 
they would represent the most common reason for psychiatric ED presentation. However, 
this study found that behavioral problems, defined as aggression or conduct problems, 
represented only a small portion of ED visits (Kalb et al., 2019). This may reflect the 
inclusion of young adults up to aged 24 in the study sample, given that the prevalence of 
conduct disorders declines with age, and is only specified for those under age 18 (Rowe 
et al., 2002). Also a likely a reflection of the age discrepancy between studies, substance 
use disorders were the second most common reason for ED presentation (Kalb et al., 
2019). The results of the current study are inconsistent with a previous study conducted 
by Holder and colleagues (2017) among 5-18 year-olds at a hospital in the Southeastern 
US. In that study, anxiety disorders were the most prevalent diagnosis in psychiatric ED 
visits (Holder, Rogers, Peterson, & Ochonma, 2017); in comparison, in the current study, 
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anxiety disorders were not among the top five most prevalent diagnoses associated with 
psychiatric ED visits. In the 2017 study, a category including pervasive and 
developmental disorders, conduct disorders, and ADHD was associated with 26.5% of 
psychiatric ED presentations (Holder, Rogers, Peterson, & Ochonma, 2017); in the 
current study, those categories combined were associated with 58% of psychiatric ED 
visits.  One possible explanation for these discrepancies is that Holder and colleagues 
(2017) examined psychiatric ED visits at a North Carolina hospital serving a suburban 
and rural area, with a predominantly White population.  
One consistent trend in the current study was an over-representation of Black 
youth in psychiatric ED presentation. Although approximately 40% of youth with 
emotional and behavioral diagnoses in the BMC system were Black, over 50% of youth 
presenting in the ED for psychiatric reasons were Black. In comparison, presentation of 
Hispanic youth in the ED (26%) was commensurate with the percentage of Hispanic 
youth in the sample (28%). White youth and youth identified as multi-racial or from 
another racial/ethnic background were under-represented in ED presentation. This is 
consistent with previous research indicating that Black youth are more likely to utilize 
psychiatric ED services than their White peers (Bruckner et al., 2014; Snowden et al., 
2008, 2009). Researchers have hypothesized that Black youth may be more reliant on ED 
services if they do not have access to needed outpatient care (Snowden et al., 2008, 
2009); however, as we will see later in this chapter, Black youth in our sample were also 
over-represented in the use of outpatient specialty mental health care.  
 
 130 
Research Question 2: Outpatient Specialty Mental Health Care. 
The second research question addressed both seasonal and secular patterns in 
outpatient specialty mental healthcare among school-aged youth with emotional or 
behavioral disorders. To my knowledge, this is the first study to examine seasonal 
patterns in outpatient mental health care among youth. Results indicated that rates of 
outpatient specialty mental health visits had trends similar to those found for ED visits.  
Outpatient visits were lowest during the summer months and were significantly higher in 
the fall months; however, and unlike established patterns in ED visits, outpatient mental 
health visits stayed low during September and peaked later in the fall (November).  
Outpatient visit rates dropped in December and then rose steadily into the spring, 
reaching their highest point during the year in March; this differs from ED visits, which 
although they also peaked twice during the year (fall and spring), reached their highest 
point in the fall peak (October). Similar to ED visits, seasonal patterns among outpatient 
visits mirror the school calendar in the Boston area. Visits were lowest in July and 
August, when school is out for summer vacation, and also reached a comparatively lower 
in December, corresponding to the longest school break besides summer vacation. 
One possible explanation for the seasonal patterns found in both ED and 
outpatient mental healthcare is that, as a number of researchers have previously 
hypothesized, school represents the major stressor in the lives of youth and may therefore 
exacerbate the symptoms of emotional and behavioral disorders (Ali et al., 2012; 
Goldstein et al., 2005; Holder, Rogers, Peterson, & Ochonma, 2017). Another possible 
contributor may be, as shown in previous literature, that school staff are instrumental in 
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referring youth for needed mental healthcare and facilitating their entry into care (Green 
et al., 2013; Wood et al., 2005). A lack of interaction with school staff during the summer 
may result in some youth not receiving access to needed care. It is also possible that the 
schedules of outpatient mental health providers align with the academic calendar; 
clinicians may themselves take vacations during school breaks for the holidays and 
summer vacation, resulting in fewer available appointments for youth in need. Family 
routines and patterns may also be better established during the school year, allowing 
youth more consistent access to outpatient services.  
 To further understand seasonal patterns in outpatient specialty mental health care, 
I examined these patterns in sub-samples stratified by race/ethnicity. Seasonal patterns in 
outpatient specialty mental health care are very similar for Black, Hispanic and White 
youth. As described in the paragraph above, visit rates are highest in March and 
November, and are lowest during the summer months.  This presents a stark contrast to 
the racial/ethnic differences in seasonal patterns found in youth psychiatric ED visits; 
whatever is causing racial/ethnic disparities in seasonal patterns of ED visits does not 
seem to be having the same impact on seasonal patterns of outpatient service use. It is 
possible that although referrals by school staff are driving disparities in seasonal patterns 
of psychiatric ED visits, school referrals do not have the same impact on outpatient 
service use. Similarities in seasonal patterns of outpatient specialty mental healthcare 
across racial/ethnic sub-samples suggests that the school environment may not be an 
exacerbating factor for youth of color with emotional behavioral disorders, or, if it is, that 
youth are not receiving additional outpatient care as a result of this.   
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 Results of the current study suggested significant changes in rates of outpatient 
specialty mental healthcare among youth with emotional and behavioral disorders 
between 2011 to 2017. Outpatient visit rates decreased significantly from 2011 to 2014 
(63% net decrease) and then increased significantly from 2014 to 2017 (88% net 
increase). Overall, there was a 25% decrease in outpatient specialty mental health visits 
from 2011-2017. This is inconsistent with recent research that has found linear increases 
in rates of outpatient mental healthcare among school-aged youth in both Canada and the 
United States (Gandhi et al., 2016; Olfson et al., 2014, 2015). When I consulted with 
clinicians in the Department of Psychiatry at BMC, they indicated that the quadratic trend 
in outpatient service use was consistent with staffing and procedural changes within the 
department. In particular, the department began to institute screening policies that may 
have excluded youth from receiving outpatient care; turnover in leadership between 2013 
and 2014 resulted in a change in these policies, potentially allowing more youth to access 
care. These findings raise questions about whether youth in need of mental health care, 
particularly those using Medicaid or health safety-net services (who were limited in their 
options to access care outside of the BMC system), may not have received needed 
outpatient specialty mental health treatment during the study period. Given that rates of 
outpatient service use have not yet reached parity with those from 2011, departmental 
policies may have impacted how and if parents and youth in the community entered 
mental healthcare.   
 Although the significant drop in service use from 2011 to 2014 was present across 
racial/ethnic categories, there were differences in how quickly service use increased after 
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2014. Rates of outpatient service use among White youth rebounded quite quickly, and 
there was a net increase from 2011 to 2017 in outpatient service use for these youth. 
Rates of service use rose more slowly among youth of color, in particular Black youth, 
who experienced a 42% net decrease in outpatient specialty mental health service use 
from 2011 to 2017. Rates of service use among Hispanic youth rebounded more quickly 
than those of Black youth, but slower than those of White youth, and rates in 2017 were 
almost at the same level as in 2011. These findings align with research showing that 
youth of color are less likely to access outpatient mental health care than White youth 
(Alegria et al., 2011; Cook et al., 2014; Cummings & Druss, 2011; Guo et al., 2014; 
Marrast et al., 2016; Olfson et al., 2015). Those who are less likely to seek care in the 
first place may be particularly discouraged by negative experiences with the mental 
healthcare system, whether they experience them personally or hear about them from 
others (Lindsey et al., 2013).   
 Although rates of outpatient specialty mental healthcare were slower to rebound 
among youth of color than among their White peers, overall, Black youth were over-
represented in outpatient service use. Although approximately 40% of youth with 
emotional and behavioral diagnoses at BMC were Black, almost 50% of youth receiving 
outpatient specialty mental healthcare were Black. Hispanic youth made up almost a third 
of youth receiving outpatient mental health services at BMC (31%), which is slightly 
higher than the percentage of Hispanic youth in the study sample (28%). White youth and 
youth identified as multi-racial or from another racial/ethnic background were under-
represented in the use of outpatient specialty mental health services at BMC (they may 
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have received outpatient specialty mental healthcare from another provider outside of 
BMC). This contrasts with previously cited research using nationally representative 
insurance claims data indicating that White youth are more likely to utilize outpatient 
specialty mental healthcare than youth of color (Cook et al., 2014; Cummings & Druss, 
2011; Guo et al., 2014; Olfson et al., 2015).  
 Youth of color were significantly more likely to use Medicaid or health safety-net 
services to pay for mental health services. Youth using Medicaid or health safety-net care 
may have been limited in where they could receive outpatient specialty mental health 
care, because not all mental health professionals take Medicaid or offer safety-net 
options. White youth, who were more likely to have private insurance, may have been 
more likely to receive specialty outpatient mental healthcare outside the BMC system, 
and this may have contributed to lower visit rates among White youth.   
 The most common reasons for outpatient specialty mental health care were 
pervasive and developmental disorders (54.8%), ADHD (53.4%), and conduct disorders 
(51.9%). In comparison, a 2015 study using nationally representative data found that 
youth ages 2-21 were most likely to receive outpatient mental health treatment for 
ADHD, mood disorders, or anxiety disorders (this study did include pervasive and 
developmental disorders as well as conduct disorders; Anderson et al., 2015). Consistent 
with my results, a 2014 study that also used nationally representative data indicated that 
Disruptive Behavior Disorders were the most common diagnosis among youth accessing 
outpatient specialty mental health treatment (Olfson et al., 2014). Externalizing problems, 
such as ADHD or conduct disorder, may present particular challenges for youth and 
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parents that compel them to engage in outpatient specialty care.   
 Almost a third of youth utilizing outpatient specialty mental health care attended 
only one outpatient visit. This is consistent with a substantial body of literature 
documenting high rates of early dropout from mental health treatment among children 
and adolescents (de Haan et al., 2013; Gearing et al., 2014; McKay et al., 2002; McKay 
& Bannon, 2004; Schwalbe & Gearing, 2012). Although previous literature indicates that 
Black youth receive fewer outpatient mental health treatment sessions than their White 
peers (Alexandre et al., 2010; Cummings & Druss, 2011), I found that Black patients in 
the study sample received significantly more outpatient visits than youth from every other 
racial/ethnic category. The reasons for this are unclear, although it may be related to the 
fact that BMC serves a primarily non-White population and may be responsive to the 
cultural and practical needs of this population.  In the next section, further findings 
related to outpatient specialty mental health care will be discussed, with a particular focus 
on racial/ethnic differences.  
Continuity of Care 
There were a number of distinct patterns in the way that different youth utilized 
care. For example, although male youth engaged in more treatment sessions than females, 
females engaged in longer treatment periods, with more visits and more frequent visits. 
This finding differs from some older studies that found males tended to engage in more 
treatment when they were receiving outpatient mental health services (Realmuto et al., 
1992; Roghmann et al., 1982). Given that there are no more recent studies for 
comparison, the current study may reflect more recent trends in specialty outpatient 
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mental health service use. A number of other sociodemographic factors were associated 
with continuity of care. Youth who were older when treatment was initiated received 
more treatment periods than youth who were younger, and these treatment periods 
included more sessions spaced further apart. Older youth, who are more independent and 
can take a more active role in arranging and attending treatment sessions may experience 
fewer barriers to care than parents with young children who are less independent, and 
may actively resist attending treatment. Patients using Medicaid engaged in more 
treatment periods than patients using private insurance, and those treatment periods were 
longer in duration and involved less frequent visits. However, the number of visits in total 
and per treatment period were not significantly different based on insurance status. It is 
unclear how the experiences of families and youth with private insurance may be 
different from those with Medicaid at BMC, a healthcare system that serves large 
numbers of people with public insurance. Patients with comorbid disorders engaged in 
more total visits and more treatment periods than patients with diagnoses from only one 
disorder category; further these treatment periods were longer in duration and visits were 
less frequent. Conceptualizing comorbidity as an indicator of complexity and/or severity 
of symptoms, this finding is consistent with research indicating that youth with more 
severe impairment receive more treatment sessions than those with less severe 
impairment (Brookman-Frazee et al., 2008).  
There were also significant differences in continuity of care based on 
race/ethnicity. Although, as mentioned earlier, Black youth received more visits in total 
than youth from another racial/ethnic background, these visits were spread across a 
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greater number of treatment periods than for White youth. Hispanic youth also engaged 
in more treatment sessions than White youth. In addition, Black and Hispanic youth 
received fewer outpatient specialty mental health visits per treatment period. These 
findings suggest that, as found in previous studies, youth of color may be more likely to 
drop out of treatment than their White peers (Gearing et al., 2014; Kazdin & Mazurick, 
1994; Pellerin et al., 2010). If treatment is discontinued prior to an adequate resolution of 
symptoms (i.e., if there is poor continuity of care) the patient may be more likely to 
return for additional treatment periods. Future research should continue to explore the 
association between sociodemographic variables and continuity of care, to provide more 
insight into these findings.  
Results indicated a number of seasonal patterns in continuity of care. Treatment 
initiated in May tended to be shorter in duration than treatment initiated during other 
times of the year. One reason for this might be that May is close to the start of summer 
vacation, when youth schedules may change and logistics around attendance at treatment 
may become more difficult. Treatment initiated in October tended to involve significantly 
more treatment sessions than treatment initiated during other times of the year. This 
finding is also potentially related to the school calendar; given that rates of outpatient 
visits decrease in the summer, it may be that beginning treatment in October allows for 
regular treatment sessions throughout the academic year, that become routine. Finally, 
treatment initiated in February through April tended to be less frequent than treatment 
initiated other times during the year. This could also be associated with the school 
calendar. Boston area schools have weeklong vacations in February and in April, which 
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have the potential to disrupt treatment that has not yet become routine. Further, summer 
break arrives only a few months later, when there is also the potential for treatment 
interruptions.   
There were also racial/ethnic variations in these seasonal patterns. As we saw 
with ED visit and outpatient visit rates, continuity of care among youth of color seems to 
align more closely to the school calendar than among White youth. Black youth engage 
in shorter treatment periods when treatment is initiated in April through June; treatment 
periods are shorter among Hispanic youth when they are initiated in May or July. White 
youth, however, engage in shorter treatment periods when treatment is initiated in 
December through January, and March. There are fewer racial/ethnic differences in 
seasonal patterns for treatment quantity. Among Black, Hispanic, and White youth, 
treatment initiated in October tends to involve relatively more treatment sessions. Black 
youth also experience higher treatment quantity for treatment initiated in March, which 
corresponds with peaks in both psychiatric ED and outpatient specialty mental health 
visit rates. Hispanic and White youth have higher treatment quantity for treatment 
initiated in December. This is surprising given the holidays in December, which have the 
potential to disrupt schedules and interrupt treatment.  Among Black youth, treatment 
initiated in February tends to be less frequent, while treatment initiated in September 
tends to be more frequent. Among Hispanic youth, treatment initiated in March tends to 
be less frequent. In regards to these findings, it is possible that treatment initiated in late 
winter or early spring becomes less frequent as the weather begins to warm up and youth 
have the opportunity to spend more time outdoors. This may be particularly important 
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among low-income youth, who may have fewer opportunities to be active during the 
winter. In the current study, this may be true for Black and Hispanic families, who were 
more likely to use Medicaid. For Black youth, it may be that treatment initiated in 
September and coinciding with the beginning of the school year is built into the regular 
routine of the family and/or patient, and therefore may be less likely to be inconsistent.  
These findings raise questions about how the academic calendar shapes mental health 
treatment for youth with emotional and behavioral disorders.  
There were significant secular trends in continuity of care from 2011 to 2017. 
Although treatment quantity remained the same across the study period, treatment 
duration and the time between visits significantly increased. Essentially, youth with 
emotional and behavioral disorders are receiving the same amount of sessions within a 
given treatment period, but the sessions are spaced further apart. This may reflect 
families’ increasingly busy schedules, but it could also be related to the availability of 
appointments. Outpatient specialty mental health providers are generally available during 
the school/work day, and it may be difficult for youth and families to attend appointments 
at these times.   
Further examination of secular patterns in sub-samples stratified by race/ethnicity 
revealed disparities in continuity of care. For White youth, treatment quantity increased 
across the study period, such that White youth are receiving more visits in 2017 than 
2011, albeit these visits are occurring significantly less frequently. In comparison, Black 
youth are receiving the same amount of visits, but visits are occurring significantly less 
frequently. Finally, Hispanic youth are receiving the same number of visits, but over a 
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significantly longer period of time, and visits are occurring less frequently. This is 
consistent with well-documented disparities in the provision and utilization of youth 
mental healthcare based on race/ethnicity (Alexandre et al., 2010; Cook et al., 2013, 
Cummings & Druss, 2011) In the next section, I will discuss the findings that address the 
association between outpatient specialty mental health care and psychiatric ED 
presentation.  
Research Questions 3: Outpatient Care and Psychiatric ED Presentation 
 To answer my third research question, I examined the association between 
outpatient specialty mental healthcare and psychiatric ED presentation. Results indicated 
that any engagement in outpatient care was significantly associated with decreased odds 
of psychiatric ED presentation. Engagement in outpatient care was also significantly 
associated with fewer visits to the ED for psychiatric reasons. This suggests that 
engagement in outpatient care may help prevent patients from presenting in the ED with 
psychiatric problems. Two studies have found that over a third of youth psychiatric ED 
visits could have been handled in an outpatient setting, even if care was delayed (Sills & 
Bland, 2002; Soto et al., 2009). Ensuring that youth are connected with needed outpatient 
care prior to an emergency, or something that can be mistaken for one, may help reduce 
ED visits, particularly those that are non-urgent.   
 A number of additional factors were significantly associated with psychiatric ED 
presentation among youth in the study sample. Results indicated that females with 
emotional and behavioral disorders were more likely than males to present in the ED for 
psychiatric reasons. This is inconsistent with a recent study showing that males are at 
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higher risk for psychiatric ED presentation, although this study was conducted among a 
nationally representative sample of youth aged 6-24 (Kalb et al., 2019). My findings also 
differ from a study indicating significant sex differences in psychiatric ED visits among a 
nationally representative sample of youth under the age of 18 (Pittsenbarger & Mannix, 
2014). However, my findings were consistent with those of Kalb and colleagues (2019) 
in that youth with comorbid diagnoses had increased odds of psychiatric ED presentation, 
despite the age discrepancy in the study samples (Kalb et al., 2019).  
Consistent with previous research, youth of color were significantly more likely to 
present in the ED for psychiatric reasons and visited the ED more often than their White 
peers (Bruckner et al., 2014; Snowden et al., 2008, 2009). Furthermore, Hispanic youth 
and youth identified as multi-racial or from another racial/ethnic background were 
significantly more likely to visit the ED for psychiatric reasons than Black youth. This is 
consistent with a recent study indicating that Hispanic youth are more likely than youth 
from another racial/ethnic background to present in the psychiatric ED (Kalb et al., 
2019). One reason why youth of color may present in the ED for psychiatric reasons 
more often than their White peers relates to disparities in inpatient admissions. Some 
research indicates that White youth are more likely to be admitted to the hospital after a 
psychiatric ED visit than youth of color (Soto et al., 2009); without needed inpatient care, 
youth of color may be more likely to have a return psychiatric visit to the ED (Soto et al., 
2009). In light of research indicating racial bias in mental health assessment and 
intervention (Snowden, 2003), it is possible that Black youth receive less adequate care 
after psychiatric ED presentation, such as needed inpatient hospitalizations, and are 
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therefore more likely to return.   
 I also examined whether continuity of outpatient specialty mental health care was 
associated with subsequent psychiatric ED presentation, among the sample of youth who 
received any outpatient specialty mental healthcare. These analyses controlled for 
comorbidity, the number of previous psychiatric ED visits, and the number of previous 
outpatient treatment periods, all of which were significantly associated with greater 
likelihood of a subsequent psychiatric ED visit. These analyses also controlled for sex 
and insurance status, which are known to have important implications for youth mental 
health service use; neither sex nor insurance status were significantly associated with 
likelihood of a subsequent ED visit. In these analyses, youth of color who utilized 
outpatient care were at greater risk for psychiatric ED presentation than White youth who 
utilized outpatient care, even when controlling for continuity of care, a finding that is 
consistent with previous research (Bruckner et al., 2014; Snowden et al., 2008, 2009). 
Both treatment duration and treatment quantity were significantly associated with greater 
risk for a subsequent ED visit. These results contradict my hypothesis that improved 
continuity of care would be associated with lower risk for subsequent ED presentation. 
One possible explanation for these results is that treatment quantity in particular reflects 
disorder severity, which has been correlated with psychiatric ED presentation among 
youth (Kalb et al., 2019).  Treatment frequency was not significantly associated with risk; 
however, when controlling for treatment quantity, longer time between outpatient visits 
was significantly associated with increased risk for subsequent ED presentation. Overall, 
findings indicate that the only aspect of continuity of care that may be positively 
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associated with subsequent ED presentation is frequency of outpatient specialty mental 
healthcare.  
Limitations 
 This study provides insight into seasonal and secular trends in both ED visits and 
outpatient specialty mental healthcare for youth with psychiatric disorders, and how these 
patterns differ by race/ethnicity. It also explores whether outpatient care is associated 
with the use of psychiatric emergency services. The retrospective analysis of EHRs to 
examine these topics was non-invasive and presented minimal risk to patients. However, 
there are a number of important limitations to keep in mind.  
The primary limitations associated with the use of EHRs is data quality and 
completeness. Clinicians and administrators vary in their comprehensiveness of recording 
information collected during patient visits and their accuracy in medical coding (Orueta 
et al., 2012; Spiranovic, Matthews, Scanlan, & Kirkby, 2016; Weiskopf & Weng, 2013). 
Because EHRs are compiled across healthcare systems, there also may be inconsistencies 
across multiple data sources, such as administrative data, clinical report, and assessment 
results (Orueta et al., 2012; Spiranovic et al., 2016; Weiskopf & Weng, 2013). One 
limitation I faced using EHRs at BMC was inconsistency in the way that gender is 
documented in the medical record. The software system currently used has a binary data 
field for gender, which is generally used to indicate sex at birth. There is no established 
procedure for providers to record transgender status, or non-binary gender identities. 
Although physicians utilize a range of strategies to manage this issue in records for 
specific patients, there is no systematic way to identify transgender and gender non-
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conforming youth in the medical records system.  
Second, a number of potentially useful variables were not available in the medical 
records. For example, the indicators of mental health service receipt in this study do not 
specify the quality or the nature of the services provided. It was not possible to determine 
whether a patient was receiving evidence-based treatment. This is a common issue in the 
study of routine mental health care (Garland et al., 2010). In addition, data did not allow 
for the identification of patients who terminated outpatient care because they completed 
treatment successfully versus those who dropped out of treatment prematurely. 
Additionally, there was no standard measure of symptom severity across the sample that 
could be used to account for the level of need or indicate whether treatment was effective.  
Third, it is important to recognize that the guidelines for the treatment of 
psychiatric disorders vary greatly by disorder type and severity (American Academy of 
Child and Adolescent Psychiatry, 2020; American Psychiatric Association, 2020; 
American Psychological Association, 2020). This study attempts to look at mental health 
service use in a large sample of youth and across a wide variety of disorders. Because of 
this, it is difficult to draw conclusions about how appropriate the number of treatment 
sessions and the length of time over which they are applied may be. Further research 
examining treatment patterns for youth with specific disorders would provide additional 
insight into whether the temporal pattern of treatment that youth receive is aligned with 
what is recommended given their clinical profile.   
Fourth, the EHRs used in this study reflect only healthcare that patients receive 
within the BMC system. Patients may have received additional treatment outside of the 
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BMC system, and it was impossible to account for outpatient or emergency services 
received at other locations. However, almost three-quarters of patients in the sample 
received care through Medicaid, and approximately 10% received health safety-net 
services during the study period. These patients were likely limited in their ability to seek 
care outside of BMC. Many community-based providers do not accept Medicaid or offer 
sliding scale payment options that could make care possible for those with public 
insurance or no insurance at all. Despite this, it is possible that some patients received 
emergency and/or outpatient care from other healthcare providers.  
Finally, the data in this study are simply a snapshot of ED and outpatient visits 
that occurred between September 1, 2010 and May 3, 2018. Some patients in the sample 
likely received mental health service prior to the start or after the end of the study period. 
Particularly when examining continuity of care, I attempted to control for both left- and 
right-censoring of the data. For example, when appropriate, I excluded treatment periods 
that may have been initiated prior to the start of the study period. The use of survival 
analysis also helped account for the incomplete nature of the data. Future studies might 
utilize a prospective design that follows a cohort of youth across time, so that data would 
be more complete. Despite these limitations, this study can contribute to our 
understanding of how school-aged youth with emotional and behavioral disorders utilize 
both emergency and outpatient mental health services, and support researchers, 
clinicians, and healthcare systems in meeting patient needs.  
Implications 
 Overall, results showed that the use of both emergency and outpatient mental 
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health services in the study sample increased from 2011–2018, and that these increases 
are larger than what might be expected based on Boston population’s growth alone 
(Boston Planning and Development Agency, 2019). This may reflect higher incidence of 
emotional and behavioral disorders in youth (Bitsko et al., 2018; Twenge et al., 2019) 
and/or improving attitudes toward mental health treatment among the American public 
(Mojtabai, 2007; Parcesepe & Cabassa, 2013). Rising use of outpatient treatment may 
also reflect local institutional policies that increased the number of youth eligible to 
receive services within the BMC Department of Psychiatry. In addition, findings suggest 
that utilization of outpatient treatment is associated with decreased risk for psychiatric 
ED presentation.  
The results of this study have a number of implications for clinicians, healthcare 
systems, and researchers, including (1) suggesting times during the year when preventive 
actions and programming may be particularly helpful, (2) informing collaboration both 
within healthcare systems and with local institutions, such as schools and mobile crisis 
units, (3) identifying at-risk communities that can be targeted for outreach and 
engagement efforts to increase continuity of outpatient care and decrease psychiatric ED 
visits, (4) informing collaboration efforts between healthcare systems, and (5) developing 
and evaluating evidence-based treatment options that align with how youth and families 
utilize services in real-time.  
The current study finds clinically relevant information about seasonal patterns in 
mental healthcare among school-aged youth. Findings suggest that there will be 
predictable increases in the need for both psychiatric and outpatient services in the fall, 
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when youth return to school, and in the late winter/early spring. It may be helpful for 
primary care physicians, outpatient mental health providers and/or care coordinators to 
contact youth with emotional and behavioral disorders and their families late in the 
summer, or in January/February. Proactively checking in with youth and strategically 
scheduling follow-up appointments could preempt mental health problems from reaching 
crisis levels and support consistent care provision, which has the potential to improve 
outcomes (Adair et al., 2005; Brekke et al., 1999; Tait et al., 2004). Healthcare systems 
may want to offer support programs for youth and families late in the summer and early 
in the fall that provide psychoeducation related to management of the transition back to 
school and strategies for accessing different levels of mental health care when needed. 
Given that youth are more likely to visit the ED for psychiatric reasons during the 
academic year, training for teachers and other potential referral sources that will have 
contact with kids in the school setting in how to identify student mental health needs and 
initiate the referral process may help connect youth with outpatient care prior to the point 
where an ED visit is needed (Atkins et al., 2017; Green et al., 2013; Reinke et al., 2011).  
Collaboration between different types of providers within healthcare systems may 
also help improve continuity of outpatient care and prevent psychiatric ED presentation. 
Approximately 25% of youth who visit the ED for psychiatric reasons do so multiple 
times; in light of this, it may be helpful to assign youth who access emergency mental 
health services case managers, who can facilitate transition to outpatient treatment and 
proactively contact youth families if such treatment is discontinued prematurely. A case 
manager could respond to specific barriers that patients and families might face in 
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regards to outpatient specialty mental health care. For example, this person might help 
connect a patient with a provider who has available appointments outside normal working 
hours or provide support if a patient does not develop a positive therapeutic alliance with 
their provider. A recent study found that case management services can reduce both 
psychiatric ED presentation and inpatient hospitalizations among children and 
adolescents (Tai et al., 2018), and research with adults has shown similar results (Kumar 
& Klein, 2013). Furthermore, one study among adolescents found that case management 
was also associated with greater use of outpatient mental health services (Bender et al., 
2011). Case managers may also be helpful for youth who prematurely discontinue 
outpatient mental healthcare and/or engage in treatment inconsistently.  
Given recent research suggesting that schools initiate a substantial portion of 
psychiatric ED visits and that these visits are less likely to be classified as appropriate or 
urgent (Grudnikoff et al., 2015), it may be helpful for healthcare institutions to develop 
collaborations that can prevent unnecessary emergency service use. Administrators might 
identify specific schools that are most likely to refer students to the ED for non-urgent 
psychiatric reasons, and develop more appropriate action plans. Some cities and towns 
have alternatives to the ED that specifically address psychiatric issues, such as mobile 
crisis units, which provide more cost efficient and clinically appropriate ways to connect 
youth with immediate psychiatric evaluation. Healthcare institutions could save valuable 
time and resources by connecting schools with these programs and investing in their 
improvement. Partnerships with community centers and local churches may also provide 
a platform to educate families and adults who work with youth about the types of services 
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available and how to access them. For example, healthcare systems could offer 
psychoeducation at these local institutions during times of the year when they have the 
potential to be most powerful, such as late summer.  Furthermore, these events could be 
targeted in communities with youth from populations at greatest risk psychiatric ED use 
and outpatient treatment dropout.  
 The results of this study indicate that youth of color are more likely to utilize 
emergency mental health services and less likely to access consistent outpatient care. 
This is evident when we consider the sharp drop in outpatient treatment use from 2011-
2014, which occurred alongside marked increase in psychiatric ED presentation from 
2012-2014. Given that outpatient treatment rates among youth of color have been slower 
to rebound from the drop in 2014 than treatment rates among White youth, messaging 
and community outreach may be important to ensure families and youth of color know 
that they will not be turned away if they are seeking treatment and that BMC respects 
their experiences and needs (Harrison et al., 2004; Snowden, 1998; Staudt, 1999). It is 
worth noting that despite these trends, there have been fewer racial/ethnic disparities in 
access to outpatient specialty mental healthcare in the BMC system over the past decade 
than studies have found in other populations (Cook et al., 2014; Cummings & Druss, 
2011; Guo et al., 2014; Olfson et al., 2015). 
Hispanic youth may be a particular target for engagement efforts, as rates of 
psychiatric ED use are increasing more rapidly in this population. Recent work has 
identified a number of strategies specifically for improving access to and quality of 
mental health services among young Latinos. These include ensuring all aspects of 
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service provision, from outreach to assessment and treatment, are linguistically and 
culturally appropriate, and may require the use of bilingual materials, interpreters, and/or 
cultural brokers. Clinicians may find tools such as the Cultural Formation Interview, 
which is included in the DSM-5 manual (cite), helpful for implementing cultural 
understanding to inform diagnostic and treatment decisions. The National Council of La 
Raza recommends that clinicians recognize experiences that may be unique to young 
Latinos, such as discrimination, acculturation, and trauma related to migration (Foxen, 
2016). It may be important for service providers to monitor symptoms of acculturative 
stress, a risk factor for depression and suicide in young Latinos (Foxen, 2016; 
Smokowski & Bacallao, 2007). Finally, healthcare systems which serve substantial 
numbers of young Latinos may want to train clinicians in a comprehensive framework 
such as the Multidimensional Ecological Comparative Approach, which seeks to reduce 
stereotyping and promote a strength-based approach for working with Latino families and 
communities (Falicov, 2014). 
 General patterns of outpatient care identified in this study suggest that many 
school-aged youth receive one, or only a few, total treatment sessions. Outpatient mental 
health clinicians at may want to consider, for example, that almost one-third of patients 
will only engage in one treatment session (this does not include intake and assessment 
appointments). Providers could be trained in single session interventions and 
subsequently provide them to new patients, when appropriate. A recent meta-analysis 
looking at 50 randomized controlled trials of single session youth mental health 
interventions found that youth receiving these interventions generally fared better than 
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youth receiving no treatment and at times fared better than youth receiving traditional 
treatment, although effects varied according to the type of mental disorder (Schleider & 
Weisz, 2017). Providers may also want to begin treatment with psychoeducation about 
mental health services, particularly information about how services are delivered (e.g., 
session frequency and length), the content of treatment, and the roles of both therapist 
and client (Lindsey et al., 2014). This knowledge prepares young people and families for 
treatment and encourages active participation. Psychoeducation has been identified as an 
effective strategy for engaging youth from underserved populations in mental health care, 
including young males of color (Lindsey et al., 2014). 
Conclusion 
 Results from the current study contribute to the field in three main ways: (1) they 
replicate and extend knowledge related to the use of ED services for psychiatric reasons 
among school-aged youth, (2) they describe how youth utilize outpatient specialty mental 
health services throughout the year and over time, and (3) they provide insight into the 
association between outpatient specialty mental health service use and psychiatric ED 
presentation in a diverse urban healthcare system. These findings have implications for 
practitioners and healthcare systems seeking to engage youth with psychiatric disorders 
in outpatient mental health care and reduce psychiatric ED visits, which have a high cost 
for healthcare systems. By responding to predictable seasonable patterns in treatment 
utilization, collaborating with schools and community organizations for family outreach 
and psychoeducation, and proactively targeting at-risk youth (particularly youth of color) 
to engage them in preventive treatment, hospital systems like BMC can continue to 
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improve the mental health care they provide and support positive outcomes for youth 
with emotional and behavioral disorders. In addition, further development and evaluation 
of brief mental health interventions, and adaptation of existing evidence-based treatments 
that are designed to be provided over a greater number of sessions, can provide clinicians 
with viable options for engaging patients even in short periods of treatment, reflecting the 
way outpatient specialty mental health care is utilized in real-world clinical settings. 
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APPENDIX A 
ICD-9 to ICD-10 Crosswalk (Developed by psychiatrists at BMC) 
 
ICD 9 Description ICD 10 code and description 
Organic, including symptomatic, mental disorders 
29040 Vascular dementia without behavioral 
disturbance 
F0150 Vascular dementia without behavioral disturbance 
29041 Vascular dementia with behavioral 
disturbance 
F0151 Vascular dementia with behavioral disturbance 
29042 Vascular dementia with behavioral 
disturbance 
F0151 Vascular dementia with behavioral disturbance 
29043 Vascular dementia with behavioral 
disturbance 
F0151 Vascular dementia with behavioral disturbance 
29410 Dementia in other diseases classified 
elsewhere, without behavioral 
disturbance 
F0280 Dementia in other diseases classified elsewhere, without behavioral disturbance 
29411 Dementia in other diseases classified 
elsewhere, with behavioral disturbance 
F0281 Dementia in other diseases classified elsewhere, with behavioral disturbance 
2900 Dementia F03 Unspecified Dementia  
29010 Dementia F03 Unspecified Dementia  
29011 Dementia F03 Unspecified Dementia  
29013 Dementia F03 Unspecified Dementia  
29021 Dementia F03 Unspecified Dementia  
2908 Other specified senile psychotic 
conditions  
F0390 Other specified senile psychotic conditions  
2909 Unspecified senile psychotic 
conditions  
F0390 Other specified senile psychotic conditions  
2940 Amnestic disorder due to known 
physiological condition 
F04 Amnestic disorder due to known physiological condition 
2903 F05 Delirium due to known 
physiological condition 
F05 Delirium due to known physiological condition 
2930 Delirium due to known physiological 
condition 
F05 Delirium due to known physiological condition 
2931 Delirium due to known physiological 
condition 
F05 Delirium due to known physiological condition 
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29012 F05 Delirium due to known 
physiological condition 
F05 Delirium due to known physiological condition 
29020 F05 Delirium due to known 
physiological condition 
F05 Delirium due to known physiological condition 
29382 Psychotic disorder with hallucinations 
due to known physiological condition 
F060 Psychotic disorder with hallucinations due to known physiological condition 
2948 Other specified mental disorders due to 
known physiological condition 
F060 Psychotic disorder with hallucinations due to known physiological condition OR F068 Other 
specified mental disorders due to known physiological condition 
2948 Catatonic disorder due to known 
physiological condition 
F061 Catatonic disorder due to known physiological condition 
29389 Puerperal psychosis F061 Catatonic disorder due to known physiological condition OR F53 Puerperal psychosis 
29381 Psychotic disorder with delusions due 
to known physiological condition 
F062 Psychotic disorder with delusions due to known physiological condition 
29383 Mood disorder due to known 
physiological condition, unspecified 
F0630 Mood disorder due to known physiological condition, unspecified 
29383 Mood disorder due to known 
physiological condition with mixed 
features 
F0631 Mood disorder due to known physiological condition with depressive features OR F0632 
Mood disorder due to known physiological condition with major depressive-like episode OR F0633 
Mood disorder due to known physiological condition with manic features OR F0634 Mood disorder 
due to known physiological condition with mixed features 
29384 Anxiety disorder due to known 
physiological condition 
F064 Anxiety disorder due to known physiological condition 
2939 Other specified mental disorders due to 
known physiological condition 
F068 Other specified mental disorders due to known physiological condition 
2949 Other specified mental disorders due to 
known physiological condition 
F068 Other specified mental disorders due to known physiological condition 
3100 Personality change due to known 
physiological condition 
F070 Personality change due to known physiological condition 
3101 Personality change due to known 
physiological condition 
F070 Personality change due to known physiological condition 
3102 Postconcussional syndrome F0781 Postconcussional syndrome 
31089 Other personality and behavioral 
disorders due to known physiological 
condition 
F0789 Other personality and behavioral disorders due to known physiological condition 
3109 Unspecified personality and behavioral 
disorder due to known physiological 
condition 
F079 Unspecified personality and behavioral disorder due to known physiological condition 
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3109 Unspecified mental disorder due to 
known physiological condition 
F09 Unspecified mental disorder due to known physiological condition 
Substance Use 
30500 Alcohol abuse, uncomplicated F1010 Alcohol abuse, uncomplicated 
30501 Alcohol abuse, uncomplicated F1010 Alcohol abuse, uncomplicated 
30502 Alcohol abuse, uncomplicated F1010 Alcohol abuse, uncomplicated 
30503 Alcohol abuse, uncomplicated F1010 Alcohol abuse, uncomplicated 
30500 Alcohol abuse with intoxication, 
unspecified 
F10120 Alcohol abuse with intoxication, uncomplicated OR F10129 Alcohol abuse with 
intoxication, unspecified 
30501 Alcohol abuse with intoxication, 
unspecified 
F10120 Alcohol abuse with intoxication, uncomplicated OR F10129 Alcohol abuse with 
intoxication, unspecified 
30502 Alcohol abuse with intoxication, 
unspecified 
F10120 Alcohol abuse with intoxication, uncomplicated OR F10129 Alcohol abuse with 
intoxication, unspecified 
30503 Alcohol abuse with intoxication, 
unspecified 
F10120 Alcohol abuse with intoxication, uncomplicated OR F10129 Alcohol abuse with 
intoxication, unspecified 
2910 Alcohol use, unspecified with 
intoxication delirium 
F10121 Alcohol abuse with intoxication delirium OR F10221 Alcohol dependence with intoxication 
delirium OR F10921 Alcohol use, unspecified with intoxication delirium 
29189 Alcohol use, unspecified with other 
alcohol-induced disorder 
F1014 Alcohol abuse with alcohol-induced mood disorder OR F1024 Alcohol dependence with 
alcohol-induced mood disorder OR F10981 Alcohol use, unspecified with alcohol-induced sexual 
dysfunction OR F10988 Alcohol use, unspecified with other alcohol-induced disorder 
2915 Alcohol dependence with alcohol-
induced psychotic disorder with 
delusions 
F10150 Alcohol abuse with alcohol-induced psychotic disorder with delusions OR F10250 Alcohol 
dependence with alcohol-induced psychotic disorder with delusions 
2913 Alcohol dependence with alcohol-
induced psychotic disorder with 
hallucinations 
F10151 Alcohol abuse with alcohol-induced psychotic disorder with hallucinations OR F10251 
Alcohol dependence with alcohol-induced psychotic disorder with hallucinations 
29189 Alcohol use, unspecified with alcohol-
induced anxiety disorder 
F10159 Alcohol abuse with alcohol-induced psychotic disorder, unspecified OR F10180 Alcohol 
abuse with alcohol-induced anxiety disorder OR F10181 Alcohol abuse with alcohol-induced sexual 
dysfunction OR F10188 Alcohol abuse with other alcohol-induced disorder OR F10259 Alcohol 
dependence with alcohol-induced psychotic disorder, unspecified OR F10280 Alcohol dependence 
with alcohol-induced anxiety disorder OR F10281 Alcohol dependence with alcohol-induced sexual 
dysfunction OR F10288 Alcohol dependence with other alcohol-induced disorder OR F10959 
Alcohol use, unspecified with alcohol-induced psychotic disorder, unspecified OR F10980 Alcohol 
use, unspecified with alcohol-induced anxiety disorder 
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29182 Alcohol use, unspecified with alcohol-
induced sleep disorder 
F10182 Alcohol abuse with alcohol-induced sleep disorder OR F10282 Alcohol dependence with 
alcohol-induced sleep disorder OR F10982 Alcohol use, unspecified with alcohol-induced sleep 
disorder 
2919 Alcohol use, unspecified with alcohol-
induced mood disorder 
F1019 Alcohol abuse with unspecified alcohol-induced disorder OR F1029 Alcohol dependence 
with unspecified alcohol-induced disorder OR F1094 Alcohol use, unspecified with alcohol-induced 
mood disorder 
30390 Alcohol dependence, uncomplicated F1020 Alcohol dependence, uncomplicated 
30391 Alcohol dependence, uncomplicated F1020 Alcohol dependence, uncomplicated 
30392 Alcohol dependence, uncomplicated F1020 Alcohol dependence, uncomplicated 
30393 Alcohol dependence, in remission F1021 Alcohol dependence, in remission 
30300 Alcohol dependence with intoxication, 
uncomplicated 
F10220 Alcohol dependence with intoxication, uncomplicated 
30301 Alcohol dependence with intoxication, 
uncomplicated 
F10220 Alcohol dependence with intoxication, uncomplicated 
30302 Alcohol dependence with intoxication, 
uncomplicated 
F10220 Alcohol dependence with intoxication, uncomplicated 
30303 Alcohol dependence with intoxication, 
uncomplicated 
F10220 Alcohol dependence with intoxication, uncomplicated 
30300 Alcohol dependence with intoxication, 
unspecified 
F10229 Alcohol dependence with intoxication, unspecified 
30301 Alcohol dependence with intoxication, 
unspecified 
F10229 Alcohol dependence with intoxication, unspecified 
30302 Alcohol dependence with intoxication, 
unspecified 
F10229 Alcohol dependence with intoxication, unspecified 
30303 Alcohol dependence with intoxication, 
unspecified 
F10229 Alcohol dependence with intoxication, unspecified 
29181 Alcohol dependence with withdrawal 
with perceptual disturbance 
F10230 Alcohol dependence with withdrawal, uncomplicated OR F10232 Alcohol dependence with 
withdrawal with perceptual disturbance 
2910 Alcohol dependence with withdrawal 
delirium 
F10231 Alcohol dependence with withdrawal delirium 
29181 Alcohol dependence with withdrawal, 
unspecified 
F10239 Alcohol dependence with withdrawal, unspecified 
2911 Alcohol use, unspecified with alcohol-
induced persisting dementia 
F1026 Alcohol dependence with alcohol-induced persisting amnestic disorder OR F1097 Alcohol 
use, unspecified with alcohol-induced persisting dementia 
2912 Alcohol dependence with alcohol-
induced persisting dementia 
F1027 Alcohol dependence with alcohol-induced persisting dementia 
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2914 Alcohol use, unspecified with 
intoxication, uncomplicated 
F10920 Alcohol use, unspecified with intoxication, uncomplicated 
2914 Alcohol use, unspecified with 
intoxication, unspecified 
F10929 Alcohol use, unspecified with intoxication, unspecified 
2915 Alcohol use, unspecified with alcohol-
induced psychotic disorder with 
delusions 
F10950 Alcohol use, unspecified with alcohol-induced psychotic disorder with delusions 
2913 Alcohol use, unspecified with alcohol-
induced psychotic disorder with 
hallucinations 
F10951 Alcohol use, unspecified with alcohol-induced psychotic disorder with hallucinations 
2911 Alcohol use, unspecified with alcohol-
induced persisting amnestic disorder 
F1096 Alcohol use, unspecified with alcohol-induced persisting amnestic disorder 
2919 Alcohol use, unspecified with 
unspecified alcohol-induced disorder 
F1099 Alcohol use, unspecified with unspecified alcohol-induced disorder 
30550 Opioid abuse, uncomplicated F1110 Opioid abuse, uncomplicated 
30551 Opioid abuse, uncomplicated F1110 Opioid abuse, uncomplicated 
30552 Opioid abuse, uncomplicated F1110 Opioid abuse, uncomplicated 
30553 Opioid abuse, uncomplicated F1110 Opioid abuse, uncomplicated 
30551 Opioid abuse with intoxication, 
unspecified 
F11120 Opioid abuse with intoxication, uncomplicated OR F11129 Opioid abuse with intoxication, 
unspecified 
30552 Opioid abuse with intoxication, 
unspecified 
F11120 Opioid abuse with intoxication, uncomplicated OR F11129 Opioid abuse with intoxication, 
unspecified 
30553 Opioid abuse with intoxication, 
unspecified 
F11120 Opioid abuse with intoxication, uncomplicated OR F11129 Opioid abuse with intoxication, 
unspecified 
30550 Opioid use, unspecified, 
uncomplicated 
F11120 Opioid abuse with intoxication, uncomplicated OR F11129 Opioid abuse with intoxication, 
unspecified OR F1190 Opioid use, unspecified, uncomplicated 
29281 Other psychoactive substance 
dependence with intoxication delirium 
F11121 Opioid abuse with intoxication delirium OR F11221 Opioid dependence with intoxication 
delirium OR F11921 Opioid use, unspecified with intoxication delirium OR F12121 Cannabis abuse 
with intoxication delirium OR F12221 Cannabis dependence with intoxication delirium OR F12921 
Cannabis use, unspecified with intoxication delirium OR F13121 Sedative, hypnotic or anxiolytic 
abuse with intoxication delirium OR F13221 Sedative, hypnotic or anxiolytic dependence with 
intoxication delirium OR F13921 Sedative, hypnotic or anxiolytic use, unspecified with intoxication 
delirium OR F14121 Cocaine abuse with intoxication with delirium OR F14221 Cocaine 
dependence with intoxication delirium OR F14921 Cocaine use, unspecified with intoxication 
delirium OR F15121 Other stimulant abuse with intoxication delirium OR F15221 Other stimulant 
dependence with intoxication delirium OR F15921 Other stimulant use, unspecified with 
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intoxication delirium OR F16121 Hallucinogen abuse with intoxication with delirium OR F16221 
Hallucinogen dependence with intoxication with delirium OR F16921 Hallucinogen use, unspecified 
with intoxication with delirium OR F18121 Inhalant abuse with intoxication delirium OR F18221 
Inhalant dependence with intoxication delirium OR F18921 Inhalant use, unspecified with 
intoxication with delirium OR F19121 Other psychoactive substance abuse with intoxication 
delirium OR F19221 Other psychoactive substance dependence with intoxication delirium 
29282 Other psychoactive substance 
dependence with psychoactive 
substance-induced persisting dementia 
F11122 Opioid abuse with intoxication with perceptual disturbance OR F1327 Sedative, hypnotic or 
anxiolytic dependence with sedative, hypnotic or anxiolytic-induced pe OR F1397 Sedative, 
hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-indu OR F1817 
Inhalant abuse with inhalant-induced dementia OR F1827 Inhalant dependence with inhalant-
induced dementia OR F1897 Inhalant use, unspecified with inhalant-induced persisting dementia 
OR F1917 Other psychoactive substance abuse with psychoactive substance-induced persisting 
dementia OR F1927 Other psychoactive substance dependence with psychoactive substance-induced 
persisting demen 
29284 Other psychoactive substance 
dependence with psychoactive 
substance-induced mood disorder 
F1114 Opioid abuse with opioid-induced mood disorder OR F1124 Opioid dependence with opioid-
induced mood disorder OR F1194 Opioid use, unspecified with opioid-induced mood disorder OR 
F1314 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced mood di 
OR F1324 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-
induced mo OR F1394 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or 
anxiolytic-indu OR F1414 Cocaine abuse with cocaine-induced mood disorder OR F1424 Cocaine 
dependence with cocaine-induced mood disorder OR F1494 Cocaine use, unspecified with cocaine-
induced mood disorder OR F1514 Other stimulant abuse with stimulant-induced mood disorder OR 
F1524 Other stimulant dependence with stimulant-induced mood disorder OR F1594 Other 
stimulant use, unspecified with stimulant-induced mood disorder OR F1614 Hallucinogen abuse 
with hallucinogen-induced mood disorder OR F1624 Hallucinogen dependence with hallucinogen-
induced mood disorder OR F1694 Hallucinogen use, unspecified with hallucinogen-induced mood 
disorder OR F1814 Inhalant abuse with inhalant-induced mood disorder OR F1824 Inhalant 
dependence with inhalant-induced mood disorder OR F1894 Inhalant use, unspecified with inhalant-
induced mood disorder OR F1914 Other psychoactive substance abuse with psychoactive substance-
induced mood disorder OR F1924 Other psychoactive substance dependence with psychoactive 
substance-induced mood disorder 
29211 Other psychoactive substance 
dependence with psychoactive 
substance-induced psychotic disord 
F11150 Opioid abuse with opioid-induced psychotic disorder with delusions OR F11250 Opioid 
dependence with opioid-induced psychotic disorder with delusions OR F11950 Opioid use, 
unspecified with opioid-induced psychotic disorder with delusions OR F12150 Cannabis abuse with 
psychotic disorder with delusions OR F12250 Cannabis dependence with psychotic disorder with 
delusions OR F12950 Cannabis use, unspecified with psychotic disorder with delusions OR F13150 
Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychot OR 
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F13250 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced 
ps OR F13950 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or 
anxiolytic-indu OR F14150 Cocaine abuse with cocaine-induced psychotic disorder with delusions 
OR F14250 Cocaine dependence with cocaine-induced psychotic disorder with delusions OR 
F14950 Cocaine use, unspecified with cocaine-induced psychotic disorder with delusions OR 
F15150 Other stimulant abuse with stimulant-induced psychotic disorder with delusions OR F15250 
Other stimulant dependence with stimulant-induced psychotic disorder with delusions OR F15950 
Other stimulant use, unspecified with stimulant-induced psychotic disorder with delusions OR 
F16150 Hallucinogen abuse with hallucinogen-induced psychotic disorder with delusions OR 
F16250 Hallucinogen dependence with hallucinogen-induced psychotic disorder with delusions OR 
F16950 Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder with delusions 
OR F18150 Inhalant abuse with inhalant-induced psychotic disorder with delusions OR F18250 
Inhalant dependence with inhalant-induced psychotic disorder with delusions OR F18950 Inhalant 
use, unspecified with inhalant-induced psychotic disorder with delusions OR F19150 Other 
psychoactive substance abuse with psychoactive substance-induced psychotic disorder wi OR 
F19250 Other psychoactive substance dependence with psychoactive substance-induced psychotic 
disord 
29212 Other psychoactive substance 
dependence with psychoactive 
substance-induced psychotic disord 
F11151 Opioid abuse with opioid-induced psychotic disorder with hallucinations OR F11251 
Opioid dependence with opioid-induced psychotic disorder with hallucinations OR F11951 Opioid 
use, unspecified with opioid-induced psychotic disorder with hallucinations OR F12151 Cannabis 
abuse with psychotic disorder with hallucinations OR F12251 Cannabis dependence with psychotic 
disorder with hallucinations OR F12951 Cannabis use, unspecified with psychotic disorder with 
hallucinations OR F13151 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or 
anxiolytic-induced psychot OR F13251 Sedative, hypnotic or anxiolytic dependence with sedative, 
hypnotic or anxiolytic-induced ps OR F13951 Sedative, hypnotic or anxiolytic use, unspecified with 
sedative, hypnotic or anxiolytic-indu OR F14151 Cocaine abuse with cocaine-induced psychotic 
disorder with hallucinations OR F14251 Cocaine dependence with cocaine-induced psychotic 
disorder with hallucinations OR F14951 Cocaine use, unspecified with cocaine-induced psychotic 
disorder with hallucinations OR F15151 Other stimulant abuse with stimulant-induced psychotic 
disorder with hallucinations OR F15251 Other stimulant dependence with stimulant-induced 
psychotic disorder with hallucinations OR F15951 Other stimulant use, unspecified with stimulant-
induced psychotic disorder with hallucinatio OR F16151 Hallucinogen abuse with hallucinogen-
induced psychotic disorder with hallucinations OR F16251 Hallucinogen dependence with 
hallucinogen-induced psychotic disorder with hallucinations OR F16951 Hallucinogen use, 
unspecified with hallucinogen-induced psychotic disorder with hallucinatio OR F18151 Inhalant 
abuse with inhalant-induced psychotic disorder with hallucinations OR F18251 Inhalant dependence 
with inhalant-induced psychotic disorder with hallucinations OR F18951 Inhalant use, unspecified 
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with inhalant-induced psychotic disorder with hallucinations OR F19151 Other psychoactive 
substance abuse with psychoactive substance-induced psychotic disorder wi OR F19251 Other 
psychoactive substance dependence with psychoactive substance-induced psychotic disord 
29289 Other psychoactive substance use, 
unspecified with other psychoactive 
substance-induced diso 
F11159 Opioid abuse with opioid-induced psychotic disorder, unspecified OR F11181 Opioid abuse 
with opioid-induced sexual dysfunction OR F11188 Opioid abuse with other opioid-induced 
disorder OR F11222 Opioid dependence with intoxication with perceptual disturbance OR F11259 
Opioid dependence with opioid-induced psychotic disorder, unspecified OR F11281 Opioid 
dependence with opioid-induced sexual dysfunction OR F11288 Opioid dependence with other 
opioid-induced disorder OR F11922 Opioid use, unspecified with intoxication with perceptual 
disturbance OR F11959 Opioid use, unspecified with opioid-induced psychotic disorder, unspecified 
OR F11981 Opioid use, unspecified with opioid-induced sexual dysfunction OR F11988 Opioid use, 
unspecified with other opioid-induced disorder OR F12122 Cannabis abuse with intoxication with 
perceptual disturbance OR F12159 Cannabis abuse with psychotic disorder, unspecified OR F12180 
Cannabis abuse with cannabis-induced anxiety disorder OR F12188 Cannabis abuse with other 
cannabis-induced disorder OR F12222 Cannabis dependence with intoxication with perceptual 
disturbance OR F12259 Cannabis dependence with psychotic disorder, unspecified OR F12280 
Cannabis dependence with cannabis-induced anxiety disorder OR F12288 Cannabis dependence 
with other cannabis-induced disorder OR F12922 Cannabis use, unspecified with intoxication with 
perceptual disturbance OR F12959 Cannabis use, unspecified with psychotic disorder, unspecified 
OR F12980 Cannabis use, unspecified with anxiety disorder OR F12988 Cannabis use, unspecified 
with other cannabis-induced disorder OR F13159 Sedative, hypnotic or anxiolytic abuse with 
sedative, hypnotic or anxiolytic-induced psychot OR F13180 Sedative, hypnotic or anxiolytic abuse 
with sedative, hypnotic or anxiolytic-induced anxiety OR F13181 Sedative, hypnotic or anxiolytic 
abuse with sedative, hypnotic or anxiolytic-induced sexual OR F13188 Sedative, hypnotic or 
anxiolytic abuse with other sedative, hypnotic or anxiolytic-induced d OR F13259 Sedative, 
hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced ps OR F13280 
Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced an OR 
F13281 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced 
se OR F13288 Sedative, hypnotic or anxiolytic dependence with other sedative, hypnotic or 
anxiolytic-indu OR F13959 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic 
or anxiolytic-indu OR F13980 Sedative, hypnotic or anxiolytic use, unspecified with sedative, 
hypnotic or anxiolytic-indu OR F13981 Sedative, hypnotic or anxiolytic use, unspecified with 
sedative, hypnotic or anxiolytic-indu OR F13988 Sedative, hypnotic or anxiolytic use, unspecified 
with other sedative, hypnotic or anxiolyti OR F14122 Cocaine abuse with intoxication with 
perceptual disturbance OR F14159 Cocaine abuse with cocaine-induced psychotic disorder, 
unspecified OR F14180 Cocaine abuse with cocaine-induced anxiety disorder OR F14181 Cocaine 
abuse with cocaine-induced sexual dysfunction OR F14188 Cocaine abuse with other cocaine-
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induced disorder OR F14222 Cocaine dependence with intoxication with perceptual disturbance OR 
F14259 Cocaine dependence with cocaine-induced psychotic disorder, unspecified OR F14280 
Cocaine dependence with cocaine-induced anxiety disorder OR F14281 Cocaine dependence with 
cocaine-induced sexual dysfunction OR F14288 Cocaine dependence with other cocaine-induced 
disorder OR F14922 Cocaine use, unspecified with intoxication with perceptual disturbance OR 
F14959 Cocaine use, unspecified with cocaine-induced psychotic disorder, unspecified OR F14980 
Cocaine use, unspecified with cocaine-induced anxiety disorder OR F14981 Cocaine use, 
unspecified with cocaine-induced sexual dysfunction OR F14988 Cocaine use, unspecified with 
other cocaine-induced disorder OR F15122 Other stimulant abuse with intoxication with perceptual 
disturbance OR F15159 Other stimulant abuse with stimulant-induced psychotic disorder, 
unspecified OR F15180 Other stimulant abuse with stimulant-induced anxiety disorder OR F15181 
Other stimulant abuse with stimulant-induced sexual dysfunction OR F15188 Other stimulant abuse 
with other stimulant-induced disorder OR F15222 Other stimulant dependence with intoxication 
with perceptual disturbance OR F15259 Other stimulant dependence with stimulant-induced 
psychotic disorder, unspecified OR F15280 Other stimulant dependence with stimulant-induced 
anxiety disorder OR F15281 Other stimulant dependence with stimulant-induced sexual dysfunction 
OR F15288 Other stimulant dependence with other stimulant-induced disorder OR F15922 Other 
stimulant use, unspecified with intoxication with perceptual disturbance OR F15959 Other stimulant 
use, unspecified with stimulant-induced psychotic disorder, unspecified OR F15980 Other stimulant 
use, unspecified with stimulant-induced anxiety disorder OR F15981 Other stimulant use, 
unspecified with stimulant-induced sexual dysfunction OR F15988 Other stimulant use, unspecified 
with other stimulant-induced disorder OR F16122 Hallucinogen abuse with intoxication with 
perceptual disturbance OR F16159 Hallucinogen abuse with hallucinogen-induced psychotic 
disorder, unspecified OR F16180 Hallucinogen abuse with hallucinogen-induced anxiety disorder 
OR F16183 Hallucinogen abuse with hallucinogen persisting perception disorder (flashbacks) OR 
F16188 Hallucinogen abuse with other hallucinogen-induced disorder OR F16259 Hallucinogen 
dependence with hallucinogen-induced psychotic disorder, unspecified OR F16280 Hallucinogen 
dependence with hallucinogen-induced anxiety disorder OR F16283 Hallucinogen dependence with 
hallucinogen persisting perception disorder (flashbacks) OR F16288 Hallucinogen dependence with 
other hallucinogen-induced disorder OR F16959 Hallucinogen use, unspecified with hallucinogen-
induced psychotic disorder, unspecified OR F16980 Hallucinogen use, unspecified with 
hallucinogen-induced anxiety disorder OR F16983 Hallucinogen use, unspecified with hallucinogen 
persisting perception disorder (flashbacks) OR F16988 Hallucinogen use, unspecified with other 
hallucinogen-induced disorder OR F17208 Nicotine dependence, unspecified, with other nicotine-
induced disorders OR F17218 Nicotine dependence, cigarettes, with other nicotine-induced 
disorders OR F17228 Nicotine dependence, chewing tobacco, with other nicotine-induced disorders 
OR F17298 Nicotine dependence, other tobacco product, with other nicotine-induced disorders OR 
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F18159 Inhalant abuse with inhalant-induced psychotic disorder, unspecified OR F18180 Inhalant 
abuse with inhalant-induced anxiety disorder OR F18188 Inhalant abuse with other inhalant-induced 
disorder OR F18259 Inhalant dependence with inhalant-induced psychotic disorder, unspecified OR 
F18280 Inhalant dependence with inhalant-induced anxiety disorder OR F18288 Inhalant 
dependence with other inhalant-induced disorder OR F18959 Inhalant use, unspecified with 
inhalant-induced psychotic disorder, unspecified OR F18980 Inhalant use, unspecified with 
inhalant-induced anxiety disorder OR F18988 Inhalant use, unspecified with other inhalant-induced 
disorder OR F19122 Other psychoactive substance abuse with intoxication with perceptual 
disturbances OR F19159 Other psychoactive substance abuse with psychoactive substance-induced 
psychotic disorder, u OR F19180 Other psychoactive substance abuse with psychoactive substance-
induced anxiety disorder OR F19181 Other psychoactive substance abuse with psychoactive 
substance-induced sexual dysfunction OR F19188 Other psychoactive substance abuse with other 
psychoactive substance-induced disorder OR F19222 Other psychoactive substance dependence 
with intoxication with perceptual disturbance OR F19259 Other psychoactive substance dependence 
with psychoactive substance-induced psychotic disord OR F19280 Other psychoactive substance 
dependence with psychoactive substance-induced anxiety disorder OR F19281 Other psychoactive 
substance dependence with psychoactive substance-induced sexual dysfuncti OR F19288 Other 
psychoactive substance dependence with other psychoactive substance-induced disorder OR F19922 
Other psychoactive substance use, unspecified with intoxication with perceptual disturbance OR 
F19959 Other psychoactive substance use, unspecified with psychoactive substance-induced 
psychotic OR F19980 Other psychoactive substance use, unspecified with psychoactive substance-
induced anxiety di OR F19981 Other psychoactive substance use, unspecified with psychoactive 
substance-induced sexual dys OR F19988 Other psychoactive substance use, unspecified with other 
psychoactive substance-induced diso 
29285 Other psychoactive substance use, 
unspecified with psychoactive 
substance-induced sleep diso 
F11182 Opioid abuse with opioid-induced sleep disorder OR F11282 Opioid dependence with 
opioid-induced sleep disorder OR F11982 Opioid use, unspecified with opioid-induced sleep 
disorder OR F13182 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-
induced sleep d OR F13282 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or 
anxiolytic-induced sl OR F13982 Sedative, hypnotic or anxiolytic use, unspecified with sedative, 
hypnotic or anxiolytic-indu OR F14182 Cocaine abuse with cocaine-induced sleep disorder OR 
F14282 Cocaine dependence with cocaine-induced sleep disorder OR F14982 Cocaine use, 
unspecified with cocaine-induced sleep disorder OR F15182 Other stimulant abuse with stimulant-
induced sleep disorder OR F15282 Other stimulant dependence with stimulant-induced sleep 
disorder OR F15982 Other stimulant use, unspecified with stimulant-induced sleep disorder OR 
F19182 Other psychoactive substance abuse with psychoactive substance-induced sleep disorder OR 
F19282 Other psychoactive substance dependence with psychoactive substance-induced sleep 
  
1
6
3
 
disorder OR F19982 Other psychoactive substance use, unspecified with psychoactive substance-
induced sleep diso 
2929 Other psychoactive substance 
dependence with unspecified 
psychoactive substance-induced diso 
F1119 Opioid abuse with unspecified opioid-induced disorder OR F1129 Opioid dependence with 
unspecified opioid-induced disorder OR F1199 Opioid use, unspecified with unspecified opioid-
induced disorder OR F1219 Cannabis abuse with unspecified cannabis-induced disorder OR F1229 
Cannabis dependence with unspecified cannabis-induced disorder OR F1299 Cannabis use, 
unspecified with unspecified cannabis-induced disorder OR F1319 Sedative, hypnotic or anxiolytic 
abuse with unspecified sedative, hypnotic or anxiolytic-ind OR F1329 Sedative, hypnotic or 
anxiolytic dependence with unspecified sedative, hypnotic or anxiolyti OR F1399 Sedative, 
hypnotic or anxiolytic use, unspecified with unspecified sedative, hypnotic or anx OR F1419 
Cocaine abuse with unspecified cocaine-induced disorder OR F1429 Cocaine dependence with 
unspecified cocaine-induced disorder OR F1499 Cocaine use, unspecified with unspecified cocaine-
induced disorder OR F1519 Other stimulant abuse with unspecified stimulant-induced disorder OR 
F1529 Other stimulant dependence with unspecified stimulant-induced disorder OR F1599 Other 
stimulant use, unspecified with unspecified stimulant-induced disorder OR F1619 Hallucinogen 
abuse with unspecified hallucinogen-induced disorder OR F1629 Hallucinogen dependence with 
unspecified hallucinogen-induced disorder OR F1699 Hallucinogen use, unspecified with 
unspecified hallucinogen-induced disorder OR F17209 Nicotine dependence, unspecified, with 
unspecified nicotine-induced disorders OR F17219 Nicotine dependence, cigarettes, with 
unspecified nicotine-induced disorders OR F17229 Nicotine dependence, chewing tobacco, with 
unspecified nicotine-induced disorders OR F17299 Nicotine dependence, other tobacco product, 
with unspecified nicotine-induced disorders OR F1819 Inhalant abuse with unspecified inhalant-
induced disorder OR F1829 Inhalant dependence with unspecified inhalant-induced disorder OR 
F1899 Inhalant use, unspecified with unspecified inhalant-induced disorder OR F1919 Other 
psychoactive substance abuse with unspecified psychoactive substance-induced disorder OR F1929 
Other psychoactive substance dependence with unspecified psychoactive substance-induced diso 
30400 Opioid dependence, uncomplicated F1120 Opioid dependence, uncomplicated 
30401 Opioid dependence, uncomplicated F1120 Opioid dependence, uncomplicated 
30402 Opioid dependence, uncomplicated F1120 Opioid dependence, uncomplicated 
30403 Opioid dependence, in remission F1121 Opioid dependence, in remission 
30400 Opioid dependence with unspecified 
opioid-induced disorder 
F11220 Opioid dependence with intoxication, uncomplicated OR F11221 Opioid dependence with 
intoxication delirium OR F11222 Opioid dependence with intoxication with perceptual disturbance 
OR F11229 Opioid dependence with intoxication, unspecified OR F1123 Opioid dependence with 
withdrawal OR F1124 Opioid dependence with opioid-induced mood disorder OR F11250 Opioid 
dependence with opioid-induced psychotic disorder with delusions OR F11251 Opioid dependence 
with opioid-induced psychotic disorder with hallucinations OR F11259 Opioid dependence with 
opioid-induced psychotic disorder, unspecified OR F11281 Opioid dependence with opioid-induced 
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sexual dysfunction OR F11282 Opioid dependence with opioid-induced sleep disorder OR F11288 
Opioid dependence with other opioid-induced disorder OR F1129 Opioid dependence with 
unspecified opioid-induced disorder 
2922 Other psychoactive substance use, 
unspecified with intoxication, 
unspecified 
F11220 Opioid dependence with intoxication, uncomplicated OR F11229 Opioid dependence with 
intoxication, unspecified OR F11920 Opioid use, unspecified with intoxication, uncomplicated OR 
F11929 Opioid use, unspecified with intoxication, unspecified OR F12120 Cannabis abuse with 
intoxication, uncomplicated OR F12129 Cannabis abuse with intoxication, unspecified OR F12220 
Cannabis dependence with intoxication, uncomplicated OR F12229 Cannabis dependence with 
intoxication, unspecified OR F12920 Cannabis use, unspecified with intoxication, uncomplicated 
OR F12929 Cannabis use, unspecified with intoxication, unspecified OR F13129 Sedative, hypnotic 
or anxiolytic abuse with intoxication, unspecified OR F13220 Sedative, hypnotic or anxiolytic 
dependence with intoxication, uncomplicated OR F13229 Sedative, hypnotic or anxiolytic 
dependence with intoxication, unspecified OR F13920 Sedative, hypnotic or anxiolytic use, 
unspecified with intoxication, uncomplicated OR F13929 Sedative, hypnotic or anxiolytic use, 
unspecified with intoxication, unspecified OR F14129 Cocaine abuse with intoxication, unspecified 
OR F14220 Cocaine dependence with intoxication, uncomplicated OR F14229 Cocaine dependence 
with intoxication, unspecified OR F14920 Cocaine use, unspecified with intoxication, 
uncomplicated OR F14929 Cocaine use, unspecified with intoxication, unspecified OR F15129 
Other stimulant abuse with intoxication, unspecified OR F15220 Other stimulant dependence with 
intoxication, uncomplicated OR F15229 Other stimulant dependence with intoxication, unspecified 
OR F15929 Other stimulant use, unspecified with intoxication, unspecified OR F16129 
Hallucinogen abuse with intoxication, unspecified OR F16220 Hallucinogen dependence with 
intoxication, uncomplicated OR F16229 Hallucinogen dependence with intoxication, unspecified 
OR F16920 Hallucinogen use, unspecified with intoxication, uncomplicated OR F16929 
Hallucinogen use, unspecified with intoxication, unspecified OR F18120 Inhalant abuse with 
intoxication, uncomplicated OR F18129 Inhalant abuse with intoxication, unspecified OR F18220 
Inhalant dependence with intoxication, uncomplicated OR F18229 Inhalant dependence with 
intoxication, unspecified OR F18920 Inhalant use, unspecified with intoxication, uncomplicated OR 
F18929 Inhalant use, unspecified with intoxication, unspecified OR F19129 Other psychoactive 
substance abuse with intoxication, unspecified OR F19220 Other psychoactive substance 
dependence with intoxication, uncomplicated OR F19229 Other psychoactive substance dependence 
with intoxication, unspecified OR F19920 Other psychoactive substance use, unspecified with 
intoxication, uncomplicated OR F19929 Other psychoactive substance use, unspecified with 
intoxication, unspecified 
2920 Other psychoactive substance use, 
unspecified with withdrawal with 
perceptual disturbance 
F1123 Opioid dependence with withdrawal OR F1193 Opioid use, unspecified with withdrawal OR 
F13230 Sedative, hypnotic or anxiolytic dependence with withdrawal, uncomplicated OR F13231 
Sedative, hypnotic or anxiolytic dependence with withdrawal delirium OR F13232 Sedative, 
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hypnotic or anxiolytic dependence with withdrawal with perceptual disturbance OR F13239 
Sedative, hypnotic or anxiolytic dependence with withdrawal, unspecified OR F13930 Sedative, 
hypnotic or anxiolytic use, unspecified with withdrawal, uncomplicated OR F13931 Sedative, 
hypnotic or anxiolytic use, unspecified with withdrawal delirium OR F13932 Sedative, hypnotic or 
anxiolytic use, unspecified with withdrawal with perceptual disturbanc OR F13939 Sedative, 
hypnotic or anxiolytic use, unspecified with withdrawal, unspecified OR F1423 Cocaine dependence 
with withdrawal OR F1523 Other stimulant dependence with withdrawal OR F1593 Other stimulant 
use, unspecified with withdrawal OR F17203 Nicotine dependence unspecified, with withdrawal OR 
F17213 Nicotine dependence, cigarettes, with withdrawal OR F17223 Nicotine dependence, 
chewing tobacco, with withdrawal OR F17293 Nicotine dependence, other tobacco product, with 
withdrawal OR F19230 Other psychoactive substance dependence with withdrawal, uncomplicated 
OR F19231 Other psychoactive substance dependence with withdrawal delirium OR F19232 Other 
psychoactive substance dependence with withdrawal with perceptual disturbance OR F19239 Other 
psychoactive substance dependence with withdrawal, unspecified OR F19930 Other psychoactive 
substance use, unspecified with withdrawal, uncomplicated OR F19931 Other psychoactive 
substance use, unspecified with withdrawal delirium OR F19932 Other psychoactive substance use, 
unspecified with withdrawal with perceptual disturbance 
30520 Cannabis abuse, uncomplicated F1210 Cannabis abuse, uncomplicated 
30521 Cannabis use, unspecified, 
uncomplicated 
F1210 Cannabis abuse, uncomplicated OR F1290 Cannabis use, unspecified, uncomplicated 
30522 Cannabis use, unspecified, 
uncomplicated 
F1210 Cannabis abuse, uncomplicated OR F1290 Cannabis use, unspecified, uncomplicated 
30523 Cannabis use, unspecified, 
uncomplicated 
F1210 Cannabis abuse, uncomplicated OR F1290 Cannabis use, unspecified, uncomplicated 
30430 Cannabis dependence, uncomplicated F1220 Cannabis dependence, uncomplicated 
30431 Cannabis dependence, uncomplicated F1220 Cannabis dependence, uncomplicated 
30432 Cannabis dependence, uncomplicated F1220 Cannabis dependence, uncomplicated 
30433 Cannabis dependence, in remission F1221 Cannabis dependence, in remission 
30430 Cannabis dependence with unspecified 
cannabis-induced disorder 
F12220 Cannabis dependence with intoxication, uncomplicated OR F12221 Cannabis dependence 
with intoxication delirium OR F12222 Cannabis dependence with intoxication with perceptual 
disturbance OR F12229 Cannabis dependence with intoxication, unspecified OR F12250 Cannabis 
dependence with psychotic disorder with delusions OR F12251 Cannabis dependence with 
psychotic disorder with hallucinations OR F12259 Cannabis dependence with psychotic disorder, 
unspecified OR F12280 Cannabis dependence with cannabis-induced anxiety disorder OR F12288 
Cannabis dependence with other cannabis-induced disorder OR F1229 Cannabis dependence with 
unspecified cannabis-induced disorder 
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30520 Cannabis use, unspecified, 
uncomplicated 
F1290 Cannabis use, unspecified, uncomplicated 
30540 Sedative, hypnotic or anxiolytic abuse, 
uncomplicated 
F1310 Sedative, hypnotic or anxiolytic abuse, uncomplicated 
30541 Sedative, hypnotic or anxiolytic abuse, 
uncomplicated 
F1310 Sedative, hypnotic or anxiolytic abuse, uncomplicated 
30542 Sedative, hypnotic or anxiolytic abuse, 
uncomplicated 
F1310 Sedative, hypnotic or anxiolytic abuse, uncomplicated 
30543 Sedative, hypnotic or anxiolytic abuse, 
uncomplicated 
F1310 Sedative, hypnotic or anxiolytic abuse, uncomplicated 
30541 Sedative, hypnotic or anxiolytic abuse 
with intoxication, uncomplicated 
F13120 Sedative, hypnotic or anxiolytic abuse with intoxication, uncomplicated 
30542 Sedative, hypnotic or anxiolytic abuse 
with intoxication, uncomplicated 
F13120 Sedative, hypnotic or anxiolytic abuse with intoxication, uncomplicated 
30543 Sedative, hypnotic or anxiolytic abuse 
with intoxication, uncomplicated 
F13120 Sedative, hypnotic or anxiolytic abuse with intoxication, uncomplicated 
30540 Sedative, hypnotic, or anxiolytic use, 
unspecified, uncomplicated 
F13120 Sedative, hypnotic or anxiolytic abuse with intoxication, uncomplicated OR F1390 
Sedative, hypnotic, or anxiolytic use, unspecified, uncomplicated 
30410 Sedative, hypnotic or anxiolytic 
dependence, uncomplicated 
F1320 Sedative, hypnotic or anxiolytic dependence, uncomplicated 
30411 Sedative, hypnotic or anxiolytic 
dependence, uncomplicated 
F1320 Sedative, hypnotic or anxiolytic dependence, uncomplicated 
30412 Sedative, hypnotic or anxiolytic 
dependence, uncomplicated 
F1320 Sedative, hypnotic or anxiolytic dependence, uncomplicated 
30413 Sedative, hypnotic or anxiolytic 
dependence, in remission 
F1321 Sedative, hypnotic or anxiolytic dependence, in remission 
30410 Sedative, hypnotic or anxiolytic 
dependence with unspecified sedative, 
hypnotic or anxiolyti 
F13220 Sedative, hypnotic or anxiolytic dependence with intoxication, uncomplicated OR F13221 
Sedative, hypnotic or anxiolytic dependence with intoxication delirium OR F13229 Sedative, 
hypnotic or anxiolytic dependence with intoxication, unspecified OR F13230 Sedative, hypnotic or 
anxiolytic dependence with withdrawal, uncomplicated OR F13231 Sedative, hypnotic or anxiolytic 
dependence with withdrawal delirium OR F13232 Sedative, hypnotic or anxiolytic dependence with 
withdrawal with perceptual disturbance OR F13239 Sedative, hypnotic or anxiolytic dependence 
with withdrawal, unspecified OR F1324 Sedative, hypnotic or anxiolytic dependence with sedative, 
hypnotic or anxiolytic-induced mo OR F13250 Sedative, hypnotic or anxiolytic dependence with 
sedative, hypnotic or anxiolytic-induced ps OR F13251 Sedative, hypnotic or anxiolytic dependence 
with sedative, hypnotic or anxiolytic-induced ps OR F13259 Sedative, hypnotic or anxiolytic 
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dependence with sedative, hypnotic or anxiolytic-induced ps OR F1326 Sedative, hypnotic or 
anxiolytic dependence with sedative, hypnotic or anxiolytic-induced pe OR F1327 Sedative, 
hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced pe OR F13280 
Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced an OR 
F13281 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced 
se OR F13282 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-
induced sl OR F13288 Sedative, hypnotic or anxiolytic dependence with other sedative, hypnotic or 
anxiolytic-indu OR F1329 Sedative, hypnotic or anxiolytic dependence with unspecified sedative, 
hypnotic or anxiolyti 
29283 Other psychoactive substance 
dependence with psychoactive 
substance-induced persisting amnes 
F1326 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced pe 
OR F1396 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-
indu OR F1916 Other psychoactive substance abuse with psychoactive substance-induced persisting 
amnestic d OR F1926 Other psychoactive substance dependence with psychoactive substance-
induced persisting amnes 
30560 Cocaine abuse, uncomplicated F1410 Cocaine abuse, uncomplicated 
30561 Cocaine abuse, uncomplicated F1410 Cocaine abuse, uncomplicated 
30562 Cocaine abuse, uncomplicated F1410 Cocaine abuse, uncomplicated 
30563 Cocaine abuse, uncomplicated F1410 Cocaine abuse, uncomplicated 
30561 Cocaine abuse with intoxication, 
uncomplicated 
F14120 Cocaine abuse with intoxication, uncomplicated 
30562 Cocaine abuse with intoxication, 
uncomplicated 
F14120 Cocaine abuse with intoxication, uncomplicated 
30563 Cocaine abuse with intoxication, 
uncomplicated 
F14120 Cocaine abuse with intoxication, uncomplicated 
30560 Cocaine use, unspecified, 
uncomplicated 
F14120 Cocaine abuse with intoxication, uncomplicated OR F1490 Cocaine use, unspecified, 
uncomplicated 
30420 Cocaine dependence, uncomplicated F1420 Cocaine dependence, uncomplicated 
30421 Cocaine dependence, uncomplicated F1420 Cocaine dependence, uncomplicated 
30422 Cocaine dependence, uncomplicated F1420 Cocaine dependence, uncomplicated 
30423 Cocaine dependence, in remission F1421 Cocaine dependence, in remission 
30420 Cocaine dependence with unspecified 
cocaine-induced disorder 
F14220 Cocaine dependence with intoxication, uncomplicated OR F14221 Cocaine dependence 
with intoxication delirium OR F14222 Cocaine dependence with intoxication with perceptual 
disturbance OR F14229 Cocaine dependence with intoxication, unspecified OR F1423 Cocaine 
dependence with withdrawal OR F1424 Cocaine dependence with cocaine-induced mood disorder 
OR F14250 Cocaine dependence with cocaine-induced psychotic disorder with delusions OR 
F14251 Cocaine dependence with cocaine-induced psychotic disorder with hallucinations OR 
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F14259 Cocaine dependence with cocaine-induced psychotic disorder, unspecified OR F14280 
Cocaine dependence with cocaine-induced anxiety disorder OR F14281 Cocaine dependence with 
cocaine-induced sexual dysfunction OR F14282 Cocaine dependence with cocaine-induced sleep 
disorder OR F14288 Cocaine dependence with other cocaine-induced disorder OR F1429 Cocaine 
dependence with unspecified cocaine-induced disorder 
30570 Other stimulant abuse, uncomplicated F1510 Other stimulant abuse, uncomplicated 
30571 Other stimulant abuse, uncomplicated F1510 Other stimulant abuse, uncomplicated 
30572 Other stimulant abuse, uncomplicated F1510 Other stimulant abuse, uncomplicated 
30573 Other stimulant abuse, uncomplicated F1510 Other stimulant abuse, uncomplicated 
30571 Other stimulant abuse with 
intoxication, uncomplicated 
F15120 Other stimulant abuse with intoxication, uncomplicated 
30572 Other stimulant abuse with 
intoxication, uncomplicated 
F15120 Other stimulant abuse with intoxication, uncomplicated 
30573 Other stimulant abuse with 
intoxication, uncomplicated 
F15120 Other stimulant abuse with intoxication, uncomplicated 
30570 Other stimulant use, unspecified, 
uncomplicated 
F15120 Other stimulant abuse with intoxication, uncomplicated OR F1590 Other stimulant use, 
unspecified, uncomplicated 
30440 Other stimulant dependence, 
uncomplicated 
F1520 Other stimulant dependence, uncomplicated 
30441 Other stimulant dependence, 
uncomplicated 
F1520 Other stimulant dependence, uncomplicated 
30442 Other stimulant dependence, 
uncomplicated 
F1520 Other stimulant dependence, uncomplicated 
30443 Other stimulant dependence, in 
remission 
F1521 Other stimulant dependence, in remission 
30440 Other stimulant dependence with 
unspecified stimulant-induced disorder 
F15220 Other stimulant dependence with intoxication, uncomplicated OR F15221 Other stimulant 
dependence with intoxication delirium OR F15222 Other stimulant dependence with intoxication 
with perceptual disturbance OR F15229 Other stimulant dependence with intoxication, unspecified 
OR F1523 Other stimulant dependence with withdrawal OR F1524 Other stimulant dependence 
with stimulant-induced mood disorder OR F15250 Other stimulant dependence with stimulant-
induced psychotic disorder with delusions OR F15251 Other stimulant dependence with stimulant-
induced psychotic disorder with hallucinations OR F15259 Other stimulant dependence with 
stimulant-induced psychotic disorder, unspecified OR F15280 Other stimulant dependence with 
stimulant-induced anxiety disorder OR F15281 Other stimulant dependence with stimulant-induced 
sexual dysfunction OR F15282 Other stimulant dependence with stimulant-induced sleep disorder 
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OR F15288 Other stimulant dependence with other stimulant-induced disorder OR F1529 Other 
stimulant dependence with unspecified stimulant-induced disorder 
2922 Other stimulant use, unspecified with 
intoxication, uncomplicated 
F15920 Other stimulant use, unspecified with intoxication, uncomplicated 
30530 Hallucinogen abuse, uncomplicated F1610 Hallucinogen abuse, uncomplicated 
30531 Hallucinogen abuse, uncomplicated F1610 Hallucinogen abuse, uncomplicated 
30532 Hallucinogen abuse, uncomplicated F1610 Hallucinogen abuse, uncomplicated 
30533 Hallucinogen abuse, uncomplicated F1610 Hallucinogen abuse, uncomplicated 
30531 Hallucinogen abuse with intoxication, 
uncomplicated 
F16120 Hallucinogen abuse with intoxication, uncomplicated 
30532 Hallucinogen abuse with intoxication, 
uncomplicated 
F16120 Hallucinogen abuse with intoxication, uncomplicated 
30533 Hallucinogen abuse with intoxication, 
uncomplicated 
F16120 Hallucinogen abuse with intoxication, uncomplicated 
30530 Hallucinogen use, unspecified, 
uncomplicated 
F16120 Hallucinogen abuse with intoxication, uncomplicated OR F1690 Hallucinogen use, 
unspecified, uncomplicated 
30450 Hallucinogen dependence, 
uncomplicated 
F1620 Hallucinogen dependence, uncomplicated 
30451 Hallucinogen dependence, 
uncomplicated 
F1620 Hallucinogen dependence, uncomplicated 
30452 Hallucinogen dependence, 
uncomplicated 
F1620 Hallucinogen dependence, uncomplicated 
30453 Hallucinogen dependence, in remission F1621 Hallucinogen dependence, in remission 
30450 Hallucinogen dependence with 
unspecified hallucinogen-induced 
disorder 
F16220 Hallucinogen dependence with intoxication, uncomplicated OR F16221 Hallucinogen 
dependence with intoxication with delirium OR F16229 Hallucinogen dependence with intoxication, 
unspecified OR F1624 Hallucinogen dependence with hallucinogen-induced mood disorder OR 
F16250 Hallucinogen dependence with hallucinogen-induced psychotic disorder with delusions OR 
F16251 Hallucinogen dependence with hallucinogen-induced psychotic disorder with hallucinations 
OR F16259 Hallucinogen dependence with hallucinogen-induced psychotic disorder, unspecified 
OR F16280 Hallucinogen dependence with hallucinogen-induced anxiety disorder OR F16283 
Hallucinogen dependence with hallucinogen persisting perception disorder (flashbacks) OR F16288 
Hallucinogen dependence with other hallucinogen-induced disorder OR F1629 Hallucinogen 
dependence with unspecified hallucinogen-induced disorder 
3051 Nicotine dependence, unspecified, 
uncomplicated 
F17200 Nicotine dependence, unspecified, uncomplicated 
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3051 Nicotine dependence, other tobacco 
product, in remission 
F17201 Nicotine dependence, unspecified, in remission OR F17210 Nicotine dependence, 
cigarettes, uncomplicated OR F17211 Nicotine dependence, cigarettes, in remission OR F17220 
Nicotine dependence, chewing tobacco, uncomplicated OR F17221 Nicotine dependence, chewing 
tobacco, in remission OR F17290 Nicotine dependence, other tobacco product, uncomplicated OR 
F17291 Nicotine dependence, other tobacco product, in remission 
30590 Inhalant abuse, uncomplicated F1810 Inhalant abuse, uncomplicated 
30591 Inhalant abuse, uncomplicated F1810 Inhalant abuse, uncomplicated 
30592 Inhalant abuse, uncomplicated F1810 Inhalant abuse, uncomplicated 
30593 Inhalant abuse, uncomplicated F1810 Inhalant abuse, uncomplicated 
30590 Abuse of other non-psychoactive 
substances 
F18120 Inhalant abuse with intoxication, uncomplicated OR F1890 Inhalant use, unspecified, 
uncomplicated OR F550 Abuse of antacids OR F551 Abuse of herbal or folk remedies OR F552 
Abuse of laxatives OR F553 Abuse of steroids or hormones OR F554 Abuse of vitamins OR F558 
Abuse of other non-psychoactive substances 
30591 Abuse of other non-psychoactive 
substances 
F18120 Inhalant abuse with intoxication, uncomplicated OR F550 Abuse of antacids OR F551 
Abuse of herbal or folk remedies OR F552 Abuse of laxatives OR F553 Abuse of steroids or 
hormones OR F554 Abuse of vitamins OR F558 Abuse of other non-psychoactive substances 
30592 Abuse of other non-psychoactive 
substances 
F18120 Inhalant abuse with intoxication, uncomplicated OR F550 Abuse of antacids OR F551 
Abuse of herbal or folk remedies OR F552 Abuse of laxatives OR F553 Abuse of steroids or 
hormones OR F554 Abuse of vitamins OR F558 Abuse of other non-psychoactive substances 
30593 Abuse of other non-psychoactive 
substances 
F18120 Inhalant abuse with intoxication, uncomplicated OR F550 Abuse of antacids OR F551 
Abuse of herbal or folk remedies OR F552 Abuse of laxatives OR F553 Abuse of steroids or 
hormones OR F554 Abuse of vitamins OR F558 Abuse of other non-psychoactive substances 
30460 Other psychoactive substance 
dependence with unspecified 
psychoactive substance-induced diso 
F1820 Inhalant dependence, uncomplicated OR F18220 Inhalant dependence with intoxication, 
uncomplicated OR F18221 Inhalant dependence with intoxication delirium OR F18229 Inhalant 
dependence with intoxication, unspecified OR F1824 Inhalant dependence with inhalant-induced 
mood disorder OR F18250 Inhalant dependence with inhalant-induced psychotic disorder with 
delusions OR F18251 Inhalant dependence with inhalant-induced psychotic disorder with 
hallucinations OR F18259 Inhalant dependence with inhalant-induced psychotic disorder, 
unspecified OR F1827 Inhalant dependence with inhalant-induced dementia OR F18280 Inhalant 
dependence with inhalant-induced anxiety disorder OR F18288 Inhalant dependence with other 
inhalant-induced disorder OR F1829 Inhalant dependence with unspecified inhalant-induced 
disorder OR F19220 Other psychoactive substance dependence with intoxication, uncomplicated 
OR F19221 Other psychoactive substance dependence with intoxication delirium OR F19222 Other 
psychoactive substance dependence with intoxication with perceptual disturbance OR F19229 Other 
psychoactive substance dependence with intoxication, unspecified OR F19230 Other psychoactive 
substance dependence with withdrawal, uncomplicated OR F19231 Other psychoactive substance 
dependence with withdrawal delirium OR F19232 Other psychoactive substance dependence with 
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withdrawal with perceptual disturbance OR F19239 Other psychoactive substance dependence with 
withdrawal, unspecified OR F1924 Other psychoactive substance dependence with psychoactive 
substance-induced mood disorder OR F19250 Other psychoactive substance dependence with 
psychoactive substance-induced psychotic disord OR F19251 Other psychoactive substance 
dependence with psychoactive substance-induced psychotic disord OR F19259 Other psychoactive 
substance dependence with psychoactive substance-induced psychotic disord OR F1926 Other 
psychoactive substance dependence with psychoactive substance-induced persisting amnes OR 
F1927 Other psychoactive substance dependence with psychoactive substance-induced persisting 
demen OR F19280 Other psychoactive substance dependence with psychoactive substance-induced 
anxiety disorder OR F19281 Other psychoactive substance dependence with psychoactive 
substance-induced sexual dysfuncti OR F19282 Other psychoactive substance dependence with 
psychoactive substance-induced sleep disorder OR F19288 Other psychoactive substance 
dependence with other psychoactive substance-induced disorder OR F1929 Other psychoactive 
substance dependence with unspecified psychoactive substance-induced diso 
30463 Inhalant dependence, in remission F1821 Inhalant dependence, in remission 
30580 Other psychoactive substance abuse, 
uncomplicated 
F1910 Other psychoactive substance abuse, uncomplicated 
30581 Other psychoactive substance abuse, 
uncomplicated 
F1910 Other psychoactive substance abuse, uncomplicated 
30582 Other psychoactive substance abuse, 
uncomplicated 
F1910 Other psychoactive substance abuse, uncomplicated 
30583 Other psychoactive substance abuse, 
uncomplicated 
F1910 Other psychoactive substance abuse, uncomplicated 
30581 Other psychoactive substance abuse 
with intoxication, uncomplicated 
F19120 Other psychoactive substance abuse with intoxication, uncomplicated 
30582 Other psychoactive substance abuse 
with intoxication, uncomplicated 
F19120 Other psychoactive substance abuse with intoxication, uncomplicated 
30583 Other psychoactive substance abuse 
with intoxication, uncomplicated 
F19120 Other psychoactive substance abuse with intoxication, uncomplicated 
30580 Other psychoactive substance use, 
unspecified, uncomplicated 
F19120 Other psychoactive substance abuse with intoxication, uncomplicated OR F1990 Other 
psychoactive substance use, unspecified, uncomplicated 
30460 Other psychoactive substance 
dependence, uncomplicated 
F1920 Other psychoactive substance dependence, uncomplicated 
30461 Other psychoactive substance 
dependence, uncomplicated 
F1920 Other psychoactive substance dependence, uncomplicated 
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30462 Other psychoactive substance 
dependence, uncomplicated 
F1920 Other psychoactive substance dependence, uncomplicated 
30470 Other psychoactive substance 
dependence, uncomplicated 
F1920 Other psychoactive substance dependence, uncomplicated 
30471 Other psychoactive substance 
dependence, uncomplicated 
F1920 Other psychoactive substance dependence, uncomplicated 
30472 Other psychoactive substance 
dependence, uncomplicated 
F1920 Other psychoactive substance dependence, uncomplicated 
30480 Other psychoactive substance 
dependence, uncomplicated 
F1920 Other psychoactive substance dependence, uncomplicated 
30481 Other psychoactive substance 
dependence, uncomplicated 
F1920 Other psychoactive substance dependence, uncomplicated 
30482 Other psychoactive substance 
dependence, uncomplicated 
F1920 Other psychoactive substance dependence, uncomplicated 
30490 Other psychoactive substance 
dependence, uncomplicated 
F1920 Other psychoactive substance dependence, uncomplicated 
30491 Other psychoactive substance 
dependence, uncomplicated 
F1920 Other psychoactive substance dependence, uncomplicated 
30492 Other psychoactive substance 
dependence, uncomplicated 
F1920 Other psychoactive substance dependence, uncomplicated 
29285 Other psychoactive substance 
dependence, in remission 
F1921 Other psychoactive substance dependence, in remission 
30463 Other psychoactive substance 
dependence, in remission 
F1921 Other psychoactive substance dependence, in remission 
30473 Other psychoactive substance 
dependence, in remission 
F1921 Other psychoactive substance dependence, in remission 
30483 Other psychoactive substance 
dependence, in remission 
F1921 Other psychoactive substance dependence, in remission 
30493 Other psychoactive substance 
dependence, in remission 
F1921 Other psychoactive substance dependence, in remission 
29281 Other psychoactive substance use, 
unspecified with intoxication with 
delirium 
F19921 Other psychoactive substance use, unspecified with intoxication with delirium 
2920 Other psychoactive substance use, 
unspecified with withdrawal, 
unspecified 
F19939 Other psychoactive substance use, unspecified with withdrawal, unspecified 
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29284 Other psychoactive substance use, 
unspecified with psychoactive 
substance-induced mood disor 
F1994 Other psychoactive substance use, unspecified with psychoactive substance-induced mood 
disor 
29211 Other psychoactive substance use, 
unspecified with psychoactive 
substance-induced psychotic 
F19950 Other psychoactive substance use, unspecified with psychoactive substance-induced 
psychotic 
29212 Other psychoactive substance use, 
unspecified with psychoactive 
substance-induced psychotic 
F19951 Other psychoactive substance use, unspecified with psychoactive substance-induced 
psychotic 
29283 Other psychoactive substance use, 
unspecified with psychoactive 
substance-induced persisting 
F1996 Other psychoactive substance use, unspecified with psychoactive substance-induced 
persisting 
29282 Other psychoactive substance use, 
unspecified with psychoactive 
substance-induced persisting 
F1997 Other psychoactive substance use, unspecified with psychoactive substance-induced 
persisting 
2929 Other psychoactive substance use, 
unspecified with unspecified 
psychoactive substance-induce 
F1999 Other psychoactive substance use, unspecified with unspecified psychoactive substance-
induce 
Schizophrenia, Schizotypal and delusional disorders 
29530 Paranoid schizophrenia F200 Paranoid schizophrenia 
29531 Paranoid schizophrenia F200 Paranoid schizophrenia 
29532 Paranoid schizophrenia F200 Paranoid schizophrenia 
29533 Paranoid schizophrenia F200 Paranoid schizophrenia 
29534 Paranoid schizophrenia F200 Paranoid schizophrenia 
29535 Paranoid schizophrenia F200 Paranoid schizophrenia 
29510 Disorganized schizophrenia F201 Disorganized schizophrenia 
29511 Disorganized schizophrenia F201 Disorganized schizophrenia 
29512 Disorganized schizophrenia F201 Disorganized schizophrenia 
29513 Disorganized schizophrenia F201 Disorganized schizophrenia 
29514 Disorganized schizophrenia F201 Disorganized schizophrenia 
29515 Disorganized schizophrenia F201 Disorganized schizophrenia 
29520 Catatonic schizophrenia F202 Catatonic schizophrenia 
29521 Catatonic schizophrenia F202 Catatonic schizophrenia 
29522 Catatonic schizophrenia F202 Catatonic schizophrenia 
29523 Catatonic schizophrenia F202 Catatonic schizophrenia 
29524 Catatonic schizophrenia F202 Catatonic schizophrenia 
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29525 Catatonic schizophrenia F202 Catatonic schizophrenia 
29590 Undifferentiated schizophrenia F203 Undifferentiated schizophrenia 
29560 Residual schizophrenia F205 Residual schizophrenia 
29561 Residual schizophrenia F205 Residual schizophrenia 
29562 Residual schizophrenia F205 Residual schizophrenia 
29563 Residual schizophrenia F205 Residual schizophrenia 
29564 Residual schizophrenia F205 Residual schizophrenia 
29565 Residual schizophrenia F205 Residual schizophrenia 
29540 Schizophreniform disorder F2081 Schizophreniform disorder 
29541 Schizophreniform disorder F2081 Schizophreniform disorder 
29542 Schizophreniform disorder F2081 Schizophreniform disorder 
29543 Schizophreniform disorder F2081 Schizophreniform disorder 
29544 Schizophreniform disorder F2081 Schizophreniform disorder 
29545 Schizophreniform disorder F2081 Schizophreniform disorder 
29500 Other schizophrenia F2089 Other schizophrenia 
29501 Other schizophrenia F2089 Other schizophrenia 
29502 Other schizophrenia F2089 Other schizophrenia 
29503 Other schizophrenia F2089 Other schizophrenia 
29504 Other schizophrenia F2089 Other schizophrenia 
29505 Other schizophrenia F2089 Other schizophrenia 
29550 Other schizophrenia F2089 Other schizophrenia 
29551 Other schizophrenia F2089 Other schizophrenia 
29552 Other schizophrenia F2089 Other schizophrenia 
29553 Other schizophrenia F2089 Other schizophrenia 
29554 Other schizophrenia F2089 Other schizophrenia 
29555 Other schizophrenia F2089 Other schizophrenia 
29580 Other schizophrenia F2089 Other schizophrenia 
29581 Other schizophrenia F2089 Other schizophrenia 
29582 Other schizophrenia F2089 Other schizophrenia 
29583 Other schizophrenia F2089 Other schizophrenia 
29584 Other schizophrenia F2089 Other schizophrenia 
29585 Other schizophrenia F2089 Other schizophrenia 
29590 Schizophrenia, unspecified F209 Schizophrenia, unspecified 
29591 Schizophrenia, unspecified F209 Schizophrenia, unspecified 
29592 Schizophrenia, unspecified F209 Schizophrenia, unspecified 
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29593 Schizophrenia, unspecified F209 Schizophrenia, unspecified 
29594 Schizophrenia, unspecified F209 Schizophrenia, unspecified 
29595 Schizophrenia, unspecified F209 Schizophrenia, unspecified 
30122 Schizotypal disorder F21 Schizotypal disorder 
2970 Delusional disorders F22 Delusional disorders 
2971 Delusional disorders F22 Delusional disorders 
2972 Delusional disorders F22 Delusional disorders 
2978 Delusional disorders F22 Delusional disorders 
2979 Brief psychotic disorder F23 Brief psychotic disorder 
2983 Brief psychotic disorder F23 Brief psychotic disorder 
2984 Brief psychotic disorder F23 Brief psychotic disorder 
2988 Brief psychotic disorder F23 Brief psychotic disorder 
2973 Shared psychotic disorder F24 Shared psychotic disorder 
29570 Other schizoaffective disorders F250 Schizoaffective disorder, bipolar type OR F251 Schizoaffective disorder, depressive type OR 
F258 Other schizoaffective disorders 
29570 Schizoaffective disorder, unspecified F259 Schizoaffective disorder, unspecified 
29571 Schizoaffective disorder, unspecified F259 Schizoaffective disorder, unspecified 
29572 Schizoaffective disorder, unspecified F259 Schizoaffective disorder, unspecified 
29573 Schizoaffective disorder, unspecified F259 Schizoaffective disorder, unspecified 
29574 Schizoaffective disorder, unspecified F259 Schizoaffective disorder, unspecified 
29575 Schizoaffective disorder, unspecified F259 Schizoaffective disorder, unspecified 
2981 Other psychotic disorder not due to a 
substance or known physiological 
condition 
F28 Other psychotic disorder not due to a substance or known physiological condition 
2989 Other psychotic disorder not due to a 
substance or known physiological 
condition 
F28 Other psychotic disorder not due to a substance or known physiological condition 
2989 Unspecified psychosis not due to a 
substance or known physiological 
condition 
F29 Unspecified psychosis not due to a substance or known physiological condition 
Mood Disorders 
29600 Manic episode without psychotic 
symptoms, unspecified 
F3010 Manic episode without psychotic symptoms, unspecified 
29610 Manic episode without psychotic 
symptoms, unspecified 
F3010 Manic episode without psychotic symptoms, unspecified 
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29601 Manic episode without psychotic 
symptoms, mild 
F3011 Manic episode without psychotic symptoms, mild 
29611 Manic episode without psychotic 
symptoms, mild 
F3011 Manic episode without psychotic symptoms, mild 
29602 Manic episode without psychotic 
symptoms, moderate 
F3012 Manic episode without psychotic symptoms, moderate 
29612 Manic episode without psychotic 
symptoms, moderate 
F3012 Manic episode without psychotic symptoms, moderate 
29603 Manic episode, severe, without 
psychotic symptoms 
F3013 Manic episode, severe, without psychotic symptoms 
29613 Manic episode, severe, without 
psychotic symptoms 
F3013 Manic episode, severe, without psychotic symptoms 
29604 Manic episode, severe with psychotic 
symptoms 
F302 Manic episode, severe with psychotic symptoms 
29614 Manic episode, severe with psychotic 
symptoms 
F302 Manic episode, severe with psychotic symptoms 
29605 Manic episode in partial remission F303 Manic episode in partial remission 
29615 Manic episode in partial remission F303 Manic episode in partial remission 
29606 Manic episode in full remission F304 Manic episode in full remission 
29616 Manic episode in full remission F304 Manic episode in full remission 
29681 Other manic episodes F308 Other manic episodes 
29600 Manic episode, unspecified F309 Manic episode, unspecified 
29640 Other bipolar disorder F310 Bipolar disorder, current episode hypomanic OR F3189 Other bipolar disorder 
29640 Bipolar disorder, current episode 
manic without psychotic features, 
unspecified 
F3110 Bipolar disorder, current episode manic without psychotic features, unspecified 
29641 Bipolar disorder, current episode 
manic without psychotic features, mild 
F3111 Bipolar disorder, current episode manic without psychotic features, mild 
29642 Bipolar disorder, current episode 
manic without psychotic features, 
moderate 
F3112 Bipolar disorder, current episode manic without psychotic features, moderate 
29643 Bipolar disorder, current episode 
manic without psychotic features, 
severe 
F3113 Bipolar disorder, current episode manic without psychotic features, severe 
29644 Bipolar disorder, current episode 
manic severe with psychotic features 
F312 Bipolar disorder, current episode manic severe with psychotic features 
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29650 Bipolar disorder, current episode 
depressed, mild or moderate severity, 
unspecified 
F3130 Bipolar disorder, current episode depressed, mild or moderate severity, unspecified 
29651 Bipolar disorder, current episode 
depressed, mild 
F3131 Bipolar disorder, current episode depressed, mild 
29652 Bipolar disorder, current episode 
depressed, moderate 
F3132 Bipolar disorder, current episode depressed, moderate 
29653 Bipolar disorder, current episode 
depressed, severe, without psychotic 
features 
F314 Bipolar disorder, current episode depressed, severe, without psychotic features 
29654 Bipolar disorder, current episode 
depressed, severe, with psychotic 
features 
F315 Bipolar disorder, current episode depressed, severe, with psychotic features 
29660 Bipolar disorder, current episode 
mixed, unspecified 
F3160 Bipolar disorder, current episode mixed, unspecified 
29661 Bipolar disorder, current episode 
mixed, mild 
F3161 Bipolar disorder, current episode mixed, mild 
29662 Bipolar disorder, current episode 
mixed, moderate 
F3162 Bipolar disorder, current episode mixed, moderate 
29663 Bipolar disorder, current episode 
mixed, severe, without psychotic 
features 
F3163 Bipolar disorder, current episode mixed, severe, without psychotic features 
29664 Bipolar disorder, current episode 
mixed, severe, with psychotic features 
F3164 Bipolar disorder, current episode mixed, severe, with psychotic features 
2967 Bipolar disorder, in full remission, 
most recent episode hypomanic 
F3170 Bipolar disorder, currently in remission, most recent episode unspecified OR F3171 Bipolar 
disorder, in partial remission, most recent episode hypomanic OR F3172 Bipolar disorder, in full 
remission, most recent episode hypomanic 
29645 Bipolar disorder, in partial remission, 
most recent episode manic 
F3173 Bipolar disorder, in partial remission, most recent episode manic 
29646 Bipolar disorder, in full remission, 
most recent episode manic 
F3174 Bipolar disorder, in full remission, most recent episode manic 
29655 Bipolar disorder, in partial remission, 
most recent episode depressed 
F3175 Bipolar disorder, in partial remission, most recent episode depressed 
29656 Bipolar disorder, in full remission, 
most recent episode depressed 
F3176 Bipolar disorder, in full remission, most recent episode depressed 
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29665 Bipolar disorder, in partial remission, 
most recent episode mixed 
F3177 Bipolar disorder, in partial remission, most recent episode mixed 
29666 Bipolar disorder, in full remission, 
most recent episode mixed 
F3178 Bipolar disorder, in full remission, most recent episode mixed 
29689 Bipolar II disorder F3181 Bipolar II disorder 
2967 Bipolar disorder, unspecified F319 Bipolar disorder, unspecified 
29680 Bipolar disorder, unspecified F319 Bipolar disorder, unspecified 
29621 Major depressive disorder, single 
episode, mild 
F320 Major depressive disorder, single episode, mild 
29622 Major depressive disorder, single 
episode, moderate 
F321 Major depressive disorder, single episode, moderate 
29623 Major depressive disorder, single 
episode, severe without psychotic 
features 
F322 Major depressive disorder, single episode, severe without psychotic features 
29624 Major depressive disorder, single 
episode, severe with psychotic features 
F323 Major depressive disorder, single episode, severe with psychotic features 
2980 Major depressive disorder, recurrent, 
severe with psychotic symptoms 
F323 Major depressive disorder, single episode, severe with psychotic features OR F333 Major 
depressive disorder, recurrent, severe with psychotic symptoms 
29625 Major depressive disorder, single 
episode, in partial remission 
F324 Major depressive disorder, single episode, in partial remission 
29626 Major depressive disorder, single 
episode, in full remission 
F325 Major depressive disorder, single episode, in full remission 
29682 Other depressive episodes F328 Other depressive episodes 
311 Major depressive disorder, single 
episode, unspecified 
F329 Major depressive disorder, single episode, unspecified 
29620 Major depressive disorder, single 
episode, unspecified 
F329 Major depressive disorder, single episode, unspecified 
29631 Major depressive disorder, recurrent, 
mild 
F330 Major depressive disorder, recurrent, mild 
29632 Major depressive disorder, recurrent, 
moderate 
F331 Major depressive disorder, recurrent, moderate 
29633 Major depressive disorder, recurrent 
severe without psychotic features 
F332 Major depressive disorder, recurrent severe without psychotic features 
29634 Major depressive disorder, recurrent, 
severe with psychotic symptoms 
F333 Major depressive disorder, recurrent, severe with psychotic symptoms 
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29630 Major depressive disorder, recurrent, 
in remission, unspecified 
F3340 Major depressive disorder, recurrent, in remission, unspecified 
29635 Major depressive disorder, recurrent, 
in partial remission 
F3341 Major depressive disorder, recurrent, in partial remission 
29636 Major depressive disorder, recurrent, 
in full remission 
F3342 Major depressive disorder, recurrent, in full remission 
29699 Persistent mood [affective] disorder, 
unspecified 
F338 Other recurrent depressive disorders OR F349 Persistent mood [affective] disorder, 
unspecified 
29630 Major depressive disorder, recurrent, 
unspecified 
F339 Major depressive disorder, recurrent, unspecified 
30110 Cyclothymic disorder F340 Cyclothymic disorder 
30113 Cyclothymic disorder F340 Cyclothymic disorder 
3004 Dysthymic disorder F341 Dysthymic disorder 
30112 Dysthymic disorder F341 Dysthymic disorder 
29699 Other persistent mood [affective] 
disorders 
F348 Other persistent mood [affective] disorders 
29690 Unspecified mood [affective] disorder F39 Unspecified mood [affective] disorder 
Anxiety, stress-related and somatoform disorders 
30022 Agoraphobia, unspecified F4000 Agoraphobia, unspecified 
30021 Agoraphobia with panic disorder F4001 Agoraphobia with panic disorder 
30022 Agoraphobia without panic disorder F4002 Agoraphobia without panic disorder 
30023 Social phobia, unspecified F4010 Social phobia, unspecified 
30023 Social phobia, generalized F4011 Social phobia, generalized 
30029 Other specified phobia F40210 Arachnophobia OR F40220 Fear of thunderstorms OR F40228 Other natural environment 
type phobia OR F40230 Fear of blood OR F40231 Fear of injections and transfusions OR F40232 
Fear of other medical care OR F40233 Fear of injury OR F40242 Fear of bridges OR F40243 Fear 
of flying OR F40248 Other situational type phobia OR F40290 Androphobia OR F40291 
Gynephobia OR F40298 Other specified phobia 
30029 Other phobic anxiety disorders F40218 Other animal type phobia OR F40240 Claustrophobia OR F40241 Acrophobia OR F408 
Other phobic anxiety disorders 
30020 Phobic anxiety disorder, unspecified F409 Phobic anxiety disorder, unspecified 
30001 Panic disorder [episodic paroxysmal 
anxiety] without agoraphobia 
F410 Panic disorder [episodic paroxysmal anxiety] without agoraphobia 
30002 Generalized anxiety disorder F411 Generalized anxiety disorder 
30009 Other mixed anxiety disorders F413 Other mixed anxiety disorders 
30009 Other specified anxiety disorders F418 Other specified anxiety disorders 
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30000 Anxiety disorder, unspecified F419 Anxiety disorder, unspecified 
3003 Obsessive-compulsive disorder F42 Obsessive-compulsive disorder 
3080 Acute stress reaction F430 Acute stress reaction 
3081 Acute stress reaction F430 Acute stress reaction 
3082 Acute stress reaction F430 Acute stress reaction 
3083 Acute stress reaction F430 Acute stress reaction 
3084 Acute stress reaction F430 Acute stress reaction 
3089 State of emotional shock and stress, 
unspecified 
F430 Acute stress reaction OR R457 State of emotional shock and stress, unspecified 
30981 Post-traumatic stress disorder, chronic F4310 Post-traumatic stress disorder, unspecified OR F4312 Post-traumatic stress disorder, chronic 
30981 Post-traumatic stress disorder, acute F4311 Post-traumatic stress disorder, acute 
3099 Adjustment disorder, unspecified F4320 Adjustment disorder, unspecified 
3090 Adjustment disorder with depressed 
mood 
F4321 Adjustment disorder with depressed mood 
3091 Adjustment disorder with depressed 
mood 
F4321 Adjustment disorder with depressed mood 
30924 Adjustment disorder with anxiety F4322 Adjustment disorder with anxiety 
30928 Adjustment disorder with mixed 
anxiety and depressed mood 
F4323 Adjustment disorder with mixed anxiety and depressed mood 
3093 Adjustment disorder with disturbance 
of conduct 
F4324 Adjustment disorder with disturbance of conduct 
3094 Adjustment disorder with mixed 
disturbance of emotions and conduct 
F4325 Adjustment disorder with mixed disturbance of emotions and conduct 
30929 Other childhood disorders of social 
functioning 
F4329 Adjustment disorder with other symptoms OR F948 Other childhood disorders of social 
functioning 
30982 Other reactions to severe stress F438 Other reactions to severe stress 
30983 Other reactions to severe stress F438 Other reactions to severe stress 
30989 Other reactions to severe stress F438 Other reactions to severe stress 
3099 Reaction to severe stress, unspecified F439 Reaction to severe stress, unspecified 
30012 Dissociative amnesia F440 Dissociative amnesia 
30013 Dissociative fugue F441 Dissociative fugue 
30019 Dissociative stupor F442 Dissociative stupor 
30011 Conversion disorder with sensory 
symptom or deficit 
F444 Conversion disorder with motor symptom or deficit OR F446 Conversion disorder with 
sensory symptom or deficit 
30011 Conversion disorder with mixed 
symptom presentation 
F445 Conversion disorder with seizures or convulsions OR F447 Conversion disorder with mixed 
symptom presentation 
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30014 Dissociative identity disorder F4481 Dissociative identity disorder 
2982 Other dissociative and conversion 
disorders 
F4489 Other dissociative and conversion disorders 
30016 Factitious disorder with predominantly 
psychological signs and symptoms 
F4489 Other dissociative and conversion disorders OR F6811 Factitious disorder with 
predominantly psychological signs and symptoms 
30010 Dissociative and conversion disorder, 
unspecified 
F449 Dissociative and conversion disorder, unspecified 
30015 Dissociative and conversion disorder, 
unspecified 
F449 Dissociative and conversion disorder, unspecified 
30081 Somatization disorder F450 Somatization disorder 
30082 Somatoform disorder, unspecified F451 Undifferentiated somatoform disorder OR F459 Somatoform disorder, unspecified 
3007 Other hypochondriacal disorders F4520 Hypochondriacal disorder, unspecified OR F4529 Other hypochondriacal disorders 
3007 Body dysmorphic disorder F4521 Hypochondriasis OR F4522 Body dysmorphic disorder 
30780 Pain disorder exclusively related to 
psychological factors 
F4541 Pain disorder exclusively related to psychological factors 
30781 Tension Headache G44209 Tension-type headache, unspecified, not intractable 
30789 Pain disorder with related 
psychological factors 
F4542 Pain disorder with related psychological factors 
3060 Other somatoform disorders F458 Other somatoform disorders 
3061 Other somatoform disorders F458 Other somatoform disorders 
3062 Other somatoform disorders F458 Other somatoform disorders 
3063 Other somatoform disorders F458 Other somatoform disorders 
3064 Other somatoform disorders F458 Other somatoform disorders 
3066 Other somatoform disorders F458 Other somatoform disorders 
3067 Other somatoform disorders F458 Other somatoform disorders 
30650 Other somatoform disorders F458 Other somatoform disorders 
30652 Other somatoform disorders F458 Other somatoform disorders 
30653 Other somatoform disorders F458 Other somatoform disorders 
30659 Other somatoform disorders F458 Other somatoform disorders 
30089 Other specified nonpsychotic mental 
disorders 
F458 Other somatoform disorders OR F488 Other specified nonpsychotic mental disorders 
3068 Unspecified behavioral syndromes 
associated with physiological 
disturbances and physical fac 
F458 Other somatoform disorders OR F59 Unspecified behavioral syndromes associated with 
physiological disturbances and physical fac 
3069 Somatoform disorder, unspecified F459 Somatoform disorder, unspecified 
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3006 Depersonalization-derealization 
syndrome 
F481 Depersonalization-derealization syndrome 
31081 Pseudodobullar Affect F482 
3005 Other specified nonpsychotic mental 
disorders  (Neurasthenia) 
F488 Other specified anxiety mental disorders 
3079 Restlessness and agitation R4581 Low self-esteem OR R4582 Worries 
3009 Mental disorder, not otherwise 
specified 
F489 Nonpsychotic mental disorder, unspecified OR F99 Mental disorder, not otherwise specified 
Behavioral disorders associated with physiological factors 
3071 Anorexia nervosa, unspecified F5000 Anorexia nervosa, unspecified 
3071 Anorexia nervosa, binge 
eating/purging type 
F5001 Anorexia nervosa, restricting type OR F5002 Anorexia nervosa, binge eating/purging type 
30751 Bulimia nervosa F502 Bulimia nervosa 
30754 Other eating disorders F508 Other eating disorders 
30759 Other feeding disorders of infancy and 
early childhood 
F508 Other eating disorders OR F9829 Other feeding disorders of infancy and early childhood 
30750 Eating disorder, unspecified F509 Eating disorder, unspecified 
30742 Other insomnia not due to a substance 
or known physiological condition 
F5101 Primary insomnia OR F5103 Paradoxical insomnia OR F5109 Other insomnia not due to a 
substance or known physiological condition 
30741 Other insomnia not due to a substance 
or known physiological condition 
F5102 Adjustment insomnia OR F5109 Other insomnia not due to a substance or known 
physiological condition 
30744 Other hypersomnia not due to a 
substance or known physiological 
condition 
F5111 Primary hypersomnia OR F5112 Insufficient sleep syndrome OR F5119 Other hypersomnia 
not due to a substance or known physiological condition 
30743 Other hypersomnia not due to a 
substance or known physiological 
condition 
F5119 Other hypersomnia not due to a substance or known physiological condition 
30746 Sleepwalking [somnambulism] F513 Sleepwalking [somnambulism] 
30746 Sleep terrors [night terrors] F514 Sleep terrors [night terrors] 
30747 Nightmare disorder F515 Nightmare disorder 
30745 Other sleep disorders not due to a 
substance or known physiological 
condition 
F518 Other sleep disorders not due to a substance or known physiological condition 
30747 Other sleep disorders not due to a 
substance or known physiological 
condition 
F518 Other sleep disorders not due to a substance or known physiological condition 
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30748 Other sleep disorders not due to a 
substance or known physiological 
condition 
F518 Other sleep disorders not due to a substance or known physiological condition 
30749 Other sleep disorders not due to a 
substance or known physiological 
condition 
F518 Other sleep disorders not due to a substance or known physiological condition 
30740 Sleep disorder not due to a substance 
or known physiological condition, 
unspecified 
F519 Sleep disorder not due to a substance or known physiological condition, unspecified 
30271 Hypoactive sexual desire disorder F520 Hypoactive sexual desire disorder 
30279 Other sexual dysfunction not due to a 
substance or known physiological 
condition 
F521 Sexual aversion disorder OR F528 Other sexual dysfunction not due to a substance or known 
physiological condition 
30272 Other sexual dysfunction not due to a 
substance or known physiological 
condition 
F5221 Male erectile disorder OR F528 Other sexual dysfunction not due to a substance or known 
physiological condition 
30272 Female sexual arousal disorder F5222 Female sexual arousal disorder 
30273 Female orgasmic disorder F5231 Female orgasmic disorder 
30274 Male orgasmic disorder F5232 Male orgasmic disorder 
30275 Premature ejaculation F524 Premature ejaculation 
30651 Vaginismus not due to a substance or 
known physiological condition 
F525 Vaginismus not due to a substance or known physiological condition 
30276 Dyspareunia not due to a substance or 
known physiological condition 
F526 Dyspareunia not due to a substance or known physiological condition 
30270 Unspecified sexual dysfunction not 
due to a substance or known 
physiological condition 
F529 Unspecified sexual dysfunction not due to a substance or known physiological condition or 
R37 
316 Psychological and behavioral factors 
associated with disorders or diseases 
classified elsewh 
F54 Psychological and behavioral factors associated with disorders or diseases classified elsewh 
Adult personality and behavior disorders 
3010 Paranoid personality disorder F600 Paranoid personality disorder 
30120 Schizoid personality disorder F601 Schizoid personality disorder 
30121 Schizoid personality disorder F601 Schizoid personality disorder 
3017 Antisocial personality disorder F602 Antisocial personality disorder 
3013 Borderline personality disorder F603 Borderline personality disorder 
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30183 Borderline personality disorder F603 Borderline personality disorder 
30150 Histrionic personality disorder F604 Histrionic personality disorder 
30159 Histrionic personality disorder F604 Histrionic personality disorder 
3014 Obsessive-compulsive personality 
disorder 
F605 Obsessive-compulsive personality disorder 
30182 Avoidant personality disorder F606 Avoidant personality disorder 
3016 Dependent personality disorder F607 Dependent personality disorder 
30181 Narcissistic personality disorder F6081 Narcissistic personality disorder 
30111 Other specific personality disorders F6089 Other specific personality disorders 
30184 Other specific personality disorders F6089 Other specific personality disorders 
30189 Other specific personality disorders F6089 Other specific personality disorders 
3019 Personality disorder, unspecified F609 Personality disorder, unspecified 
31231 Pathological gambling F630 Pathological gambling 
31233 Pyromania F631 Pyromania 
31232 Kleptomania F632 Kleptomania 
31239 Other impulse disorders F633 Trichotillomania OR F6389 Other impulse disorders 
31234 Intermittent explosive disorder F6381 Intermittent explosive disorder 
31235 Intermittent explosive disorder F6381 Intermittent explosive disorder 
31230 Impulse disorder, unspecified F639 Impulse disorder, unspecified 
30251 Gender identity disorder in 
adolescence and adulthood 
F641 Gender identity disorder in adolescence and adulthood 
30252 Gender identity disorder in 
adolescence and adulthood 
F641 Gender identity disorder in adolescence and adulthood 
30253 Gender identity disorder in 
adolescence and adulthood 
F641 Gender identity disorder in adolescence and adulthood 
30285 Gender identity disorder in 
adolescence and adulthood 
F641 Gender identity disorder in adolescence and adulthood 
30250 Personal history of sex reassignment F641 Gender identity disorder in adolescence and adulthood OR Z87890 Personal history of sex 
reassignment 
3026 Gender identity disorder of childhood F642 Gender identity disorder of childhood 
3026 Gender identity disorder, unspecified F648 Other gender identity disorders OR F649 Gender identity disorder, unspecified 
30281 Fetishism F650 Fetishism 
3023 Transvestic fetishism F651 Transvestic fetishism 
3024 Exhibitionism F652 Exhibitionism 
30282 Voyeurism F653 Voyeurism 
3022 Pedophilia F654 Pedophilia 
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30284 Sadomasochism, unspecified F6550 Sadomasochism, unspecified 
30283 Sexual masochism F6551 Sexual masochism 
30284 Sexual sadism F6552 Sexual sadism 
30289 Other sexual disorders F6581 Frotteurism OR F6589 Other paraphilias OR F66 Other sexual disorders 
3021 Other paraphilias F6589 Other paraphilias 
3029 Paraphilia, unspecified F659 Paraphilia, unspecified 
3020 Other sexual disorders F66 Other sexual disorders 
30151 Factitious disorder with combined 
psychological and physical signs and 
symptoms 
F6810 Factitious disorder, unspecified OR F6813 Factitious disorder with combined psychological 
and physical signs and symptoms 
30151 Factitious disorder with predominantly 
physical signs and symptoms 
F6812 Factitious disorder with predominantly physical signs and symptoms 
30016 Factitious disorder with combined 
psychological and physical signs and 
symptoms 
F6813 Factitious disorder with combined psychological and physical signs and symptoms 
30019 Other specified disorders of adult 
personality and behavior 
F688 Other specified disorders of adult personality and behavior 
3019 Unspecified disorder of adult 
personality and behavior 
F69 Unspecified disorder of adult personality and behavior 
Psychological development disorders 
31539 Other fluency disorder F800 Phonological disorder OR F8089 
31531 Expressive language disorder F801 Expressive language disorder 
31532 Central auditory processing disorder F802 Mixed receptive-expressive language disorder OR H9325 Central auditory processing disorder 
31534 Speech and language development 
delay due to hearing loss 
F804 Speech and language development delay due to hearing loss 
31535 Childhood onset fluency disorder F8081 
31539 Developmental disorder of speech or 
language, unspecified 
F809 Developmental disorder of speech or language, unspecified 
31500 Specific reading disorder F810 Specific reading disorder 
31501 Dyslexia and alexia R480 Dyslexia and alexia 
31502 Specific reading disorder F810 Specific reading disorder 
3151 Mathematics disorder F812 Mathematics disorder 
31509 Disorder of written expression F8181 Disorder of written expression 
3152 Other developmental disorders of 
scholastic skills 
F8181 Disorder of written expression OR F8189 Other developmental disorders of scholastic skills 
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3159 Unspecified disorder of psychological 
development 
F819 Developmental disorder of scholastic skills, unspecified OR F89 Unspecified disorder of 
psychological development 
3154 Specific developmental disorder of 
motor function 
F82 Specific developmental disorder of motor function 
3155 Specific developmental disorder of 
motor function 
F82 Specific developmental disorder of motor function 
29900 Autistic disorder F840 Autistic disorder 
29901 Autistic disorder F840 Autistic disorder 
29910 Other childhood disintegrative disorder F843 Other childhood disintegrative disorder 
29911 Other childhood disintegrative disorder F843 Other childhood disintegrative disorder 
29980 Other pervasive developmental 
disorders 
F845 Asperger's syndrome OR F848 Other pervasive developmental disorders 
29981 Other pervasive developmental 
disorders 
F845 Asperger's syndrome OR F848 Other pervasive developmental disorders 
29990 Pervasive developmental disorder, 
unspecified 
F849 Pervasive developmental disorder, unspecified 
29991 Pervasive developmental disorder, 
unspecified 
F849 Pervasive developmental disorder, unspecified 
3158 Other disorders of psychological 
development 
F88 Other disorders of psychological development 
Childhood onset emotional and behavioral disorders 
31401 Attention-deficit hyperactivity 
disorder, unspecified type 
F900 Attention-deficit hyperactivity disorder, predominantly inattentive type OR F901 Attention-
deficit hyperactivity disorder, predominantly hyperactive type OR F902 Attention-deficit 
hyperactivity disorder, combined type OR F909 Attention-deficit hyperactivity disorder, unspecified 
type 
3141 Attention-deficit hyperactivity 
disorder, other type 
F908 Attention-deficit hyperactivity disorder, other type 
3142 Attention-deficit hyperactivity 
disorder, other type 
F908 Attention-deficit hyperactivity disorder, other type 
3148 Attention-deficit hyperactivity 
disorder, other type 
F908 Attention-deficit hyperactivity disorder, other type 
31401 Attention-deficit hyperactivity 
disorder, other type 
F908 Attention-deficit hyperactivity disorder, other type 
3149 Attention-deficit hyperactivity 
disorder, unspecified type 
F909 Attention-deficit hyperactivity disorder, unspecified type 
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31400 Attention-deficit hyperactivity 
disorder, unspecified type 
F909 Attention-deficit hyperactivity disorder, unspecified type 
31289 Conduct disorder confined to family 
context 
F910 Conduct disorder confined to family context 
31200 Conduct disorder, childhood-onset 
type 
F911 Conduct disorder, childhood-onset type 
31201 Conduct disorder, childhood-onset 
type 
F911 Conduct disorder, childhood-onset type 
31202 Conduct disorder, childhood-onset 
type 
F911 Conduct disorder, childhood-onset type 
31203 Conduct disorder, childhood-onset 
type 
F911 Conduct disorder, childhood-onset type 
31281 Conduct disorder, childhood-onset 
type 
F911 Conduct disorder, childhood-onset type 
31220 Conduct disorder, adolescent-onset 
type 
F912 Conduct disorder, adolescent-onset type 
31221 Conduct disorder, adolescent-onset 
type 
F912 Conduct disorder, adolescent-onset type 
31222 Conduct disorder, adolescent-onset 
type 
F912 Conduct disorder, adolescent-onset type 
31223 Conduct disorder, adolescent-onset 
type 
F912 Conduct disorder, adolescent-onset type 
31282 Conduct disorder, adolescent-onset 
type 
F912 Conduct disorder, adolescent-onset type 
31381 Oppositional defiant disorder F913 Oppositional defiant disorder 
3124 Other conduct disorders F918 Other conduct disorders 
31210 Other conduct disorders F918 Other conduct disorders 
31211 Other conduct disorders F918 Other conduct disorders 
31212 Other conduct disorders F918 Other conduct disorders 
31213 Other conduct disorders F918 Other conduct disorders 
31289 Other conduct disorders F918 Other conduct disorders 
3129 Conduct disorder, unspecified F919 Conduct disorder, unspecified 
30921 Separation anxiety disorder of 
childhood 
F930 Separation anxiety disorder of childhood 
3130 Other childhood emotional disorders F938 Other childhood emotional disorders 
3131 Other childhood emotional disorders F938 Other childhood emotional disorders 
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3133 Other childhood emotional disorders F938 Other childhood emotional disorders 
31321 Other childhood emotional disorders F938 Other childhood emotional disorders 
31322 Other childhood emotional disorders F938 Other childhood emotional disorders 
31382 Other childhood emotional disorders F938 Other childhood emotional disorders 
31383 Other childhood emotional disorders F938 Other childhood emotional disorders 
31389 Other specified behavioral and 
emotional disorders with onset usually 
occurring in childhood 
F938 Other childhood emotional disorders OR F941 Reactive attachment disorder of childhood OR 
F988 Other specified behavioral and emotional disorders with onset usually occurring in childhood 
3139 Unspecified behavioral and emotional 
disorders with onset usually occurring 
in childhood and 
F939 Childhood emotional disorder, unspecified OR F948 Other childhood disorders of social 
functioning OR F989 Unspecified behavioral and emotional disorders with onset usually occurring 
in childhood and 
31323 Selective mutism F940 Selective mutism 
31389 Childhood disorder of social 
functioning, unspecified 
F942 Disinhibited attachment disorder of childhood OR F949 Childhood disorder of social 
functioning, unspecified 
30922 Other childhood disorders of social 
functioning 
F948 Other childhood disorders of social functioning 
30923 Other childhood disorders of social 
functioning 
F948 Other childhood disorders of social functioning 
30721 Transient tic disorder F950 Transient tic disorder 
30722 Chronic motor or vocal tic disorder F951 Chronic motor or vocal tic disorder 
30723 Tourette's disorder F952 Tourette's disorder 
30720 Other tic disorders F958 Other tic disorders 
30720 Tic disorder, unspecified F959 Tic disorder, unspecified 
3076 Enuresis not due to a substance or 
known physiological condition 
F980 Enuresis not due to a substance or known physiological condition 
3077 Encopresis not due to a substance or 
known physiological condition 
F981 Encopresis not due to a substance or known physiological condition 
30753 Rumination disorder of infancy F9821 Rumination disorder of infancy 
30752 Pica of infancy and childhood F983 Pica of infancy and childhood 
3073 Stereotyped movement disorders F984 Stereotyped movement disorders 
3070 Stuttering [stammering] F985 Stuttering [stammering] 
Other Mental Disorder NOS 
V71.09   F99 Mental disorder, not otherwise specified 
 
 189 
APPENDIX B 
Racial/ethnic differences in number of disorder categories: One-way ANOVA with imputed data 
 
 Race/ethnicity N Mean SD F 
Original Data Black 8534 2.1376 1.52138 91.33*** 
 White 5972 2.0070 1.37566  
 Hispanic 5508 1.8197 1.16233  
 Multi-racial/other 1065 1.5915 1.07489  
Imputation 1 Black 9988 2.1235 1.49488 90.51*** 
White 7088 1.9931 1.35774  
Hispanic 7144 1.8491 1.17056  
Multi-racial/other 1325 1.6249 1.05748  
Imputation 2 Black 9958 2.1275 1.49983 97.06*** 
White 7237 1.9979 1.35242  
Hispanic 7048 1.8367 1.16028  
Multi-racial/other 1302 1.6206 1.07181  
Imputation 3 Black 10015 2.1237 1.49654 95.58*** 
White 7129 2.0004 1.35851  
Hispanic 7120 1.8413 1.16214  
Multi-racial/other 1281 1.6081 1.05522  
Imputation 4 Black 9949 2.1237 1.49798 93.45*** 
White 7154 2.0028 1.35772  
Hispanic 7130 1.8374 1.15611  
Multi-racial/other 1312 1.6326 1.10367  
Imputation 5 Black 10030 2.1220 1.49931 95.41*** 
White 7154 2.0031 1.35288  
Hispanic 7078 1.8401 1.16354  
Multi-racial/other 1283 1.6072 1.04725  
Imputation 6 Black 9974 2.1204 1.49676 95.93*** 
White 7161 2.0084 1.35735  
Hispanic 7122 1.8402 1.16376  
Multi-racial/other 1288 1.6017 1.05875  
Imputation 7 Black 10004 2.1200 1.49557 93.92*** 
White 7159 2.0024 1.35956  
Hispanic 7086 1.8469 1.16227  
Multi-racial/other 1296 1.5972 1.06025  
Imputation 8 Black 9955 2.1202 1.49519 94.84*** 
White 7170 2.0082 1.36332  
Hispanic 7117 1.8404 1.16129  
Multi-racial/other 1303 1.6086 1.05617  
Imputation 9 Black 10029 2.1276 1.49892 99.95*** 
White 7115 1.9962 1.35445  
Hispanic 7101 1.8430 1.16316  
Multi-racial/other 1300 1.5938 1.04242  
Imputation 10 Black 10030 2.1229 1.49321 98.77*** 
White 7090 2.0039 1.36848  
Hispanic 7093 1.8439 1.15922  
Multi-racial/other 1332 1.5916 1.03936  
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Post-hoc comparisons: Tukey HSD 
 
 Race/ethnicity 1 Race/ethnicity 2 Mean 
difference 
Std. Error Sig. 
Original data Black Hispanic .13053* .02316 .000 
Black White .31785* .02373 .000 
Black Multi-racial/other .54602* .04461 .000 
Hispanic White .18732* .02565 .000 
Hispanic Multi-racial/other .41548* .04566 .000 
White Multi-racial/other .22817* .04595 .000 
Imputation 1 Black Hispanic .13046* .02099 .000 
Black White .27444* .02094 .000 
Black Multi-racial/other .49864* .03951 .000 
Hispanic White .14398* .02266 .000 
Hispanic Multi-racial/other .36818* .04045 .000 
White Multi-racial/other .22420* .04042 .000 
Imputation 2 Black Hispanic .12961* .02087 .000 
Black White .29084* .02103 .000 
Black Multi-racial/other .50695* .03981 .000 
Hispanic White .16124* .02261 .000 
Hispanic Multi-racial/other .37734* .04067 .000 
White Multi-racial/other .21611* .04075 .000 
Imputation 3 Black Hispanic .12329* .02094 .000 
Black White .28242* .02094 .000 
Black Multi-racial/other .51560* .04009 .000 
Hispanic White .15913* .02264 .000 
Hispanic Multi-racial/other .39230* .04100 .000 
White Multi-racial/other .23317* .04100 .000 
Imputation 4 Black Hispanic .12094* .02095 .000 
Black White .28628* .02097 .000 
Black Multi-racial/other .49111* .03969 .000 
Hispanic White .16535* .02261 .000 
Hispanic Multi-racial/other .37017* .04058 .000 
White Multi-racial/other .20483* .04059 .000 
Imputation 5 Black Hispanic .11896* .02091 .000 
Black White .28197* .02097 .000 
Black Multi-racial/other .51486* .04006 .000 
Hispanic White .16301* .02265 .000 
Hispanic Multi-racial/other .39590* .04096 .000 
White Multi-racial/other .23290* .04100 .000 
Imputation 6 Black Hispanic .11203* .02093 .000 
Black White .28020* .02096 .000 
Black Multi-racial/other .51870* .04000 .000 
Hispanic White .16817* .02261 .000 
Hispanic Multi-racial/other .40667* .04089 .000 
White Multi-racial/other .23851* .04091 .000 
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 Race/ethnicity 1 Race/ethnicity 2 Mean 
difference 
Std. Error Sig. 
Imputation 7 Black Hispanic .11758* .02092 .000 
Black White .27307* .02098 .000 
Black Multi-racial/other .52273* .03989 .000 
Hispanic White .15549* .02264 .000 
Hispanic Multi-racial/other .40515* .04079 .000 
White Multi-racial/other .24966* .04082 .000 
Imputation 8 Black Hispanic .11201* .02093 .000 
Black White .27986* .02097 .000 
Black Multi-racial/other .51165* .03980 .000 
Hispanic White .16785* .02261 .000 
Hispanic Multi-racial/other .39963* .04069 .000 
White Multi-racial/other .23179* .04071 .000 
Imputation 9 Black Hispanic .13142* .02094 .000 
Black White .28465* .02095 .000 
Black Multi-racial/other .53378* .03982 .000 
Hispanic White .15323* .02266 .000 
Hispanic Multi-racial/other .40236* .04074 .000 
White Multi-racial/other .24913* .04075 .000 
Imputation 10 Black Hispanic .11898* .02096 .000 
Black White .27900* .02096 .000 
Black Multi-racial/other .53134* .03939 .000 
Hispanic White .16002* .02269 .000 
Hispanic Multi-racial/other .41236* .04034 .000 
White Multi-racial/other .25234* .04034 .000 
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APPENDIX C 
 
Racial/ethnic differences in lifetime Medicaid use: Chi-square and post-hoc comparisons with imputed data 
 
 Race/ethnicity 1 % using Medicaid Race/ethnicity 2 % using Medicaid Chi-square df Sig. 
Original data Overall 3725.61 3 .000 
Black 83.8% Hispanic 87.2% 32.06 1 .000 
Black 83.8% White 41.5% 2592.90 1 .000 
Black 83.8% Multi-racial/other 61.1% 307.76 1 .000 
Hispanic 87.2% White 41.5% 2509.10 1 .000 
Hispanic 87.2% Multi-racial/other 61.1% 425.08 1 .000 
White 41.5% Multi-racial/other 61.1% 132.96 1 .000 
Imputation 1 Overall 4798.97 3 .000 
Black 83.3% Hispanic 86.9% 41.15 1 .000 
Black 83.3% White 41.1% 3288.27 1 .000 
Black 83.3% Multi-racial/other 60.5% 389.46 1 .000 
Hispanic 86.9% White 41.1% 3229.89 1 .000 
Hispanic 86.9% Multi-racial/other 60.5% 543.57 1 .000 
White 41.1% Multi-racial/other 60.5% 170.09 1 .000 
Imputation 2 Overall 4890.93 3 .000 
Black 83.2% Hispanic 86.9% 44.00 1 .000 
Black 83.2% White 40.5% 3334.15 1 .000 
Black 83.2% Multi-racial/other 61.3% 356.64 1 .000 
Hispanic 86.9% White 40.5% 3336.99 1 .000 
Hispanic 86.9% Multi-racial/other 61.3% 514.51 1 .000 
White 40.5% Multi-racial/other 61.3% 192.33 1 .000 
Imputation 3 Overall 4698.85 3 .000 
Black 83.1% Hispanic 86.8% 45.92 1 .000 
Black 83.1% White 41.5% 3198.16 1 .000 
Black 83.1% Multi-racial/other 60.3% 372.92 1 .000 
Hispanic 86.8% White 41.5% 3190.71 1 .000 
Hispanic 86.8% Multi-racial/other 60.3% 535.56 1 .000 
White 41.5% Multi-racial/other 60.3% 156.85 1 .000 
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 Race/ethnicity 1 % using Medicaid Race/ethnicity 2 % using Medicaid Chi-square df Sig. 
Imputation 4 Overall 4748.33 3 .000 
Black 83.2% Hispanic 87.0% 47.67 1 .000 
Black 83.2% White 41.4% 3217.73 1 .000 
Black 83.2% Multi-racial/other 60.7% 371.38 1 .000 
Hispanic 87.0% White 41.4% 3235.41 1 .000 
Hispanic 87.0% Multi-racial/other 60.7% 539.84 1 .000 
White 41.4% Multi-racial/other 60.7% 168.47 1 .000 
Imputation 5 Overall 4645.57 3 .000 
Black 83.2% Hispanic 86.4% 31.81 1 .000 
Black 83.2% White 41.5% 3219.40 1 .000 
Black 83.2% Multi-racial/other 61.0% 362.57 1 .000 
Hispanic 86.4% White 41.5% 3114.13 1 .000 
Hispanic 86.4% Multi-racial/other 61.0% 487.84 1 .000 
White 41.5% Multi-racial/other 61.0% 166.49 1 .000 
Imputation 6 Overall 4771.08 3 .000 
Black 83.3% Hispanic 86.6% 35.04 1 .000 
Black 83.3% White 41.2% 3279.92 1 .000 
Black 83.3% Multi-racial/other 59.9% 402.88 1 .000 
Hispanic 86.6% White 41.2% 3200.81 1 .000 
Hispanic 86.6% Multi-racial/other 59.9% 543.42 1 .000 
White 41.2% Multi-racial/other 59.9% 154.40 1 .000 
Imputation 7 Overall 4816.61 3 .000 
Black 83.2% Hispanic 86.8% 40.82 1 .000 
Black 83.2% White 40.8% 3304.63 1 .000 
Black 83.2% Multi-racial/other 61.2% 357.78 1 .000 
Hispanic 86.8% White 40.8% 3260.01 1 .000 
Hispanic 86.8% Multi-racial/other 61.2% 506.33 1 .000 
White 40.8% Multi-racial/other 61.2% 184.10 1 .000 
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 Race/ethnicity 1 % using Medicaid Race/ethnicity 2 % using Medicaid Chi-square df Sig. 
Imputation 8 Overall 4768.91 3 .000 
Black 83.4% Hispanic 86.5% 31.56 1 .000 
Black 83.4% White 41.1% 3291.73 1 .000 
Black 83.4% Multi-racial/other 60.1% 401.69 1 .000 
Hispanic 86.5% White 41.1% 3190.15 1 .000 
Hispanic 86.5% Multi-racial/other 60.1% 532.79 1 .000 
White 41.1% Multi-racial/other 60.1% 160.47 1 .000 
Imputation 9 Overall 4779.10 3 .000 
Black 83.2% Hispanic 86.7% 38.60 1 .000 
Black 83.2% White 41.0% 3290.19 1 .000 
Black 83.2% Multi-racial/other 60.5% 377.44 1 .000 
Hispanic 86.7% White 41.0% 3216.35 1 .000 
Hispanic 86.7% Multi-racial/other 60.5% 522.54 1 .000 
White 41.0% Multi-racial/other 60.5% 171.10 1 .000 
Imputation 10 Overall 4735.55 3 .000 
Black 83.5% Hispanic 86.5% 29.62 1 .000 
Black 83.5% White 41.3% 3293.26 1 .000 
Black 83.5% Multi-racial/other 60.4% 404.63 1 .000 
Hispanic 86.5% White 41.3% 3141.72 1 .000 
Hispanic 86.5% Multi-racial/other 60.4% 528.49 1 .000 
White 41.3% Multi-racial/other 60.4% 164.95 1 .000 
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APPENDIX D 
 
Racial/ethnic differences in lifetime health safety-net use: Chi-square and post-hoc comparisons with imputed data 
 
 Race/ethnicity 1 % using health 
safety-net 
Race/ethnicity 2 % using health 
safety-net 
Chi-square df Sig. 
Original data Overall 289.00 3 .000 
Black 17.1% Hispanic 10.5% 119.23 1 .000 
Black 17.1% White 7.7% 236.56 1 .000 
Black 17.1% Multi-racial/other 10.7% 26.81 1 .000 
Hispanic 10.5% White 7.7% 24.36 1 .000 
Hispanic 10.5% Multi-racial/other 10.7% .05 1 .817 
White 7.7% Multi-racial/other 10.7% 10.04 1 .002 
Imputation 1 Overall 386.24 3 .000 
Black 16.7% Hispanic 10.2% 145.06 1 .000 
Black 16.7% White 7.3% 326.82 1 .000 
Black 16.7% Multi-racial/other 9.7% 43.30 1 .000 
Hispanic 10.2% White 7.3% 36.55 1 .000 
Hispanic 10.2% Multi-racial/other 9.7% .36 1 .550 
White 7.3% Multi-racial/other 9.7% 8.51 1 .004 
Imputation 2 Overall 395.34 3 .000 
Black 16.7% Hispanic 9.8% 166.97 1 .000 
Black 16.7% White 7.3% 322.69 1 .000 
Black 16.7% Multi-racial/other 9.8% 40.22 1 .000 
Hispanic 9.8% White 7.3% 27.62 1 .000 
Hispanic 9.8% Multi-racial/other 9.8% .00 1 .957 
White 7.3% Multi-racial/other 9.8% 9.73 1 .002 
Imputation 3 Overall 402.29 3 .000 
Black 16.7% Hispanic 10.1% 148.81 1 .000 
Black 16.7% White 7.1% 343.67 1 .000 
Black 16.7% Multi-racial/other 9.8% 39.92 1 .000 
Hispanic 10.1% White 7.1% 41.22 1 .000 
Hispanic 10.1% Multi-racial/other 9.8% .11 1 .738 
White 7.1% Multi-racial/other 9.8% 11.49 1 .001 
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 Race/ethnicity 1 % using health 
safety-net 
Race/ethnicity 2 % using health 
safety-net 
Chi-square df Sig. 
Imputation 4 Overall 410.62 3 .000 
Black 16.7% Hispanic 10.0% 157.62 1 .000 
Black 16.7% White 7.0% 350.01 1 .000 
Black 16.7% Multi-racial/other 10.3% 35.48 1 .000 
Hispanic 10.0% White 7.0% 39.28 1 .000 
Hispanic 10.0% Multi-racial/other 10.3% .13 1 .720 
White 7.0% Multi-racial/other 10.3% 16.77 1 .000 
Imputation 5 Overall 378.84 3 .000 
Black 16.6% Hispanic 10.1% 143.53 1 .000 
Black 16.6% White 7.2% 324.42 1 .000 
Black 16.6% Multi-racial/other 10.3% 33.55 1 .000 
Hispanic 10.1% White 7.2% 37.66 1 .000 
Hispanic 10.1% Multi-racial/other 10.3% .02 1 .878 
White 7.2% Multi-racial/other 10.3% 14.10 1 .000 
Imputation 6 Overall 377.16 3 .000 
Black 16.5% Hispanic 10.3% 133.41 1 .000 
Black 16.5% White 7.1% 331.22 1 .000 
Black 16.5% Multi-racial/other 10.4% 31.53 1 .000 
Hispanic 10.3% White 7.1% 45.28 1 .000 
Hispanic 10.3% Multi-racial/other 10.4% .02 1 .891 
White 7.1% Multi-racial/other 10.4% 16.88 1 .000 
Imputation 7 Overall 428.35 3 .000 
Black 16.9% Hispanic 10.0% 167.88 1 .000 
Black 16.9% White 7.1% 359.87 1 .000 
Black 16.9% Multi-racial/other 10.1% 39.37 1 .000 
Hispanic 10.0% White 7.1% 38.13 1 .000 
Hispanic 10.0% Multi-racial/other 10.1% .03 1 .870 
White 7.1% Multi-racial/other 10.1% 14.50 1 .000 
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 Race/ethnicity 1 % using health 
safety-net  
Race/ethnicity 2 % using health 
safety-net 
Chi-square df Sig. 
Imputation 8 Overall 412.56 3 .000 
Black 16.9% Hispanic 9.9% 168.30 1 .000 
Black 16.9% White 7.3% 340.86 1 .000 
Black 16.9% Multi-racial/other 9.9% 41.98 1 .000 
Hispanic 9.9% White 7.3% 31.52 1 .000 
Hispanic 9.9% Multi-racial/other 9.9% .00 1 .961 
White 7.3% Multi-racial/other 9.9% 10.42 1 .001 
Imputation 9 Overall 401.65 3 .000 
Black 16.7% Hispanic 9.9% 165.23 1 .000 
Black 16.7% White 7.3% 331.83 1 .000 
Black 16.7% Multi-racial/other 10.1% 38.08 1 .000 
Hispanic 9.9% White 7.3% 29.66 1 .000 
Hispanic 9.9% Multi-racial/other 10.1% .06 1 .803 
White 7.3% Multi-racial/other 10.1% 11.93 1 .001 
Imputation 10 Overall 409.58 3 .000 
Black 16.6% Hispanic 10.2% 142.09 1 .000 
Black 16.6% White 7.0% 348.94 1 .000 
Black 16.6% Multi-racial/other 9.0% 51.62 1 .000 
Hispanic 10.2% White 7.0% 46.66 1 .000 
Hispanic 10.2% Multi-racial/other 9.0% 1.84 1 .175 
White 7.0% Multi-racial/other 9.0% 6.62 1 .010 
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APPENDIX E 
 
Racial/ethnic differences in lifetime private health insurance use: Chi-square and post-hoc comparisons with imputed data 
 
 Race/ethnicity 1 % using private 
insurance 
Race/ethnicity 2 % using private 
insurance 
Chi-square df Sig. 
Original data Overall 1620.88 3 .000 
Black 34.6% Hispanic 22.6% 232.41 1 .000 
Black 34.6% White 59.3% 790.38 1 .000 
Black 34.6% Multi-racial/other 42.4% 24.50 1 .000 
Hispanic 22.6% White 59.3% 1522.33 1 .000 
Hispanic 22.6% Multi-racial/other 42.4% 178.95 1 .000 
White 59.3% Multi-racial/other 42.4% 99.52 1 .000 
Imputation 1 Overall 2194.87 3 .000 
Black 34.7% Hispanic 22.7% 286.67 1 .000 
Black 34.7% White 59.9% 1068.79 1 .000 
Black 34.7% Multi-racial/other 57.4% 32.41 1 .000 
Hispanic 22.7% White 59.9% 2032.97 1 .000 
Hispanic 22.7% Multi-racial/other 57.4% 232.84 1 .000 
White 59.9% Multi-racial/other 57.4% 135.70 1 .000 
Imputation 2 Overall 2289.38 3 .000 
Black 34.6% Hispanic 22.5% 296.14 1 .000 
Black 34.6% White 60.5% 1113.91 1 .000 
Black 34.6% Multi-racial/other 42.9% 34.59 1 .000 
Hispanic 22.5% White 60.5% 2126.39 1 .000 
Hispanic 22.5% Multi-racial/other 42.9% 241.54 1 .000 
White 60.5% Multi-racial/other 42.9% 138.98 1 .000 
Imputation 3 Overall 2172.29 3 .000 
Black 34.8% Hispanic 22.6% 297.64 1 .000 
Black 34.8% White 59.7% 1037.31 1 .000 
Black 34.8% Multi-racial/other 43.4% 36.43 1 .000 
Hispanic 22.6% White 59.7% 2021.33 1 .000 
Hispanic 22.6% Multi-racial/other 43.4% 245.75 1 .000 
White 59.7% Multi-racial/other 43.4% 117.23 1 .000 
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 Race/ethnicity 1 % using private 
insurance 
Race/ethnicity 2 % using private 
insurance 
Chi-square df Sig. 
Imputation 4 Overall 2173.99 3 .000 
Black 34.9% Hispanic 22.5% 304.33 1 .000 
Black 34.9% White 59.6% 1024.02 1 .000 
Black 34.9% Multi-racial/other 43.6% 38.03 1 .000 
Hispanic 22.5% White 59.6% 2028.30 1 .000 
Hispanic 22.5% Multi-racial/other 43.6% 256.58 1 .000 
White 59.6% Multi-racial/other 43.6% 116.17 1 .000 
Imputation 5 Overall 2073.81 3 .000 
Black 34.6% Hispanic 23.4% 247.46 1 .000 
Black 34.6% White 59.5% 1041.51 1 .000 
Black 34.6% Multi-racial/other 43.0% 35.44 1 .000 
Hispanic 23.4% White 59.5% 1908.18 1 .000 
Hispanic 23.4% Multi-racial/other 43.0% 214.98 1 .000 
White 59.5% Multi-racial/other 43.0% 120.18 1 .000 
Imputation 6 Overall 2146.57 3 .000 
Black 34.5% Hispanic 23.1% 263.53 1 .000 
Black 34.5% White 59.7% 1061.98 1 .000 
Black 34.5% Multi-racial/other 43.6% 41.06 1 .000 
Hispanic 23.1% White 59.7% 1977.66 1 .000 
Hispanic 23.1% Multi-racial/other 43.6% 239.12 1 .000 
White 59.7% Multi-racial/other 43.6% 115.07 1 .000 
Imputation 7 Overall 2192.17 3 .000 
Black 34.7% Hispanic 22.8% 282.13 1 .000 
Black 34.7% White 60.0% 1073.92 1 .000 
Black 34.7% Multi-racial/other 42.1% 27.67 1 .000 
Hispanic 22.8% White 60.0% 2033.50 1 .000 
Hispanic 22.8% Multi-racial/other 42.1% 214.10 1 .000 
White 60.0% Multi-racial/other 42.1% 143.28 1 .000 
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 Race/ethnicity 1 % using private 
insurance 
Race/ethnicity 2 % using private 
insurance 
Chi-square df Sig. 
Imputation 8 Overall 2156.79 3 .000 
Black 34.6% Hispanic 23.1% 267.07 1 .000 
Black 34.6% White 59.8% 1062.76 1 .000 
Black 34.6% Multi-racial/other 43.7% 41.56 1 .000 
Hispanic 23.1% White 59.8% 1989.73 1 .000 
Hispanic 23.1% Multi-racial/other 43.7% 243.51 1 .000 
White 59.8% Multi-racial/other 43.7% 116.47 1 .000 
Imputation 9 Overall 2150.94 3 .000 
Black 34.6% Hispanic 23.0% 267.09 1 .000 
Black 34.6% White 59.9% 1068.44 1 .000 
Black 34.6% Multi-racial/other 42.7% 32.57 1 .000 
Hispanic 23.0% White 59.9% 1984.93 1 .000 
Hispanic 23.0% Multi-racial/other 42.7% 219.96 1 .000 
White 59.9% Multi-racial/other 42.7% 132.37 1 .000 
Imputation 10 Overall 2141.89 3 .000 
Black 34.5% Hispanic 22.9% 265.69 1 .000 
Black 34.5% White 59.7% 1063.97 1 .000 
Black 34.5% Multi-racial/other 43.1% 37.86 1 .000 
Hispanic 22.9% White 59.7% 1973.00 1 .000 
Hispanic 22.9% Multi-racial/other 43.1% 235.74 1 .000 
White 59.7% Multi-racial/other 43.1% 125.90 1 .000 
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APPENDIX F 
 
Racial/ethnic differences in number of ED visits: One-way ANOVA 
 
 Race/ethnicity N Mean SD F 
Original Data Black 2728 1.85 1.951 49.40*** 
 White 1565 1.57 1.337  
 Hispanic 1180 1.27 1.045  
 Multi-racial/other 322 1.13 .521  
Imputation 1 Black 2852 1.83 1.923 49.82*** 
White 1649 1.55 1.316  
Hispanic 1247 1.27 1.044  
Multi-racial/other 343 1.15 .553  
Imputation 2 Black 2849 1.83 1.925 49.93*** 
White 1665 1.56 1.320  
Hispanic 1240 1.27 1.034  
Multi-racial/other 337 1.13 .513  
Imputation 3 Black 2860 1.82 1.915 47.58*** 
White 1650 1.56 1.327  
Hispanic 1244 1.28 1.062  
Multi-racial/other 337 1.13 .510  
Imputation 4 Black 2863 1.83 1.921 50.60*** 
White 1643 1.56 1.328  
Hispanic 1252 1.26 1.021  
Multi-racial/other 333 1.14 .525  
Imputation 5 Black 2858 1.83 1.923 51.23*** 
White 1645 1.57 1.327  
Hispanic 1247 1.26 1.025  
Multi-racial/other 341 1.13 .508  
Imputation 6 Black 2860 1.83 1.922 49.86*** 
White 1656 1.56 1.323  
Hispanic 1239 1.26 1.027  
Multi-racial/other 336 1.14 .537  
Imputation 7 Black 2861 1.83 1.921 50.42*** 
White 1645 1.56 1.325  
Hispanic 1250 1.27 1.031  
Multi-racial/other 335 1.13 .512  
Imputation 8 Black 2851 1.83 1.918 49.20*** 
White 1658 1.57 1.338  
Hispanic 1244 1.27 1.031  
Multi-racial/other 338 1.14 .524  
Imputation 9 Black 2865 1.83 1.919 48.40*** 
White 1646 1.56 1.321  
Hispanic 1240 1.27 1.032  
Multi-racial/other 340 1.16 .629  
Imputation 10 Black 2856 1.83 1.923 49.71*** 
White 1650 1.56 1.319  
Hispanic 1239 1.27 1.032  
Multi-racial/other 346 1.14 .597  
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Post-hoc comparisons: Tukey HSD 
 
 Race/ethnicity 1 Race/ethnicity 2 Mean 
difference 
Std. Error Sig. 
Original data Black Hispanic .281* .050 .000 
Black White .583* .055 .000 
Black Multi-racial/other .719* .093 .000 
Hispanic White .302* .061 .000 
Hispanic Multi-racial/other .438* .097 .000 
White Multi-racial/other .136 .100 .522 
Imputation 1 Black White .283* .048 .000 
Black Hispanic .562* .053 .000 
Black Multi-racial/other .689* .089 .000 
Hispanic White .279* .059 .000 
Hispanic Multi-racial/other .406* .093 .000 
White Multi-racial/other .127 .095 .543 
Imputation 2 Black Hispanic .269* .048 .000 
Black White .563* .053 .000 
Black Multi-racial/other .701* .090 .000 
Hispanic White .294* .059 .000 
Hispanic Multi-racial/other .432* .093 .000 
White Multi-racial/other .137 .096 .481 
Imputation 3 Black Hispanic .262* .048 .000 
Black White .544* .053 .000 
Black Multi-racial/other .697* .090 .000 
Hispanic White .282* .059 .000 
Hispanic Multi-racial/other .435* .093 .000 
White Multi-racial/other .153 .096 .383 
Imputation 4 Black Hispanic .268* .048 .000 
Black White .570* .053 .000 
Black Multi-racial/other .694* .090 .000 
Hispanic White .302* .059 .000 
Hispanic Multi-racial/other .425* .094 .000 
White Multi-racial/other .123 .096 .577 
Imputation 5 Black Hispanic .266* .048 .000 
Black White .570* .053 .000 
Black Multi-racial/other .706* .089 .000 
Hispanic White .304* .059 .000 
Hispanic Multi-racial/other .440* .093 .000 
White Multi-racial/other .136 .095 .483 
Imputation 6 Black Hispanic .268* .048 .000 
Black White .566* .053 .000 
Black Multi-racial/other .691* .090 .000 
Hispanic White .298* .059 .000 
Hispanic Multi-racial/other .422* .093 .000 
White Multi-racial/other .124 .096 .569 
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 Race/ethnicity 1 Race/ethnicity 2 Mean 
difference 
Std. Error Sig. 
Imputation 7 Black Hispanic .271* .048 .000 
Black White .565* .053 .000 
Black Multi-racial/other .704* .090 .000 
Hispanic White .294* .059 .000 
Hispanic Multi-racial/other .433* .094 .000 
White Multi-racial/other .139 .096 .472 
Imputation 8 Black Hispanic .262* .048 .000 
Black White .562* .053 .000 
Black Multi-racial/other .689* .090 .000 
Hispanic White .299* .059 .000 
Hispanic Multi-racial/other .427* .093 .000 
White Multi-racial/other .128 .096 .542 
Imputation 9 Black Hispanic .267* .048 .000 
Black White .562* .053 .000 
Black Multi-racial/other .666* .090 .000 
Hispanic White .295* .059 .000 
Hispanic Multi-racial/other .399* .093 .000 
White Multi-racial/other .104 .096 .695 
Imputation 10 Black Hispanic .274* .048 .000 
Black White .563* .053 .000 
Black Multi-racial/other .687* .089 .000 
Hispanic White .289* .059 .000 
Hispanic Multi-racial/other .414* .092 .000 
White Multi-racial/other .124 .095 .558 
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APPENDIX G 
 
Racial/ethnic variations in seasonal psychiatric ED patterns: GLMs with 95% confidence intervals 
 
 Black Hispanic White Multi-racial/other 
 (n=5054) (n=2459) (n=1498) (n=365) 
Month Mean rate 
ratio 
95% CI Mean rate 
ratio 
95% CI Mean rate 
ratio 
95% CI Mean rate 
ratio 
95% CI 
January ref - ref - ref - ref - 
February .95 .83, 1.09 1.15 .95, 1.38 1.09 .86, 1.39 1.79* 1.07, 2.97 
March 1.24*** 1.09, 1.25 1.18 .98, 1.41 1.08 .85, 1.37 1.04 .59, 1.82 
April 1.10 .96, 1.25 1.17 .97, 1.40 .92 .71, 1.17 1.33 .78, 2.27 
May 1.36*** 1.20, 1.55 1.23* 1.02, 1.48 .71* .54, .93 1.13 .64, 2.00 
June 1.01 .88, 1.16 .87 .71, 1.07 .80 .61, 1.05 .83 .45, 1.55 
July .68*** .58, .79 .62*** .49, .78 .60*** .45, .80 .52 .25, 1.06 
August .77*** .66, .89 .65*** .52, .81 .69** .52, .91 .62 .31, 1.21 
September .92 .81, 1.06 1.01 .83, 1.23 1.44** 1.15, 1.80 2.19** 1.35, 3.57 
October 1.10 .97, 1.25 1.24* 1.03, 1.49 1.57*** 1.26, 1.95 2.16** 1.33, 3.52 
November 1.12 .98, 1.27 1.25* 1.04, 1.50 1.07 .84, 1.36 1.80* 1.08, 2.98 
December 1.01 .89, 1.16 .97 .80, 1.18 .77* .60, 1.00 1.61 .97, 2.69 
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APPENDIX H 
 
Racial/ethnic differences in number of ED visits: One-way ANOVA 
 
 Race/ethnicity N Mean SD F 
Original Data Black 1572 10.42 17.125 10.09*** 
 White 1021 7.71 12.240  
 Hispanic 562 7.61 16.234  
 Multi-racial/other 113 5.73 8.188  
Imputation 1 Black 1792 10.10 17.088 16.90*** 
White 1173 7.26 11.685  
Hispanic 781 6.55 14.269  
Multi-racial/other 147 5.00 7.428  
Imputation 2 Black 1788 9.97 16.889 14.52*** 
White 1189 7.46 12.174  
Hispanic 769 6.49 14.284  
Multi-racial/other 147 5.43 7.798  
Imputation 3 Black 1811 9.99 16.985 14.69*** 
White 1184 7.27 11.732  
Hispanic 768 6.59 14.371  
Multi-racial/other 130 5.53 7.827  
Imputation 4 Black 1790 9.97 16.603 14.87*** 
White 1188 7.52 12.853  
Hispanic 771 6.40 14.133  
Multi-racial/other 144 5.32 7.528  
Imputation 5 Black 1787 9.97 16.710 14.20*** 
White 1195 7.28 11.588  
Hispanic 773 6.78 15.468  
Multi-racial/other 138 5.20 7.574  
Imputation 6 Black 1797 9.89 16.841 13.71*** 
White 1177 7.56 12.313  
Hispanic 778 6.51 14.180  
Multi-racial/other 141 5.25 7.544  
Imputation 7 Black 1805 10.00 17.027 15.08*** 
White 1183 7.32 11.751  
Hispanic 764 6.53 14.326  
Multi-racial/other 141 5.44 7.647  
Imputation 8 Black 1793 9.89 16.465 13.04*** 
White 1196 7.35 12.045  
Hispanic 755 6.83 15.644  
Multi-racial/other 149 5.33 7.644  
Imputation 9 Black 1814 9.78 16.407 12.06*** 
White 1170 7.60 12.916  
Hispanic 773 6.63 14.490  
Multi-racial/other 136 5.28 7.614  
Imputation 10 Black 1805 9.92 16.605 13.43*** 
White 1179 7.31 11.784  
Hispanic 768 6.73 15.413  
Multi-racial/other 141 5.55 7.978  
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Post-hoc comparisons: Tukey HSD 
 
 Race/ethnicity 1 Race/ethnicity 2 Mean 
difference 
Std. Error Sig. 
Original data Black Hispanic 2.706 .617 .000 
Black White 2.805 .754 .001 
Black Multi-racial/other 4.691 1.495 .009 
Hispanic White .099 .806 .999 
Hispanic Multi-racial/other 1.985 1.522 .560 
White Multi-racial/other 1.886 1.582 .632 
Imputation 1 Black White 2.846 .555 .000 
Black Hispanic 3.550 .634 .000 
Black Multi-racial/other 5.104 1.268 .000 
Hispanic White .704 .683 .731 
Hispanic Multi-racial/other 2.258 1.293 .300 
White Multi-racial/other 1.554 1.329 .646 
Imputation 2 Black Hispanic 2.507 .554 .000 
Black White 3.478 .638 .000 
Black Multi-racial/other 4.537 1.270 .002 
Hispanic White .972 .685 .487 
Hispanic Multi-racial/other 2.031 1.294 .396 
White Multi-racial/other 1.059 1.332 .857 
Imputation 3 Black Hispanic 2.713 .553 .000 
Black White 3.401 .637 .000 
Black Multi-racial/other 4.456 1.343 .005 
Hispanic White .688 .685 .748 
Hispanic Multi-racial/other 1.743 1.367 .579 
White Multi-racial/other 1.055 1.403 .876 
Imputation 4 Black Hispanic 2.449 .554 .000 
Black White 3.570 .637 .000 
Black Multi-racial/other 4.649 1.281 .002 
Hispanic White 1.121 .684 .357 
Hispanic Multi-racial/other 2.200 1.305 .332 
White Multi-racial/other 1.079 1.343 .853 
Imputation 5 Black Hispanic 2.691 .553 .000 
Black White 3.186 .637 .000 
Black Multi-racial/other 4.774 1.307 .002 
Hispanic White .495 .683 .887 
Hispanic Multi-racial/other 2.083 1.330 .398 
White Multi-racial/other 1.588 1.367 .651 
Imputation 6 Black Hispanic 2.335 .555 .000 
Black White 3.385 .635 .000 
Black Multi-racial/other 4.644 1.294 .002 
Hispanic White 1.050 .684 .417 
Hispanic Multi-racial/other 2.309 1.319 .298 
White Multi-racial/other 1.259 1.355 .789 
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 Race/ethnicity 1 Race/ethnicity 2 Mean 
difference 
Std. Error Sig. 
Imputation 7 Black Hispanic 2.681 .553 .000 
Black White 3.470 .638 .000 
Black Multi-racial/other 4.563 1.294 .002 
Hispanic White .789 .687 .659 
Hispanic Multi-racial/other 1.882 1.318 .482 
White Multi-racial/other 1.093 1.356 .852 
Imputation 8 Black Hispanic 2.541 .553 .000 
Black White 3.067 .642 .000 
Black Multi-racial/other 4.563 1.262 .002 
Hispanic White .526 .688 .870 
Hispanic Multi-racial/other 2.022 1.286 .395 
White Multi-racial/other 1.496 1.327 .673 
Imputation 9 Black Hispanic 2.176 .555 .001 
Black White 3.152 .636 .000 
Black Multi-racial/other 4.500 1.317 .004 
Hispanic White .975 .686 .486 
Hispanic Multi-racial/other 2.323 1.342 .307 
White Multi-racial/other 1.348 1.377 .762 
Imputation 10 Black Hispanic 2.609 .554 .000 
Black White 3.185 .638 .000 
Black Multi-racial/other 4.365 1.294 .004 
Hispanic White .577 .686 .835 
Hispanic Multi-racial/other 1.756 1.319 .543 
White Multi-racial/other 1.180 1.356 .820 
 
 
  
APPENDIX I 
 
Racial/ethnic variations in seasonal outpatient treatment patterns: GLMs with 95% confidence intervals 
 
 Black Hispanic White Multi-racial/other 
 (n=5054) (n=2459) (n=1498) (n=365) 
Month Mean rate 
ratio 
95% CI Mean rate 
ratio 
95% CI Mean rate 
ratio 
95% CI Mean rate 
ratio 
95% CI 
January 1.03 .96, 1.11 1.10 .98, 1.22 1.12 .97, 1.29 .96 .65, 1.40 
February 1.08* 1.00, 1.16 1.21*** 1.08, 1.34 1.17* 1.02, 1.35 .95 .64, 1.41 
March 1.23*** 1.14, 1.31 1.26*** 1.13, 1.40 1.23** 1.07, 1.41 .96 .65, 1.40 
April 1.11** 1.03, 1.19 1.23*** 1.11, 1.37 1.02 .88, 1.17 1.01 .69, 1.48 
May 1.08* 1.00, 1.16 1.18** 1.06, 1.32 .96 .83, 1.12 1.25 .86, 1.80 
June .98 .91, 1.06 1.07 .96, 1.20 .95 .82, 1.11 .85 .56, 1.28 
July .87*** .80, .94 .97 .86, 1.09 .77** .65, .90 1.12 .77, 1.64 
August .87*** .81, .93 .91 .81, 1.02 .87 .74, 1.01 1.09 .76, 1.58 
September .83*** .77, .89 .92 .82, 1.04 .91 .78, 1.06 .96 .65, 1.41 
October .95 .88, 1.02 1.07 .96, 1.19 .97 .84, 1.13 1.19 .83, 1.70 
November 1.01 .94, 1.09 1.15** 1.04, 1.29 1.15 .99, 1.32 1.24 .87, 1.78 
December ref - ref - ref - ref - 
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APPENDIX J 
 
Racial/ethnic differences in number of outpatient treatment periods: One-way ANOVA 
 
 Race/ethnicity N Mean SD F 
Original Data Black 1158 2.4836 2.21864 13.25*** 
 White 714 2.2255 1.95414  
 Hispanic 387 1.8346 1.33837  
 Multi-racial/other 74 1.6486 .71063  
Imputation 1 Black 1301 2.4443 2.15963 19.17*** 
White 814 2.1634 1.89687  
Hispanic 531 1.7759 1.33341  
Multi-racial/other 94 1.5851 .72453  
Imputation 2 Black 1303 2.4244 2.15710 16.49*** 
White 825 2.1709 1.90264  
Hispanic 514 1.7899 1.33283  
Multi-racial/other 98 1.6633 .75905  
Imputation 3 Black 1318 2.4074 2.14016 15.00*** 
White 828 2.1812 1.92320  
Hispanic 509 1.7839 1.30431  
Multi-racial/other 85 1.7176 .90779  
Imputation 4 Black 1310 2.4305 2.15715 19.10*** 
White 815 2.1926 1.91745  
Hispanic 518 1.7490 1.28326  
Multi-racial/other 97 1.6082 .68552  
Imputation 5 Black 1295 2.4247 2.15662 18.37*** 
White 825 2.2024 1.93937  
Hispanic 528 1.7595 1.25077  
Multi-racial/other 92 1.5978 .71190  
Imputation 6 Black 1305 2.4077 2.13845 17.67*** 
White 823 2.2272 1.97629  
Hispanic 520 1.7442 1.22040  
Multi-racial/other 92 1.6413 .73502  
Imputation 7 Black 1312 2.4146 2.14331 16.48*** 
White 816 2.1936 1.90621  
Hispanic 519 1.7592 1.30702  
Multi-racial/other 93 1.7419 1.23273  
Imputation 8 Black 1315 2.4076 2.13607 15.68*** 
White 818 2.1944 1.92455  
Hispanic 512 1.7852 1.35511  
Multi-racial/other 95 1.6632 .78021  
Imputation 9 Black 1329 2.4048 2.14466 16.66*** 
White 799 2.2103 1.93914  
Hispanic 524 1.7786 1.27958  
Multi-racial/other 88 1.5795 .69019  
Imputation 10 Black 1307 2.4323 2.16168 19.13*** 
White 819 2.1905 1.90748  
Hispanic 525 1.7429 1.27235  
Multi-racial/other 89 1.6292 .77433  
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Post-hoc comparisons: Tukey HSD 
 
 Race/ethnicity 1 Race/ethnicity 2 Mean 
difference 
Std. Error Sig. 
Original data Black Hispanic .25810 .09429 .032 
Black White .64897 .11636 .000 
Black Multi-racial/other .83494 .23761 .003 
Hispanic White .39086 .12509 .010 
Hispanic Multi-racial/other .57684 .24201 .081 
White Multi-racial/other .18598 .25143 .881 
Imputation 1 Black White .28088 .08535 .006 
Black Hispanic .66838 .09835 .000 
Black Multi-racial/other .85917 .20398 .000 
Hispanic White .38750 .10654 .002 
Hispanic Multi-racial/other .57828 .20805 .028 
White Multi-racial/other .19079 .21371 .809 
Imputation 2 Black Hispanic .25350 .08510 .015 
Black White .63452 .09962 .000 
Black Multi-racial/other .76114 .20034 .001 
Hispanic White .38103 .10747 .002 
Hispanic Multi-racial/other .50764 .20435 .063 
White Multi-racial/other .12662 .21082 .932 
Imputation 3 Black Hispanic .22628 .08488 .039 
Black White .62355 .09989 .000 
Black Multi-racial/other .68979 .21421 .007 
Hispanic White .39727 .10781 .001 
Hispanic Multi-racial/other .46351 .21801 .145 
White Multi-racial/other .06624 .22428 .991 
Imputation 4 Black Hispanic .23790 .08521 .027 
Black White .68150 .09913 .000 
Black Multi-racial/other .82229 .20097 .000 
Hispanic White .44360 .10732 .000 
Hispanic Multi-racial/other .58439 .20514 .023 
White Multi-racial/other .14079 .21130 .910 
Imputation 5 Black Hispanic .22229 .08511 .045 
Black White .66524 .09866 .000 
Black Multi-racial/other .82688 .20616 .000 
Hispanic White .44295 .10649 .000 
Hispanic Multi-racial/other .60460 .21001 .021 
White Multi-racial/other .16164 .21586 .877 
Imputation 6 Black Hispanic .18045 .08508 .147 
Black White .66343 .09912 .000 
Black Multi-racial/other .76636 .20618 .001 
Hispanic White .48299 .10707 .000 
Hispanic Multi-racial/other .58591 .21012 .027 
White Multi-racial/other .10293 .21619 .964 
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 Race/ethnicity 1 Race/ethnicity 2 Mean 
difference 
Std. Error Sig. 
Imputation 7 Black Hispanic .22101 .08527 .047 
Black White .65548 .09918 .000 
Black Multi-racial/other .67270 .20524 .006 
Hispanic White .43448 .10738 .000 
Hispanic Multi-racial/other .45169 .20933 .135 
White Multi-racial/other .01722 .21537 1.000 
Imputation 8 Black Hispanic .21323 .08521 .060 
Black White .62245 .09968 .000 
Black Multi-racial/other .74445 .20328 .001 
Hispanic White .40922 .10783 .001 
Hispanic Multi-racial/other .53122 .20740 .051 
White Multi-racial/other .12200 .21375 .941 
Imputation 9 Black Hispanic .19455 .08561 .105 
Black White .62619 .09865 .000 
Black Multi-racial/other .82527 .21051 .001 
Hispanic White .43164 .10750 .000 
Hispanic Multi-racial/other .63072 .21480 .018 
White Multi-racial/other .19908 .22032 .803 
Imputation 10 Black Hispanic .24181 .08512 .023 
Black White .68943 .09869 .000 
Black Multi-racial/other .80307 .20923 .001 
Hispanic White .44762 .10678 .000 
Hispanic Multi-racial/other .56126 .21316 .042 
White Multi-racial/other .11364 .21894 .955 
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APPENDIX K 
 
Secular trends in median treatment duration estimates: sensitivity analysis 
 
 Median estimate 95% CI 
2011 14.00 9.37, 18.63 
2012 34.00 20.78, 47.22 
2013 54.00 43.05, 64.95 
2014 55.00 43.37, 66.63 
2015 63.00 53.53, 72.47 
2016 49.00 40.46, 57.55 
2017 61.00 53.89, 68.11 
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APPENDIX L 
 
Racial/ethnic differences in frequency of treatment: One-way ANOVA 
 
 Race/ethnicity N Mean SD F 
Original Data Black 1830 21.6019 10.19552 3.77* 
 White 1055 21.4873 10.19964  
 Hispanic 462 21.1030 9.83419  
 Multi-racial/other 69 17.5270 8.12283  
Imputation 1 Black 2014 21.6196 10.21464 3.53* 
White 1164 21.4064 10.13013  
Hispanic 604 20.5963 10.14780  
Multi-racial/other 88 18.7374 9.45862  
Imputation 2 Black 2004 21.5377 10.26408 2.30 
White 1185 21.3977 10.13053  
Hispanic 589 20.8477 10.04043  
Multi-racial/other 92 19.0323 9.27677  
Imputation 3 Black 2018 21.5482 10.20990 3.97** 
White 1179 21.5087 10.27747  
Hispanic 591 20.6742 9.95287  
Multi-racial/other 82 18.1285 8.60274  
Imputation 4 Black 2013 21.6445 10.20417 5.62** 
White 1177 21.4419 10.21217  
Hispanic 591 20.5904 10.05475  
Multi-racial/other 89 17.6581 8.80616  
Imputation 5 Black 1988 21.5961 10.25428 5.83** 
White 1196 21.5263 10.18548  
Hispanic 604 20.6075 9.97551  
Multi-racial/other 82 17.3488 8.34281  
Imputation 6 Black 1993 21.5174 10.20533 4.81** 
White 1196 21.6898 10.20050  
Hispanic 593 20.4134 10.02865  
Multi-racial/other 88 18.3819 9.29737  
Imputation 7 Black 2014 21.4989 10.18963 2.24 
White 1170 21.4819 10.25695  
Hispanic 592 20.8030 10.06719  
Multi-racial/other 94 19.1495 9.13921  
Imputation 8 Black 2015 21.4939 10.16755 4.15** 
White 1183 21.5233 10.27639  
Hispanic 579 20.9155 10.05528  
Multi-racial/other 93 17.9092 9.08624  
Imputation 9 Black 2031 21.5568 10.22353 6.07*** 
White 1160 21.4896 10.17833  
Hispanic 596 20.8615 10.07036  
Multi-racial/other 83 16.9247 8.47449  
Imputation 10 Black 2011 21.6485 10.21503 4.75** 
White 1180 21.3865 10.26815  
Hispanic 594 20.6237 9.94247  
Multi-racial/other 85 17.9565 8.60248  
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Post-hoc comparisons: Tukey HSD 
 
 Race/ethnicity 1 Race/ethnicity 2 Mean 
difference 
Std. Error Sig. 
Original data Black Hispanic .11462 .39087 .991 
Black White .49894 .52647 .779 
Black Multi-racial/other 4.07495 1.24000 .006 
Hispanic White .38432 .56410 .904 
Hispanic Multi-racial/other 3.96033 1.25644 .009 
White Multi-racial/other 3.57601 1.30501 .031 
Imputation 1 Black White .21323 .37417 .941 
Black Hispanic 1.02334 .47145 .132 
Black Multi-racial/other 2.88226 1.10673 .046 
Hispanic White .81011 .50962 .385 
Hispanic Multi-racial/other 2.66903 1.12352 .082 
White Multi-racial/other 1.85892 1.15955 .377 
Imputation 2 Black Hispanic .14001 .37258 .982 
Black White .68993 .47654 .470 
Black Multi-racial/other 2.50536 1.08406 .096 
Hispanic White .54992 .51258 .706 
Hispanic Multi-racial/other 2.36534 1.10038 .138 
White Multi-racial/other 1.81543 1.13979 .383 
Imputation 3 Black Hispanic .03947 .37246 1.000 
Black White .87400 .47523 .255 
Black Multi-racial/other 3.41969 1.14463 .015 
Hispanic White .83453 .51210 .362 
Hispanic Multi-racial/other 3.38022 1.16042 .019 
White Multi-racial/other 2.54569 1.19737 .145 
Imputation 4 Black Hispanic .20257 .37259 .948 
Black White 1.05407 .47506 .118 
Black Multi-racial/other 3.98636 1.09988 .002 
Hispanic White .85151 .51192 .343 
Hispanic Multi-racial/other 3.78379 1.11630 .004 
White Multi-racial/other 2.93228 1.15455 .054 
Imputation 5 Black Hispanic .06988 .37156 .998 
Black White .98869 .47174 .155 
Black Multi-racial/other 4.24738 1.14414 .001 
Hispanic White .91881 .50683 .267 
Hispanic Multi-racial/other 4.17750 1.15905 .002 
White Multi-racial/other 3.25869 1.19494 .033 
Imputation 6 Black Hispanic -.17239 .37153 .967 
Black White 1.10398 .47513 .093 
Black Multi-racial/other 3.13553 1.10643 .024 
Hispanic White 1.27637 .51015 .060 
Hispanic Multi-racial/other 3.30792 1.12191 .017 
White Multi-racial/other 2.03155 1.16034 .298 
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 Race/ethnicity 1 Race/ethnicity 2 Mean 
difference 
Std. Error Sig. 
Imputation 7 Black Hispanic .01701 .37375 1.000 
Black White .69596 .47535 .459 
Black Multi-racial/other 2.34938 1.07289 .126 
Hispanic White .67895 .51282 .548 
Hispanic Multi-racial/other 2.33237 1.09001 .141 
White Multi-racial/other 1.65342 1.12889 .459 
Imputation 8 Black Hispanic -.02939 .37214 1.000 
Black White .57847 .47907 .622 
Black Multi-racial/other 3.58478 1.07758 .005 
Hispanic White .60785 .51530 .640 
Hispanic Multi-racial/other 3.61417 1.09417 .005 
White Multi-racial/other 3.00632 1.13500 .040 
Imputation 9 Black Hispanic .06718 .37364 .998 
Black White .69528 .47296 .456 
Black Multi-racial/other 4.63214 1.13692 .000 
Hispanic White .62811 .51166 .609 
Hispanic Multi-racial/other 4.56497 1.15355 .000 
White Multi-racial/other 3.93686 1.18944 .005 
Imputation 10 Black Hispanic .26207 .37248 .896 
Black White 1.02480 .47435 .135 
Black Multi-racial/other 3.69199 1.12479 .006 
Hispanic White .76273 .51101 .442 
Hispanic Multi-racial/other 3.42992 1.14074 .014 
White Multi-racial/other 2.66719 1.17794 .107 
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APPENDIX M 
 
Seasonal patterns in treatment frequency: GLM with imputed data 
 
 Model 1 
 Pooled B (SE) 
Month  
     January -.86 (.76) 
     February -1.82 (.79)* 
     March -1.77 (.73)* 
     April -1.93 (.78)* 
     May -.42 (.79) 
     June -.60 (.85) 
     July -.91 (.84) 
     August .28 (.73) 
     September 1.17 (.74) 
     October -.41 (.74) 
     November .40 (.76) 
     December ref 
Year .73 (.06)*** 
Age -.39 (.04)*** 
Female -2.32 (.33)*** 
Race/Ethnicity  
     Black ref 
     Hispanic -.42 (.39) 
     White -.27 (.50) 
     Multi-racial/other -3.08 (1.31)* 
Insurance  
     Medicaid ref 
     HSN -2.86 (1.25)* 
     Private -1.48 (.41)*** 
Comorbidity .43 (.09)*** 
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APPENDIX N 
 
Association between any outpatient treatment and psychiatric ED presentation: Pooled 
results from binary logistic regressions with imputed data 
 
 Model 1 Model 2 
 OR 95% CI OR 95% CI 
Female 1.39*** 1.31, 1.47 1.39*** 1.31, 1.48 
Race/ethnicity     
     Black ref - ref - 
     Hispanic .79*** .73, .85 .79*** .73, .85 
     White .59*** .54, .64 .58*** .54, .63 
     Multi-racial/other 1.02 .89, 1.18 1.02 .88, 1.18 
Lifetime use of Medicaid .87** .80, .94 .89** .81, .96 
Lifetime use of safety-net care 1.77*** 1.63, 1.93 1.79*** 1.64, 1.95 
Lifetime use of private insurance .85*** .79, .92 .87*** .81, .94 
Comorbidity 1.23*** 1.21, 1.26 1.28*** 1.25, 1.31 
Outpatient service use   .70 .64, .76 
 
 
  
 218 
APPENDIX O 
 
Association between any outpatient treatment and number of psychiatric ED visits: 
Pooled results from linear regression models with imputed data 
 
 Model 1 Model 2 
 B SE B SE 
Female .10*** .01 .10*** .01 
Race/ethnicity     
     Black ref - ref - 
     Hispanic -.13*** .02 -.13*** .02 
     White -.20*** .02 -.21*** .02 
     Multi-racial/other -.09** .03 -.09** .03 
Lifetime use of Medicaid .02 .02 .03 .02 
Lifetime use of safety-net care .15*** .02 .15*** .02 
Lifetime use of private insurance -.03 .02 -.02 .02 
Comorbidity .22*** .01 .24*** .01 
Outpatient service use   -.14*** .02 
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APPENDIX P 
 
Psychiatric ED presentation among youth who received outpatient treatment: Pooled 
results from Cox proportional hazards models with imputed data 
 
 Model 1 Model 2 
 λ 95% CI λ 95% CI 
Age 1.00 .98, 1.02 .98 .96, 1.00 
Female 1.24** 1.06, 1.45 1.28** 1.10, 1.50 
Race/ethnicity     
     Black ref - ref - 
     Hispanic .99 .83, 1.18 1.02 .85, 1.21 
     White .67** .51, .89 .68** .51, .90 
     Multi-racial/other .66 .37, 1.17 .70 .39, 1.24 
Insurance     
     Medicaid ref - ref - 
     Health safety-net 1.18 .68, 2.05 1.31 .75, 2.27 
     Private .67*** .54, .82 .71** .57, .88 
Comorbidity 1.50*** 1.45, 1.56 1.47*** 1.41, 1.52 
# previous ED visits   1.42*** 1.33, 1.52 
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APPENDIX Q 
 
Continuity of outpatient treatment and subsequent psychiatric ED presentation: Pooled 
results from Cox proportional hazards models with imputed data 
 
 Model 1 Model 2 
 λ 95% CI λ 95% CI 
Age 1.00 .98, 1.02 1.00 .98, 1.02 
Female 1.40*** 1.20, 1.64 1.39*** 1.19, 1.63 
Race/ethnicity     
     Black ref - ref - 
     Hispanic 1.01 .85, 1.21 1.03 .86, 1.22 
     White .73* .55, .98 .70* .53, .94 
     Multi-racial/other .80 .45, 1.43 .80 .45, 1.42 
Insurance     
     Medicaid ref - ref - 
     Health safety-net 1.29 .74, 2.24 1.30 .75, 2.25 
     Private .78* .63, .97 .77* .62, .96 
Comorbidity 1.36*** 1.30, 1.41 1.36*** 1.31, 1.41 
# previous ED visits 1.44*** 1.35, 1.55 1.45*** 1.35, 1.55 
# previous treatment periods 1.25*** 1.21, 1.29 1.25*** 1.22, 1.29 
Treatment duration (days) 1.00*** 1.00, 1.00   
Treatment quantity (visits)   1.02*** 1.02, 1.02 
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APPENDIX R 
 
Continuity of outpatient care and subsequent psychiatric ED presentation: Pooled results 
from Cox proportional hazards models with imputed data 
 
 Model 3 Model 4 
 λ 95% CI λ 95% CI 
Age 1.01 .99, 1.04 1.01 .99, 1.04 
Female 1.20 .99, 1.47 1.20 .99, 1.47 
Race/ethnicity     
     Black ref - ref - 
     Hispanic .79 .63, 1.01 .80 .62, 1.01 
     White .65* .45, .92 .62** .43, .88 
     Multi-racial/other 1.07 .53, 2.17 .59 .26, 1.34 
Insurance     
     Medicaid ref - ref  
     Health safety-net 1.07 .53, 2.17 1.15 .57, 2.32 
     Private .82 .61, 1.09 .81 .61, 1.08 
Comorbidity 1.36*** 1.29, 1.44 1.32*** 1.25, 1.40 
# previous ED visits 1.34*** 1.22, 1.47 1.36*** 1.24, 1.49 
# previous treatment periods 1.18*** 1.13, 1.23 1.20*** 1.15, 1.25 
Treatment quantity (visits)   1.02*** 1.01, 1.02 
Treatment frequency (days) 1.01 1.00, 1.02 1.01* 1.00, 1.02 
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